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ABSTRACT OF THE THESIS
The uptake and metabolism of the vitamers pyridoxine and
pyridoxal by T.brucei (TREU 55) was investigated. The results of
these investigations indicate that these vitamers are taken up by
simple diffusion followed by metabolic trapping. Beth pyridoxine and
pyridoxal were found to be metabloised to pyridoxal phosphate in
whole cells. The majority of pyridoxal taken up appears to remain as
pyridoxal (perhaps protein bound) the remainder being slowly
phosphorylated to pyridoxal phosphate by pyridoxal kinase.The
majority of pyridoxine taken up was found to be rapidly metabolised
to pyridoxal. Evidence was also found supporting the hypothesis that
pyridoxine may be phosphorylated to pyridoxine phosphate and then
rapidly converted to pyridoxal phosphate.
The uptake of adenosine, adenine and hypoxanthine by T.brucei
(TREU 55) was also investigated and found to be mediated by high
affinity active transport systems (Km < 1jiM). The presence of two
(possibly three) separate transporters at the level of the plasma
membrane was demonstrated by the use of nucleoside analogue
inhibitors of uptake which showed differing affinities for each of
the transporters. The adenosine transport protein has been
tentatively identified one or possibly two proteins with molecular
weights of 51 and 57KDa by affinity labelling experiments using
radiolabelled dialdehyde adenosine as a probe for the transport
protein. These experiments were carried out using both whole cells
and partially purified plasma membranes.
The metabolism of adenosine, adenine and hypoxanthine to
nucleotides was also investigated. Adenosine was found to be very
rapidly metabolised to adenine in a cell lysate by adenosine
-IX-
hydrolase as opposed to a phosphorylase as is normally found in
mammalian tissues. The adenine formed in this reaction was shown to
be converted to AMP by the action of adenosine
phosphoribosyltransferase. Hypoxanthine was also rapidly converted
to nucleotide (IMP) by a hypoxanthine phosphoribosyl transferase
which as in mammalian systems appeared to show some specificity
towards guanine as substrate.
The transport systems for adenosine, adenine and hypoxanthine
appeared to be under some form of control since uptake was shown to
stop after two minutes although metabolism of the material already
taken up continued. Preliminary results are presented which
implicate phosphorylation by a protein kinase as the regulatory
mechanism since high levels of AMP have been shown to stimulate the
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1. INTRODUCTION
1.1 NATURAL HISTORY OF SLEEPING SICKNESS AND CONTROL OF
THE DISEASE.
African sleeping sickness (trypanosomiasis) is caused by
trypanosomes of the brucei group which are not limited to Africa but
are spread throughout the world (Ormerod,1979). T.rhodesiense and
T.gambiense are responsible for the acute and chronic forms of the
human disease respectively. T.brucei appears to be infective only to
cattle, some game animals and rodents.
Both human and cattle forms (Nagana) of Trypanosomiasis are
major health and economic problems in Africa. It is estimated that
some 20,000 people die from this disease per year and since 1974
83,000 head of cattle have died, at a cost of^J 11 million, from the
disease in the North-East of Africa alone. The disease is transmitted
by an insect vector, the tse-tse fly, which in Mozambique and
2
Zimbabwe is extending its range at a rate of 10km per year since
independence wars and cutbacks in control measures. The affected area
2
covers 322,000 km which at present supports 650,000 head of cattle
which could be increased to 6.7 million head if the tse-tse fly or
trypanosomes were eliminated.
Eradication of the tse-tse fly is to be attempted by spraying
vast areas of Zimbabwe, Zambia, Malawi and Mozambique with the
insecticide, Endosulfan. Initial trials are to be conducted by
2
spraying 20,600 km although the effects of such large scale spraying
on the ecosystem are unknown. Alternatives to spraying have been
considered such as the release of sterile male flies (Dame,1970). The
main problems with this approach are the reduction of the fly






Figure 1.1 LIFE CYCLE OF THE AFRICAN TRYPANOSOMAS
After Gutteridge (1977 )•
and the production of sterile male flies in sufficient numbers
(WHO,1977).
Another method for control of the disease is to remove the
reservoir of infection, which in largely agricultural areas resides
in man and his domestic animals, by selective chemotherapy. This
method would not work in the bush area since the reservoir of
infection resides in the wild game animals. Unfortunately there are
few drugs available for this strategy, those in use being suramin and
pentamidine for prophylaxis and cure in early stages of the disease
with melarsoprol and nitrofurazone used for curative purposes in the
late stages of the disease. The melaminyl arsenical drugs are used in
the late stages of the disease since of the drugs listed above only
they are capable of crossing the blood brain barrier. These drugs
also have serious side-effects and resistant strains of trypanosomes
are beginning to appear in the wild. These problems can only be solved
by the development of new drugs (see Van den Bossche( 1978) and Marr
et al.(1978b) ).
1.1.1 Life Cycle of the African Trypanosomes.
The life cycle of the pleomorphic African trypanosomes can be
considered in two parts. The insect stage and the mammalian host
stage, as summarised in Figure 1.1. When a tse-tse fly takes a blood
meal from an infected mammal short stumpy trypomastigotes are
ingested and lodge in the fly's gut where they differentiate into
procyclic forms which are biochemically equivalent to culture forms
of trypanosomes. The metabolic potentials of each of the
morphological forms encountered in the life cycle are summarised in
Table 1.1. In the gut of the fly the procyclic forms divide by
-2-































Growth temperature ( C) 37 37 25
+, present absent. Based on Table lof Guttaridge and
Rogerson (1979).
longitudinal binary fission and eventually migrate to the fly's
salivary glands where they differentiate further into the
epimastigote form and the metacyclic form which is infective to
mammals. The mammalian host is infected when the fly takes a blood
meal and metacyclic forms are released from the fly's salivary
glands. In the host bloodstream the trypanosomes differentiate into
the long slender trypornasigote form which lacks the TCA cycle enzymes
(see Table 1.1) and divides by longitudinal binary fission. As the
numbers of trypomastigotes in the host's bloodstream increases a
fever results until the host's immune system recognises the infection
and destroys the trypanosomes. However not all of the trypanosomes
are destroyed since they have the ability to change their antigenic
glycoprotein coat which covers the cell surface. This ability to
evade the host's immune system results in repeated bouts of fever the
frequency of which depends on the trypanosome species causing the
infection. The process of antigenic variation has been recently
reviewed by Turner(1982) as has the mechanism of release of the
glycoprotein coat (Turner et al.,1985). This antigenic variation
allows a relapsing parasitaemia to continue until the long slender
trypomastigotes invade the host's central nervous system which
eventually results in death if not treated. As the numbers of long
slender trypomastigotes increase a certain proportion differentiate
into short stumpy trypomastigotes which are infective to the tse-tse
fly so completing the life cycle.
1.1.2 Glycolysis in Bloodstream Trypanosomes.
The changes in trypanosomal metabolism which occur during the
life cycle are summarised in Table 1.1 which shows that in the
-3-








































The scheme was constructed frcm results published by Oduro (1977)j
Opperdoas at al. (1977) and Opperdoes and Borst (1977)
mammalian bloodstream the trypanosomes rely totally on glycolysis for
their ATP production. The general metabolism of glucose and the
distribution of the glycolytic enzymes in bloodstream forms of
T.brucei are shown in Figure 1.2. It has been suggested that the
enzymes of glycolysis ( hexokinase to phosphoglycerate kinase) are
contained within the glycosome to maintain optimal concentrations of
enzymes, subtrates and co-factors for glycolysis. (Opperdoes &
Borst,1977; Oduro,1977). Similar glycosome like organelles have been
identified in C.fasciculata and T.cruzi leading to the suggestion
that the glycosome is a feature of all the Kinetoplastida (Taylor
et al.,1980a).
1.2 UPTAKE AND TRANSPORT : GENERAL CONSIDERATIONS.
Throughout this thesis the following distinctions are made
between uptake and transport. "Uptake" is used to denote accumulation
of exogenously added radiolabelled substrate regardless of any
metabolic conversions of the substrate, in the same sense as used by
Berlin and 01iver(1975). "Transport" is used when describing the
transfer or translocation of a substrate across a membrane as
mediated by a saturable selective carrier. The action of this carrier
may or may not be dependent on an energy source. If transport is
dependent on an energy source other than a concentration gradient of
substrate across the membrane and free unmetabolised substrate
accumulates against its concentration gradient, it will be described
as "active transport".
1.2.1 Methods of Uptake and Transport.
Uptake of solutes from the external environment can occur by
-4-
three different mechanisms as listed below.
1) Uptake may be by simple non-carrier mediated diffusion
with or without subsequent trapping by metabolism or intracellular
binding. This' method of uptake does not involve a transport step as
defined above (Section 1.2).
2) Uptake may be mediated by facilitated diffusion involving
the transport of the solute across the membrane by a carrier
molecule. This mechanism of uptake may or may not involve metabolism
of the transported solute in order to maintain a gradient of solute
across the membrane.
3) Uptake may be mediated by an active transport system
involving a solute carrier in the membrane, as for facilitated
diffusion, but in this case the system is capable of accumulating
solute against its concentration gradient by using an energy source
to drive transport. Active transport is therefore not dependent on
metabolism of the solute taken up to maintain a favourable
concentration gradient for uptake. Each of the above transport and
uptake systems will now be considered in more detail.
Uptake by simple diffusion is exemplified by the uptake of
neutral lipophilic compounds which can diffuse through the
hydrophobic lipid bilayer of a membrane. The uptake of salicylic acid
from the stomach by the epithelial cells of the stomach lining is by
diffusion. In the acid environment of the stomach the weak acid
becomes protonated which abolishes the negative charge of the free
carboxyl group allowing the salicylate to partition into the plasma
membranes of the stomach epithelial cells. From the plasma membrane
the salicylate diffuses into the cytoplasm of the cells where it
dissociates at the higher intracellular pH once again becoming
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negatively charged preventing exit back through the plasma membrane.
The rate of uptake by diffusion is therefore limited by the solute's
partition co-efficient between the aqueous phase and the lipid phase
of the membrane and also its pK if a weak acid or base (Leib &
Stein, 1971; Graff et al.,1977). Once the solute has entered the cell
it may be metabolised which will maintain a concentration gradient of
solute across the membrane allowing diffusion to continue. In the
case of a weak acid, such as salicylate, the solute may be
accumulated against its concentration gradient without metabolism if
the pH inside the cell is higher than outside. This occurs since it
is the protonated form of the acid which diffuses across the membrane
to equilibrium and at the higher intracellular pH dissociates
according to its pKa therefore more of the solute will be required on
the cytoplasmic side of the membrane to give equal concentrations of
the protonated form across the membrane. This effect is described in
more detail in Section 2.19 as a useful tool in the measurement of
ApH across a membrane. Uptake by simple diffusion is usually
characterised by being non-saturable, non-inhibitable by solute
analogues and showing little temperature dependence.
Facilitated diffusion differs from simple diffusion, described
above, in that a carrier molecule is involved in the translocation of
the solute across the membrane. Once the solute has entered the cell
the diffusion gradient may be maintained by metabolism of the solute.
It is also possible that the transported solute or another solute
with affinity for the carrier may recombine with the carrier and be
transported back across the membrane. This effect can be of use in
determining the initial rates of transport in metabolically enfeebled
cells as described in Section 1.2.2. Facilitated diffusion is
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incapable of accumulation of solute against its concentration
gradient but allows diffusion of the solute across the membrane to be
independent of the lipid solubility of the solute. Facilitated
diffusion is characterised by the ability to saturate transport and
by transport rates showing marked temperature dependence. The
specificity also allows inhibition of transport by analogues of the
carriers natural substrate or substrates. Examples of facilitated
diffusion are detailed in Section 1.2.2.
Active transport, like facilitated diffusion, is mediated by a
specific carrier molecule in the membrane, the nature of which is
determined by the energy source to which transport is coupled. Active
transport can be subdivided into three different types.
a) The transport of a solute may require the direct
hydrolysis of one or more ATP molecules.
b) The transport of a solute may be coupled to a
pre-existing gradient of another solute across the membrane or which
is established by another transport system.
c) The transport of a solute may be concomitant with the
solutes metabolism.
The first type (a) of active transport is restricted to the
translocation of ions across a membrane as typified by the
Na+/K+-ATPase, H+-ATPase and the Ca2+-ATPase of plasma membranes,
mitochondria, chloroplasts and sarcoplasmic reticulum of striated
muscle cells. These transport systems are responsible for the
maintenance of the internal ionic environment of the cell,synthesis
of ATP,generation of ion gradients to be used by type b transports as
defined above and control of muscle contraction depending on their
location and the organism in which they are found. The Na+/K+-ATPase
-7-
is responsible for the maintenance of a membrane potential in most
animal cells and regeneration of the membrane potential in nerve
cells after conduction of an action potential, which involves influx
of Na+and efflux of K+(Korenbrot, 1977). The Na+ and K+ gradients
generated by this ion pump can be used as energy sources for
co-transport of other solutes in kidney proximal tubular epithelial
cells and intestinal epithelium. (See Section 1.2.2).
Proton translocating ATPases can be differentiated into two types,
the plasma membrane type involved in generating ion gradients for b
type active transport systems (Goffeau & Slayman,1981;
Villalobo,1982) or the ATP synthetase type typical of mitochondria,
bacteria and chloroplasts (Fillingame,1981; Njus et al., 1981;
Nelson,1981). The bacterial H+-ATPase can work in either direction,
generating a proton gradient for use in transport or using a proton
gradient for the synthesis of ATP. In anaerobic bacteria the ATPase
functions to generate a proton gradient for use in transport
(Abrams,1976).
2+
The Ca -ATPase of the sarcoplasmic reticulum is responsible for
control of striated muscle contraction by controlling cytoplasmic
concentrations of calcium ion as reviewed by Korenbrot( 1977). Many
different cell types have been shown to possess a plasma membrane
2+
Ca -ATPase which keeps cytoplasmic calcium ion concentrations below
2+
1/iM. The functions,properties and distributions of the Ca -ATPases,
and the other ATPases mentioned above, are extensively reviewed in
"Transport ATPases" (Annals of the New York Academy of Science
vol.402 (1982)).
The final type of active transport to be considered, involving
concomitant transport and metabolism (type c), is referred to as
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group translocation. The best characterised system of this type is
the phosphotransferase system for sugar transport in E coli . The
details of this active transport mechanism are reviewed by
Oxender(1972) and Boos(1974). The net result of transport is that a
sugar molecule is translocated across the bacterial plasma membrane
and at the same time is phosphorylated via a series of reactions
involving phosphate transfer from the glycolytic intermediate,
phosphoenol pyruvate.
Having outlined the various types of transport which can occur
in prokaryotic and eukaryotic cells, methods of investigating these
systems will be considered.
1.2.2 Methods of Investigating Uptake and Transport.
Investigation of transport as distinct from uptake can be
complicated by metabolism or catabolism of the solute once it has
entered the cell. This problem has been well documented in the case
of nucleoside transport in animal cells. It has been found that
uptake of nucleosides by animal cells is apparently linear over a
time period of 1-10 minutes (Plagemann,1971a&b; Plagemann &
Richey,1974; Zylka & Plagemann,1975; Loike & Horwitz,1976; Lynch
et al. ,1978: Mizel & Wilson, 1972; Paterson e_t _al., 1975; Schuster &
Hare,1971). It was therefore assumed that measurements of the rates
of uptake in this time period were a reflection of the initial rates
of transport from which the kinetic parameters of transport were
estimated. The assumption that initial rates of transport were being
measured was supported by the observation that simple
Michaelis-Menten kinetics were obeyed which was suggestive of a
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single, saturable, rate-limiting step for uptake and also the kinetic
constants measured for uptake were lower than those measured for the
metabolism of substrate in cell lysates. It was also noted that the
concentration ratio of substrate inside:outside never exceeded unity.
These observations supported the view that uptake occurred by
facilitated diffusion followed by metabolic trapping. However it was
found that the experiments, in which uptake rates were being measured
over a time period greater than one minute, were measuring the rates
of formation of nucleotide at steady state intracellular
concentrations of nucleoside (Wohlhueter et al.,1976 & 1979;
Plagemann,1971b; Lum et al., 1979; Marz et aJ., 1979). These authors
showed that transport allowed equilibration of intra- and
extracellular substrate within a few seconds at substrate
concentrations below or near to the Km for transport.
Measurement of initial rates of uptake may therefore require
methods which allow very short incubation times and rapid sampling.
It is also advantageous if metabolism of the transported solute can
be reduced or eliminated. Reduction of metabolism can be accomplished
by using mutant cell lines deficient in the enzymes required for
metabolism of the transported solute, a method first used in
mammalian cells by Kessel & Shurin(1968) using a mouse leukemia cell
line. This technique has since been applied by many authors in the
study of nucleoside transport.(Lieu et_ al.,1971; Plagemann
jet_ _al., 1978; Witney & Taylor, 1978; Murphy et al.,1977)
Metabolism of substrates which require ATP or PRPP can be
reduced if cellular ATP is depleted by preincubation of the cells in
glucose free media containing KCN and iodoacetate (Plagemann &
Erbe,1973; Plagemann et al.,1976; Wolhueter et al.,1978). This method
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has the disadvantage that it may decrease cellular integrity
(Plagemann et al.,1976; Gazitt et al.,1976). Substrate metabolism may
also be reduced by the use of enzyme inhibitors specific for the
metabolising enzymes. However this requires that the inhibitors used
do not have any effect on transport (Lum et al.,1979).
A third method of reducing the interference of metabolism when
measuring transport rates is to use non-metabolisable substrates for
the transport assay (Kessel,1978; Ungenmach & Hegner, 1978). However
this method requires that the analogue used in the transport assay
uses the same carrier to enter the cell as the substrate being
investigated and of course all kinetic parameters estimated apply
only to the analogue used and may bear little relation to the
parameters of transport for the natural substrate.
Reduction of metabolism makes the assay of transport alone less
difficult but since the carriers may allow the equilibration of
substrate across the membrane in a matter of seconds rapid sampling
techniques are still required if initial rates of transport are to be
measured. Many methods have been devised for the determination of
initial rates of transport, the most frequently used being described
below. In experiments in which the influx of substrate into the cell
is measured the cells can be removed from the external medium by
centrifugation through an inert oil layer such as silicon oil with a
density greater than that of the incubation medium but less than that
of the cells. The amount of substrate taken up or transported can be
measured in the cell pellet or, depending on the amounts taken up,
the depletion of substrate in the incubation medium can be measured.
This procedure has been applied to measurements of the distribution
of various compounds across mitochondrial membranes (Werkheiser &
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Bartley,1957), the influx of labelled uridine into erythrocytes
(Oliver & Paterson,1971) and nucleoside and base influx in cultured
cells (Wohlhueter et_ al., 1976 & 1978; Ungenmach & Hegner, 1978;
Strauss et al_., 1976; Pofit & Strauss, 1977) .This technique was also
used in a study of the uptake of the trypanocidal drug pentamidine by
trypanosomes (Damper and Patton, 1976a). This technique has the
advantage that the cells can be centrifuged into various stopping
solutions of the appropriate density which can stop metabolism of any
substrates transported. The main disadvantage of this technique is
that the cells carry some of the incubation medium containing
substrate through the oil phase giving an over-estimate of transport
or uptake. This carry-through can be corrected for by including a
labelled compound in the incubation medium which can not penetrate
the cells, such as inulin or L-glucose.
Cells cultured on glass cover slips can be used in rapid assays
of transport since they can be dipped into incubation medium
containing the compound to be transported for a few seconds and then
rinsed in ice cold buffer. This technique obviously requires that the
cells being studied can be cultured fixed to glass, but it also
suffers from a more serious drawback. During the rinse in buffer,
even at low temperatures, efflux of transported substrate is a major
consideration. It has been calculated that Novikoff cells treated in
this way could lose upto 50% of their thymidine pool during a A3
second wash period (Wohlhueter _et_ al., 1979). Another disadvantage of
this technique is the small amount of material which can be used in
any one assay.
Rapid filtration of cells from the suspending medium by
"Millipore" filters has also been used as a sampling technique for
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estimating efflux of substrates from preloaded cells by measuring
substrate released into the filtrate (Cabantchik & Ginsburg, 1977).
Estimation of transport or uptake by this method suffers from
problems of quantitative estimation of substrate taken up due to high
and inconsistent background binding of radiolabeled substrates to
the filters, (Section 3.1).
The use of accelerated exchange diffusion (carrier mediated) has
been used to measure the kinetic parameters of nucleoside transport
in many types of animal cell. This method involves loading cells with
radiolabelled substrate and measuring the rates of efflux of this
substrate in response to different concentrations of a second
substrate which uses the same carrier. The labelled substrate can be
present on either side of the membrane in this type of experiment.
The various experimental protocols which can be used in this type of
assay have been extensively reviewed by Plagemann & Wohlhueter(1980)
and Young & Jarvis(1983). This type of experiment requires that many
substrates use the same transporter and that there is no metabolism
of any of the substrates used.
The methods of analysis of transport described above are
applicable to estimation of the kinetic properties of transport
systems. However other methods are required for more detailed
investigations of transport and uptake systems. Identification and
purification of carrier molecules requires assay systems for
measuring the activity of the carrier as it is purified and methods
of labelling the carrier so that it can be identified. The hexose
transporter of erythrocytes was purified using reconstitution of
transport activity into phospholipid vesicles as an assay of the
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amount of carrier present (Kasahara & Hinkle, 1976 & 1977). This
method was also applied in the purification of the anion channel from
erythrocytes (Ross & McConnell,1977) and the ATP/ADP nucleotide
carrier of mitochondria (Schertzer & Racker,1976). Identification of
the transport protein can be accomplished by radiolabelling the
transporter with reactive radioactive analogues of transported
substrates or tightly binding inhibitors of transport. The anion
channel of the erythrocyte was identified by radiolabelling the
channel with the channel blockers SITS and DIDS (Cabantchick &
Rothstein, 1974). This methodology has also been applied to the
identification of the protein responsible for ATP/ADP exchange across
the mitochondrial membrane using the radiolabelled inhibitors
atractyloside and bongkrekic acid (Brandolin et_ al_., 1974; Block
_et_ al., 1981). The nucleotide transporter of the bovine chromaffin
granule has been identified by labelling with the radioactive
reactive substrate analogues _p-fluorosulphonyl adenosine and 8-azido
ATP (Gruniger,1982). A variation on this labelling technique was used
to identify the protein associated with lactose permease activity in
14
E.coli. by labelling it with N-[U- C] ethylmaleimide after
protecting it with substrate during a pre-incubation with unlabelled
N-ethylmaleimide (Fox & Kennedy,1965).
Effects of temperature on uptake and transport can provide
information as to the type of transport system operating, if one is
present, and its environment. The value of the activation energy
calculated from an Arrhenius plot of transport or uptake rates can
give an indication as to whether substrate entry into the cell is
carrier— mediated or by simple diffusion (Dixon & Webb,1964; Goldman
et al.,1968; Damper & Patton, 1976b). Sharp breaks in Arrhenius plots
-14-
may be a reflection of temperature dependent phase transitions in
the lipid phase of the membrane. A change from liquid crystalline
state to fluid state would result in a lowering of the activation
energy of transport if the transport mechanism requires movement of
the carrier protein (Plagemann & Erbe,1975; Stein & Rozengurt,1975;
Zylka & Plagemann,1975)
The methodologies described above are applicable to the study of
active transport systems, but since active transport is coupled to an
energy source it is susceptible to inhibition by methods other than
those described above. It has been shown that nucleoside transport in
E.coli. K12 (Munch-Petersen & Pihl,1980) E.coli. B (Roy-Burman
et_ al.,1978) and S.typhimurium (Rader & Hochstadt,1976) is coupled to
a proton gradient which is generated by proton pumping electron
transport chains. This makes uptake susceptible to inhibition by
metabolic inhibitors which interfere with electron transport such as
sodium azide or protonophores which render the plasma membrane
permeable to protons such as 2,4-dinitrophenol and FCCP. The lactose
permease (West & Michell,1973) and dicarboxylic acid (Ramos &
Kabach,1977) transport systems of E.coli are also coupled to proton
gradients and show the same susceptibility to inhibition by electron
transport inhibitors and protonophores. The bacterium Halobacterium
halobium uses a light driven proton pump (bacterial rhodopsin) to
generate a transmembrane proton gradient (Bogomolni et al.,1976),
which in turn maintains a gradient of Na+ across the membrane using a
sodium proton antiport system to pump sodium ions out of the cell
(Lanyi & MacDonald,1976). Vesicles can be prepared from the membrane
of this organism which are capable of accumulating amino-acids
against their concentration gradients when illuminated. The uptake of
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the amino acid glutainate appears to be dependent on the presence of a
sodium ion gradient alone, sodium ions being co-transported across
the membrane (Lanyi et_ al_., 1976). Other amino-acids transported
appear to be dependent on the sodium ion gradient and a membrane
potential generated by the ion pumps. The requirement for a membrane
potential was shown by the use of ionophores such as valinomycin and
gramicidin which are capable of allowing selected ions (depending on
the ionophores specificity) to pass across the membrane and so
collapse or generate membrane potentials depending on the
experimental conditions. The properties and specificities of most of
the commonly used ionophores are reviewed by Pressman(1976). Many
other bacterial transport systems have been shown to be dependent on
Na+ or H+ gradients. Melibiose and glutamate transport in E.coli are
dependent on a sodium gradient (Tsuchiya etal.,1977a & 1977b) as are
the proline transport system in Mycobacterium phlei (Hirata
et al.,1974) and melibiose in Salmonella (Tokuda & Kaback, 1977). The
transport of lactate and alanine (Collins et_ al.,1976) and
accumulation of galactosides (Flagg & Wilson,1976) in E.coli are
driven by a pH gradient across the plasma membrane. The various
methods, both hypothetical and proven, for coupling transport of
solutes to metabolism via proton and other ion gradients in
microorganisms has been comprehensively reviewed by Eday(1978).
Some of the transport systems described above have been
investigated in preparations of membrane vesicles. This technique is
described in detail by Muner & Kine(1980) as applied to mammalian
cells but the principles apply to all cell types if vesicles can be
made from their plasma membranes.
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Active transport in eukaryotic cells has also been shown to be
coupled to ion gradients and membrane potentials. The best studied
mammalian systems are those for the transport of amino acids and
glucose by intestinal epithelial cells in which these solutes are
taken up by co-transport with sodium ions (Kaunitz et_ al_., 1982) and
glucose Na+ co-transport by the proximal tubule of the kidney (Hopfer
& Groseclose,1980; Koepsell; _et al., 1983). These systems are
susceptible to inhibition and manipulation in the same manner as the
bacterial systems already described.
In summary the active transport systems described above which
are dependent on ion gradients and membrane potentials can be
investigated by using ionophores to manipulate the membrane potential
and magnitude of the ion gradients. The use of specific ionophores is
detailed in Sections 3.6 to 3.6.8.
Having described the methods available for the study of
transport and uptake of solutes their application to the study of the
transport systems of trypanosomes will now be considered.
1.2.3 Trypanosomal Transport Systems.
Since trypanosomes are parasitic organisms they rely on their
hosts to provide many of the nutrients they require. The African
trypanosomes, for example, are incapable of de novo synthesis of the
purine ring (Fish et al.,1982a) as are T.cruzi (Berens et al., 1981;
Gutteridge & Gaborak,1979) and Leishmania spp. (Marr et al.,1978a).
They therefore obtain all their purines from the host organism. For
this purpose they have evolved transport systems for the uptake of
these nutrients. The transport of purine nucleosides and bases and
their subsequent metabolism will be considered in detail in Section
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1.4.1. The most extensively studied uptake systems in trypanosomes
are the carbohydrate and amino acid uptake systems. These systems
will be considered in turn.
The uptake and transport of glucose and other carbohydrates by
trypanosomes have received very little attention compared to the
metabolism of these compounds. Carbohydrate transport has been shown
to be carrier-mediated in T.gambiense (Southworth & Read, 1969 & 1970)
and T.rhodesiense (Seed et al_., 1965) and the specificities of the
carriers investigated. The results presented by Southworth &
Read(1969 & 1970) indicate the presence of two loci for the uptake of
carbohydrate, one specific for the uptake of glucose, mannose and
glycerol, the other specific for fructose and glucosamine. These
specificities differ from those reported by Ruff & Read(1974) for
T.equiperdum which was found to have two loci for carbohydrate
transport but one specific for hexoses and one for glycerol. The
transport of glucose across the trypanosomal plasma membrane has been
shown to be the rate limiting step in glucose metabolism by Gruenberg
_et_ al_. ( 1978) who also showed that glucose transport was by
facilitated diffusion. The glucose transported was rapidly
phosphorylated by hexokinase so maintaining a diffusion gradient for
glucose across the membrane. This facilitated diffusion uptake
contrasts with the active transport of glucose by Leishmania donovani
(Zilberstein & Dwyer.1984) indicated by this organism's ability to
accumulate glucose and the partially metabolised glucose analogue,
2-deoxyglucose, against their concentration gradients. The transport
can be inhibited by metabolic poisons and the uncoupler
2,4-dinitrophenol which suggests the coupling of transport to an
energy source, the nature of which has yet to be elucidated.
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The uptake of amino acids by T.brucei has been shown to be a
carrier-mediated process for the amino-acids lysine, glycine, alanine
and leucine although at high concentration (>1.0mM) leucine ana
lysine uptake appears to be by simple diffusion. The uptake of
ornithine, aspartate, arginine and glutamate did not show saturation
kinetics suggesting that they enter the cell by passive diffusion
(Southworth & Read,1972). The apparent diffusion of leucine and
lysine at high concentrations may be due to increasing the
intracellular concentrations of these amino acids to a point where
some metabolising step in the cell becomes saturated. An increase in
external concentration will therefore cause an increase in
intracellular concentration via a linear relationship whether or not
a carrier exists so long as it is not saturated. T.brucei has been
shown to have four distinct amino acid transporters (Voorheis.1971)
designated, according to their specificites, as follows.
(a) Neutral amino acid carrier one (N^), transporting glycine,
alanine, serine and threonine.
(b) Neutral carrier two (N^), transporting valine, leucine,
proline anamethionine.
(c) Acid carrier one (A^), transporting glutamic acid.
(d) Basic carrier one (B^), transporting lysine.
Threonine uptake via carrier N1 is mediated by active transport
(Voorheis, 1971; Fricker jet al_., 1984) but the energy source has not
yet been defined. Voorheis(1977) has shown that transport is
independent of Na+ concentration, which is in agreement with Fricker
et al.(1984), and is also independent of a proton gradient.
Voorheis(1980) also provided evidence that transport was dependent on
a glycolytic intermediate from before the aldolase reaction. Fricker
-19-
et_ al. ( 1984) proposed that the uptake of threonine may be dependent
on an exchange system with alanine which is formed from pyruvate by
transamination and accumulates in the cell to high concentrations
(Chappell _et al., 1972). However no direct evidence for this
hypothesis is available. Uptake of amino acids by T.gambiense has
been investigated by Hansen(1979) who found five transport loci
specific for different groups of amino-acids on the basis of mutual
inhibition or stimulation of uptake between amino acids. This author
in contrast to the results presented by Fricker e_t al^. ( 1984) and
Voorheis(1977) found threonine uptake to be Na+ dependent and
sensitive to inhibition by ouabain. This disagreement in the mode of
transport for threonine may be due to species differences. In
addition to membrane transport systems trypanosomes can take up
proteins by endocytosis which are digested in lysosomes to release
amino acids. Endocytosis has been shown to mediate the uptake of the
albumin bound trypanocide suramin (Fairlamb & Bowman,1980) and other
macromolecules and serum proteins (Langreth & Balber,1975; Opperdoes
& Vanroy,1982).
A recent study of trypanosomal transport in connection with the
post-translational modification of the glycoprotein coat has shown
that ethanolamine is taken up by facilitated diffusion in T.brucei
(Rifkin & Fairlamb,1985). It has also been reported that the plasma
membrane of T.rhodesiense contains a calcium pumping ATPase which is
implicated in the regulation of intracellular calcium concentrations
(McLaughlin,1985).
In summary, the little information available regarding
trypanosomal transport systems indicates that there is wide diversity
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Table 1-2 ENZYMES REQUIRING PYRIDOXAL PHOSPHATE
AS CO-FACTOR
of trypanosomes on exogenous supplies of nutrients and enzyme
co-factors warrants further investigation into their modes of
transport with a view to determining differences between the host and
parasite.
1.3 FUNCTIONS AND BIOSYNTHESIS OF VITAMIN B&.
Vitamin is synthesised by all higher plants and many
microorganisms but is required preformed by some fungi,protozoa and
bacteria. The vitamin occurs naturally in three major forms, which
are pyridoxine(PN), pyridoxal(PA) and pyridoxamine(PAM). Very low
levels of these three compounds are found in animal tissues and
bacteria, most occurring as the corresponding phosphate esters. Of
the three phosphorylated forms of B^,
pyridoxal-5-phosphate(PAP),pyridoxamine-5-phosphate(PAMP) and
pyridoxine-5-phosphate(PNP) only PAP and PAMP have functions as
co-enzymes.
Pyridoxal-5-phosphate and pyridoxamine-5-phosphate function as
co-factors in many enzyme reactions. The most common reaction in
which these co-factors are involved is transamination. In this
reaction the enzyme bound PAP is converted to PAMP by donation of the
amino group of the amino acid, the PAP being regenerated when the
amino group is transferred to the keto acid. Vitamin B^ is involved
in many other reactions of amino acid metabolism including
decarboxylation and desulfhydration. Vitamin is also required for
the oxidation of amines, phosphorylase activity of muscle, conversion
of tryptophan to nicotinic acid and conversion of amino acids to
biogenic amines. Some of the enzymes which use PAP as a co-factor are
listed in Table 1.2.
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The biosynthesis of vitamin has been reviewed by Plaut
et al.(1974) detailing the results of tracer experiments in which
various bacteria and yeasts were grown in media containing
radiolabeled glycerol, glucose, pyruvate and serine and the
distribution of label in synthesised was determined. Hill and
Spencer, (1973) and Hill et al.( 1972) proposed that dihydroxyacetone
phosphate condenses with acetaldehyde derived from pyruvate to yield
a pentulose-1-phosphate intermediate which could then condense with
glyceraldehyde-3-phosphate the intermediate so formed being
subsequently converted to PAP. More recent work by Vella et al.(1981)
has shown that the two carbon unit C-2-2'(See Figure 1.3 for
structure) of PN is derived from pyruvate and provides some evidence
that acetyl thiamine pyrophosphate is the final precursor metabolite
of pyruvate before incorporation into the B, molecule. A detailed
o
description of the labelling experiments described briefly above is
outside the scope of this introduction. However it should be borne in
mind that the results presented in the references quoted above
indicate only which compounds are capable of being utilised in the
synthesis of vitamin B^; none of the hypothetical intermediates
required in the proposed syntheses have been detected. Also the
enzymes required for the synthesis of some of these intermediates
have not been detected in any of the yeast or bacteria known to be
capable of the synthesis of vitamin B,. Whether or not the African
o
trypanosomes can synthesise vitamin B^ is unknown; however
Tetrahymena geleii, a ciliated protozoan, nas been shown to require
vitamin B^ preformed for normal growth in culture(Kidder and Dewey,
1949a & 1949b).
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1.3.1 Uptake of Vitamin B,.
o
Uptake of PN by the yeast Saccharomyces carlsbergensis has been
found to be mediated by active transport. The yeast has two transport
systems specific for different forms of the vitamin. One transport
system is specific for PN and the other,specific for PA, is also
capable of transporting PN. The transport system was shown to be
active by its ability to concentrate PN against its concentration
gradient several hundred fold as free PN and not as a metabolite
(Shane & Snell,1976). This yeast active transport system contrasts
with the facilitated diffusion mechanism for transport in
Salmonella typhimurium, uptake being maintained by conversion of the
substrate taken up to its corresponding phosphate ester by the enzyme
PA kinase (EC 2.7.1.35) (Mulligan & Snell,1976). The same mechanism
of Bg uptake is used by Streptococcus faecalis (Mulligan &
Snell,1977).
The uptake of vitamin by the intestinal tract of the rat has
also been extensively studied. The uptake of B, by the jejunum of the
o
rat is achieved by simple non-carrier mediated diffusion followed by
metabolic trapping by pyridoxal kinase (Middleton, 1977). Uptake by
the rat jejunum was shown to be non-mediated by being non-saturable,
insensitive to inhibition by the pyridoxine analogue
A-deoxypyridoxine,anoxia, ouabain or removal of Na+ from the medium.
Uptake of PN was also shown to be relatively insensitive to
temperature changes again indicating that uptake is not carrier
mediated. Uptake of B^ by the rat small intestine is not carrier
mediated but is achieved by simple diffusion followed by metabolic
trapping in the same manner as occurs in the rat jejunum (Mehansho
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et_ al., 1978). These authors also investigated the ability of the rat
intestine to take up the phosphorylated forms of B^. It was found
that the was dephosphorylated in the lumen of the intestine before
being taken up by diffusion. Using perfused intestine these authors
also found that the main form of B, released into the portal blood by
o
the intestine was PA regardless of whether PA or PAP was introduced
into the lumen of the perfused intestine.
Transport and metabolism of vitamin B^ by the choroid plexus of
rabbits and by mitochondria has also been investigated. One of the
effects of B^ deficiency in man and other animals is convulsions
which is thought to be due to a lack of production of the
neurotransmitter gamma-aminobutyric acid (GABA) which requires PAP as
a co-factor in its biosynthesis. However, convulsions and abnormal
behaviour patterns can also be induced by overdoses of B^. For these
reasons Spector(1978a & 1978b) investigated the control of entry of
B^ into the cerebro-spinal fluid and brain through the choroid
plexus. It was found that the cells of the choroid plexus were
capable of the active transport of non-phosphorylated forms of B^
into the cerebro-spinal fluid although the control mechanism for
regulation of transport,if one exists, remains to be elucidated. The
uptake and metabolism of B^ by mitochondria has been investigated by
Lui _et_ _al. ( 1981 A 1982)who found that uptake was by simple
non-carrier-mediated diffusion followed by metabolic trapping.
The transport and uptake of vitamin B^ by rat and human
erythrocytes has been investigated by Mehansho & Henderson!1980) who
found that uptake was by passive diffusion followed by metabolic
trapping by pyridoxal kinase. This is in disagreement with the








METABOLISM OF VITAMIN B6 IN THE RAT.
(Mehansho & at,1980)
uptake of by erythrocytes was mediated by active transport. These
authors used long incubation periods for their uptake assays (>1
minute) ana did not differentiate between the transported forms of B,
o
and metabolites when estimating intracellular concentrations of
transported B,. Mehansho & Henderson(1980) used short incubation
o
times for their assays and so measured initial rates of uptake and
not rates of metabolism. These authors also distinguished between
metabolised and unmetabolised B, when calculating intracellular
o
concentrations of B^ taken up. They also showed that some apparent
concentration of unmetabolised PA was due to PA binding to
haemoglobin.
1.3.2 Metabolism of Vitamin B,.
o
The metabolism of vitamin B^ by animal cells has been more
thoroughly investigated than in any microorganism. The most complete
picture of vitamin B, metabolism available is for metabolism in the
o
rat. Figure 1.4 shows diagrammatically pathways for absorbtion and
metabolism of vitamin B, in the rat. Vitamin B, is absorbed from the
o b
intestine by passive diffusion in the case of PN, PA and PAM. The
corresponding phosphorylated forms of B^ are dephosphorylated before
being taken up.(Mehansho et al.,1980). The unphosphorylated forms of
B^ taken up by the intestinal cells are either phosphorylated or
released unchanged into the portal bloodstream. The PN taken up by
the intestinal mucosa cells can be converted to PA by being
phosphorylated to PNP by pyridoxal kinase then oxidised to PAP by PN
phosphate oxidase (EC 1.4.3.5) and subsequently dephosphorylated to
PA. The vitamers released by the intestine into the portal
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bloodstream are taken up by the liver again by passive diffusion
followed by metabolic trapping (Mehansho et al_., 1980). The vitamers
PA and PN are phosphorylated to their corresponding 5-phosphate
esters by pyridoxal kinase. As in the intestinal mucosa PN taken up
is converted to PAP or PA via PNP. The liver can therefore take up PN
and release PA. This PA released is essential for erythrocytes and
muscle since these cell types lack PN phosphate oxidase. In this
respect the rat erythrocyte differs from the human erythrocyte which
is capable of metabolising labelled PN to labelled PA (Anderson
et _al., 1971). The liver also releases PAP into the bloodstream in
very small amounts compared to the release of PA but PAP is found to
be the most prevalent form of B, in the plasma.(Sauberlich
o
e_t al, 1972; Lumeng _et al., 1980). This can be accounted for by the
fact that other body tissues remove PA from the bloodstream but do
not remove PAP which remains in the plasma complexed with serum
albumin (Lumeng et_ al, 1974; Mehansho et al.,1980).
In summary it appears that the mode of entry of vitamin into
animal cells is by diffusion with the exception of the choroid plexus
cells. The mode of entry in those bacteria which have been studied
appears to be by facilitated diffusion with active transport being
used for uptake by Saccharomyces carlsbergensis. To date no
information on the uptake or metabolism of vitamin B, by trypanosomesb
has been published.
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1.4 FUNCTIONS AND BIOSYNTHESIS OF PURINE NUCLEOTIDES.
Purine nucleotides are required as activated precursors for DNA
and RNA synthesis by all cells with the exception of the mature
mammalian erythrocyte. Nucleoside triphosphates are also required as
energy sources to drive many biosynthetic reactions and to act as a
store for energy released by the cells catabolic reactions. Adenine
nucleotides are also components of four important coenzymes; NADP+,
NAD , FAD and co-enzyme A. Many metabolic pathways, such as
glycolysis, are regulated by the intracellular concentrations of
adenosine mono-, di- and triphosphates. Adenosine monophosphate is
also involved in the regulation of cellular functions in the form of
3',5'-cyclic AMP which may be formed in response to an extracellular
stimulus. The effect of 3',5'-cyclic AMP on metabolism may also be
dependent on ATP as is exemplified by the inhibition of glycogen
synthetase by 3',5'-cyclic AMP dependent protein kinases. In view of
these requirements for purines, cells ,if they are to reproduce and
function normally, must either synthesise purines de novo or obtain
them preformed from the environment via salvage pathways which are
capable of converting naturally occurring purines into the forms
required by the cell.
Most animal cells are capable of the de novo synthesis of the
purine ring and the salvage of preformed purine compounds. However
erythrocytes and lymphocytes (Scholar & Calabresi,1973) lack the
enzymes of the de novo synthetic pathway but are capable of purine
salvage. The de novo pathway for purine biosynthesis (Buchanan &
Hartraan,1959) is shown in Figure 1.5. The enzymes involved in the
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No. Enzyme EC No.
1 Ribose phosphate pyrophosphokinase 2.7.6.1
2 Amido phosphoribosyltransferase 2.4.2.14
3 Phosphoribosyl-glycinamide synthetase 6.3.1.3
4 Phosphoribosyl-glycinamide formyltransferase 2.1.2.2
5 Phosphoribosyl-formylglycinamide synthetase 6.3.5.3
6 Phosphoribosyl-aminoimidazole synthetase 6.3.3.1
7 Phosphoribosyl-aminoimidazole carboxylase 4.1.1.21
8 Phosphoribosyl-aminoimidazole-succino
carboxamide synthetase 6.3.2.6
9 Adenylosuccinate lyase 4.3.2.2
10 Phosphoribosyl-aminoimidazole
carboxamide formyltransferase 6.3.2.6
11 IMP Cyclohydrolase 3.5.4.10
The formation of IMP by the pathway outlined in Figure 1.5 is
regulated by the intracellular concentrations of purine nucleotides,
the ultimate end products of the pathway, via feedback inhibition to
enzyme two of the pathway, amidophosphoribosyltransferase (Rowe &
Wyngaarden,1968; Neirlich & Magasanik,1965). The end product (IMP) of
the pathway shown is further metabolised to form GTP and ATP as the
ultimate end products of purine nucleotide biosynthesis. The IMP can
be converted to xanthylic acid by IMP dehydrogenase (EC 1.2.1.14),
which is inhibited by GMP, and finally converted to GMP by GMP
synthetase (EC 6.3.4.4) in a reaction requiring ATP. The GMP so
formed can be converted to GTP by the action of nucleotide kinases.
The IMP produced by the de novo pathway can also be used in the




(1) AMP DEAMINASE (EC 3.3.4.6)
(2) ADENYLOSUCCINATE SYNTHETASE (6.3.4.4)
(3) ADENYLOSUCCINATE LYASE (EC 4.3.2.2)
(4) IMP DEHYDROGENASE (EC 1.2.1.14)
(3) BMP SYNTHETASE (EC 6.3.4.1)
(6) 3'-NUCLEOTIDEASE (EC 3.1.3.3)
(7) NUCLEOSIDE KINASE (EC 2.7.1.20)
(8) PURINE NUCLEOSIDASE (EC 3.2.2.1)
(9) PURINE NUCLEOSIDE PHOSPHORYLASE (EC 2.2.4.1)
(10) ADENINE PHOSPHORIBOSYLTRANSFERASE (EC 2.4.2.7)
(11) HYPOXANTHINE/GUANINE PHOSPHORIBOSYLTRANSFERASE
(EC 2.4.2.8)
(12) ADENOSINE DEAMINASE (EC 3.3.4.4)
(13) ADENINE DEAMINASE (EC 3.3.4.2)
(14) QUANINE DEAMINASE (EC 3.3.4.3)
(15) XANTHINE OXIDASE (EC 1.2.3.2)
Figure 1-6 PURINE SALVAGE PATHWAYS
adenylosuccinate synthetase (EC 6.3.4.A) in a reaction which requires
GTP and is inhibited by AMP. The final reaction to form AMP is
catalysed by adenylosuccinate lyase which is enzyme 9 in the de novo
synthetic pathway. The dependence of the adenylosuccinate synthetase
on GTP and the dependence of GMP synthetase on ATP keeps the ratio
of AMP to GMP and hence the ratio of ATP to GTP in balance. The
enzymes of purine biosynthesis are considered in detail in Methods in
Enzymologyf1978).
The pathways by which purines may be salvaged and the enzymes
required are shown in Figure 1.6. These pathways and their importance
in relation to transport of purines are considered below.
1.4.1 Uptake and Metabolism of Purine Nucleotides,
Nucleosides and Bases.
The uptake and metabolism of purine nucleosides and bases have
been extensively investigated in various cell types. The transport
and metabolism of purine nucleosides and bases have been most
thoroughly studied in the mammalian erythrocyte and bacteria.
The erythrocyte nucleoside transporter shows broad specificity
towards the base moiety of nucleosides but is relatively specific
towards the sugar moiety (Oliver & Paterson, 1971; Cass &
Paterson, 1973). The single carrier hypothesis is based on the fact
that many purine and pyrimidine nucleosides can cause accelerated
exchange diffusion of uridine and thymidine from preloaded
erythrocytes. The uptake of bases by erythrocytes appears to be
mediated by a different carrier since the uptake of nucleosides is
strongly inhibited by p-nitrobenzylthioinosine (NBTI) (Jarvis &
Young, 1980) whereas the uptake of bases such as hypoxanthine are not
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inhibited (Paterson & Oliver;1971). The nucleoside and base carriers
of the erythrocyte mediate uptake by facilitated diffusion followed
by metabolic trapping (Cabantchik & Ginsburg,1977; Cass &
Paterson,1972 & 1973). Metabolic trapping of purines by erythrocytes
as nucleotides is accomplished by purine salvage enzymes. Adenosine
is directly converted to AMP by adenosine kinase or deaminated to
inosine by adenosine deaminase (Agarwal & Parks,1978). The inosine so
formed can be converted to free base (hypoxanthine) and
ribose-1-phosphate by the action of purine nucleoside phosphorylase.
The hypoxanthine is then converted to IMP by hypoxanthine/guanine
phosphoribosyltransferase (HxGPRT). Adenosine does not give rise to
adenine and ribose-1-phosphate since the nucleoside phosphorylase of
the erythrocyte is specific for inosine and guanosine (Cabrio
et al.,1956). Inosine and guanosine when transported are converted to
their respective free bases and ribose-1-phosphate by nucleoside
phosphorylase, the free bases being converted to IMP and GMP
respectively by HxGPRT. Adenine when transported is converted to AMP
by a specific adenine phosphoribosyltransferase (APRT) (Grimes,1980).
The nucleoside carrier of the erythrocyte has been identified as
a band A.5 polypeptide with a molecular weight of 45-65KD as
determined by SDS gel electrophoresis. The transport protein was
1 L\
identified by radiolabelling with C-NBTI and N -(-p-azidobenzyl)
adenosine (Young et al.,1983; Young & Jarvis, 1983). Earlier work by
Jarvis & Young(1980) resulted in estimates of 120KD for the molecular
weight of the nucleoside transporter in erythrocyte ghosts as
determined by radiation inactivation of the ghosts' ability to bind
radiolabelled NBTI. The molecular weight of 120KD estimated for the
intact nucleoside transporter suggests that the transporter exists as
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a dimer in the erythrocyte membrane (Young et al.,1983).
The transport and metabolism of nucleosides and bases have been
studied in other mammalian cells although in less detail than for the
erythrocyte. The uptake of nucleosides by mammalian cells has been
reviewed by Plagemann & Wohlhueter, 1980 and Young e_t al., 1983. The
general consensus given by the literature is that uptake of
nucleosides and bases by animal cells is by facilitated diffusion
followed by metabolic trapping as phosphate esters. This has been
shown to be the case for Novikoff rat hepatoma cells (Marz
_et a_l., 1979) , mouse leukemia cells, canine thymocytes, peripheral
blood leukocytes (Lum e_t al., 1979) and brain tissue (Shimizu
_et_ _al., 1972) . When considering transport as distinct from uptake full
account must be taken of metabolism as discussed in Section 1.2.1. In
studies of transport of nucleosides and bases where short incubation
times have been used, and metabolism of the transported substrates
reduced by the use of inhibitors or mutant cell lines lacking
metabolising enzymes, it has been shown that nucleoside and base
concentrations come to equilibrium across the cell membrane in a
matter of seconds (Lum et_ al., 1979; Marz et al., 1979), all further
uptake being due to metabolism maintaining a diffusion gradient.
In erythrocytes all nucleosides enter the cell via a single
transporter (Oliver & Paterson,1971; Cass & Paterson, 1973). Initial
studies of uptake by cultured cells, Novikoff rat hepatoma (Plagemann
& Erbe,1974) and HeLa cells (Cass & Paterson,1977) using long
incubation periods demonstrated that some nucleosides showed mutual
inhibition of uptake whereas others did not suggesting the existence
of transport systems specific for different groups of nucleosides. It
has since been shown that these specificities were in fact a
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reflection of the specificities of the metabolising enzymes rather
than transport, since uptake measured over long time periods measures
uptake due to metabolism rather than transport (Section 1.2.1; Taub &
Berlin, 1972; Mulder & Harrap, 1975; Heichal et al., 1979). Information
on the number of transport systems for base transport is not as clear
cut as that for nucleoside transport. Hypoxanthine and guanine are
apparently transported by the same system in hepatoma cells since
they inhibit each others transport to the same extent (Marz
et_ al.,1979). Nucleoside transport is inhibited by hypoxanthine and
hypoxanthine transport is inhibited by nucleosides (Marz et al.,1979;
Plagemann et al.,1978). These results suggest that hypoxanthine and
guanine enter the cells via the nucleoside transport system. However
there are distinct differences between the susceptibilities of
nucleoside and base transport to inhibition by
nitrobenzylthionucleosides, nucleoside transport being totally
inhibited at concentrations which have no effect on base
transport.(Cohen et al., 1979)♦
Nucleotides are not transported by mammalian cells (Plagemann &
Wohlhueter,1980) due to a lack of transport systems and their high
negative charge decreasing their lipid partition co-efficients which
reduces the possibility of uptake by diffusion through the cell
membrane. Although mammalian cells do not take up nucleotides they do
release 3',5'-cyclic AMP from a variety of cell types by an active
transport mechanism in response to hormonal stimulation of the cell.
Davoren & Sutherlandt 1963) were the first to observe that the
3',5'-cyclic AMP produced by pigeon erythrocytes in response to
treatment with adrenalin was released from the cell and after 120
minutes the medium concentration of 3',5'-cyclic AMP exceeded the
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intracellular concentration. This release of 3',5'-cyclic AMP was not
inhibited by high concentrations of 3',5'-cyclic AMP in the
incubation medium before the treatment with adrenalin, suggesting the
existence of an active transport system for the extrusion of
3',5'-cyclic AMP from the cell. The extrusion of 3',5'-cyclic AMP has
been demonstrated in many other cell types, including rat adipose
tissue in response to lipolytic hormones such as adrenalin and
glucagon (Zumstein et_ a^.,1974), isoproterenol treated mouse glioma
cells (Doore et al.,1975; Rindler et al.,1978), Simian virus 40
transformed human fibroblasts after exposure to prostaglandin
(Chalpowski et al.,1978; Rindler _et al., 1978) and
isoproterenol-treated perfused rat heart (O'Brien & Strange 1975).
The 3',5'-cyclic AMP extrusion mechanism has been shown to be
unidirectional (Schroder & Plagemann,1971; Hsie _et al., 1975; Granner
_et al. , 1975) by the inability of cells to accumulate radiolabelled
3',5'-cyclic AMP although label was rapidly accumulated. The
accumulation of label was found to occur after degradation of the
3',5'-cyclic AMP by phosphodiesterase and 5'-nucleotidase located on
the cell membranes or in the cell culture media used.
Purine nucleoside and base uptake has also been extensively
studied in bacteria. Nucleoside transport in E.coli was first studied
by Petersen & Koch(1966) and Petersen _et al.(1967),who investigated
the kinetics of transport, metabolism of the nucleosides taken up and
the energy requirements for transport. The above authors also
investigated the mutual inhibitory effects of nucleosides on
transport and concluded that in E.coli there was more than one
nucleoside transport system with specificities distinguishable from
those of the metabolising enzymes. It has been suggested that
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transport of nucleosides in E.coli and S.typhimurium occurs by a
group translocation mechanism mediated by nucleoside phosphorylases
(Hochstadt & Stadman,1971; Rader & Hochstadt,1976). These authors
proposed that nucleosides bound to the plasma membrane of the
bacteria and the ribose moiety of the nucleoside was taken up as
ribose-1-phosphate during phosphorolysis of the nucleoside by
nucleoside phosphorylase. They also proposed that the base moiety
released by this reaction would be taken up by a second group
translocation mechanism mediated by phosphoribosyltransferases
(Hochstadt & Stadman,1971; Hochstadt,197A). These hypotheses were
based on the observations that membrane vesicles prepared from E.coli
and S.typhimurium accumulated ribose-1-phosphate and released free
base into the medium when incubated with nucleosides.
Doubt has been cast on the hypothesis that nucleoside uptake in
bacteria is mediated solely by group translocation by the following
observations; that mutant strains of E.coli which lack purine
nucleoside phosphorylase are still able to utilise inosine as a
purine source (Hoffmeyer & Neuhard, 1971); that mutants lacking
nucleoside phosphorylase transport and concentrate nucleosides
(Munch-Petersen & Mygind,1976; Mygind & Munch-Petersen,1975); and
that mutants have been isolated which are incapable of nucleoside
transport but have a full complement of nucleoside phosphorylases and
phosphoribosyltransferases (Munch-Petersen 4 Mygind,1976). Two
transport systems for nucleosides have been identified in E.coli
designated the C ana the G systems (Munch-Petersen et al.,1979). The
C system is specific for cytosine and the G system specific for
guanosine. The specificities of the two transport systems are
indicated by the mutual inhibitory effects of various nucleosides on
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each others transport. The purine specificities of the two systems
are as follows. The C system transports adenosine and deoxyadenosine
but will not transport guanosine, deoxyguanosine or inosine. The G
system on the other hand will transport all nucleosides.
In E.coli K12, E.coli B and S.typhimurium nucleoside uptake is
mediated by an active transport process as demonstrated by the
ability of mutant cells, which lack nucleoside metabolising enzymes,
to accumulate nucleosides to a concentration several hundred times
that of the incubation medium (Munch-Petersen & Mygind,1976;
Munch-Petersen & Pihl,1980). Active transport has been shown not to
require ATP directly in cells containing only the G system
(Munch-Petersen & Pihl,1980); however, in membrane vesicles active
transport was supported by the addition of electron donors and was
shown to be sensitive to inhibition by 2,4-dinitrophenol
(Munch-Petersen et al_., 1979) which suggests that transport is
dependent on a proton gradient generated by an electron transport
chain in the bacterial membrane. Similar results have been obtained
for S.typhimurium (Rader & Hochstadt, 1976) and E.coli B (Roy-Burman
et al.,1978).
The transport systems for nucleobases in bacteria are less well
defined than those for nucleoside transport. There is some dispute as
to whether or not uptake of nucleobases is mediated by group
translocation. The same arguments as have been presented for and
against uptake of nucleosides by group translocation, as regards the
use of mutants and membrane vesicles, can be applied to the problem
of nucleobase transport (See Hays,1978 for a review). Investigations
into the cellular localisation of purine phosphoribosyltransferases
(Page & Burton,1978) indicate that these enzymes are cytoplasmic as
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shown by subcellular fractionation and the observation that they are
not inactivated by impermeant enzyme inhibitors in whole cells but
are inactivated completely by the same reagents in a cell lysate
(Kabach,1971;Futai, 1974). This distribution of the
phosphoribosyltransferases is consistent with a facilitated diffusion
mechanism for transport followed by metabolic trapping rather than
group translocation. That transport may be by facilitated diffusion
is supported by the observation that experiments designed to show
active transport of purine bases have given inconclusive results
(Burton,1977).
In summary mammalian cells transport purine nucleosides and
pyrimidine nucleosides by a facilitated diffusion mechanism followed
by metabolic trapping by the purine and pyrimidine salvage enzymes.
Purine bases are transported in mammalian cells by a separate carrier
but by the same mechanism. In bacteria nucleosides are transported by
active transport systems which appear to be dependent on a proton
gradient generated by proton translocating electron transport chains
in the bacterial plasma membrane. Bacteria contain at least two
different transport systems which differ in their specificities for
nucleosides transported. Bacteria also take up purine bases, mediated
by facilitated diffusion followed by metabolic trapping. With this
background in mind the transport, uptake and metabolism of purine
nucleotides, nucleosides and bases by trypanosomes will be examined.
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1.4.2 Uptake and Metabolism of Purine Nucleotides,
Nucleosides and Bases by Trypanosomes.
In comparison to mammalian cells and bacteria very little is
known about the uptake, transport and metabolism of purine
nucleotides, nucleosides and bases by the Trypanosomatidae. The
Trypanosomatidae are incapable of de novo synthesis of the purine
ring as indicated by their inability to incorporate radiolabeled
precursors into their nucleotides (Marr et_ al., 1978a; Gutteridge &
Gaborak, 1979, Ceron _et al., 1979; Fish _et_ al., 1982a) . The lack of
de novo synthesis of the purine ring is also indicated by the
requirement for preformed purines for growth of trypanosomes in
culture (Berens _et_ al., 1981; Fish _et _al., 1982b). They therefore must
obtain their purines preformed from the host organism in vivo, which
requires that they have mechanisms for the uptake of purine
nucleosides and bases and also purine salvage enzymes capable of
forming nucleotides.
The existence of salvage pathways in trypanosomes is
substantiated by the ability of single purine compounds to support
the growth of various trypanosomes in culture, although not all
purines are equally effective. Hypoxanthine ana adenosine are equally
effective in promoting the growth of Leishmania donovani with inosine
only supporting growth after a lag period of two days and guanosine
stimulating growth in a manner intermediate between adenosine and
inosine (Marr et al.,1978a). The growth of T.gambiense is supported
by adenine, hypoxanthine,guanine and xanthine in order of decreasing
efficiency whereas the order for T.rhodesiense is hypoxanthine,
adenine, guanine and xanthine (Schmidt et al.,1975; Fish
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_et_ al., 1982a; Fish et_ al., 1982b). Other orders of purine preference
are possible in other species such as T.cruzi (Gutteridge &
Gaborak, 1979).
The individual enzymes of purine salvage have been studied in
cell lysates of various trypanosomes. Hypoxanthine, guanine and
adenosine phosphoribosyltransferase activities have been detected in
Crithidia fasciculata (Kidder et al.,1979), L.donovani (Tuttle &
Krenitsky,1980), T.cruzi (Gutteridge & Davies,1981 & 1982) and
T.brucei and L.mexicana (Davies et al.,1983). In most cases the
hypoxanthine and guanine phosphoribosyltransferase activities have
been found to be associated with a single enzyme as is the case in
mammalian tissues. However these activities have been shown to be
associated with separate enzymes in C.fasciculata (Kidder
et al.,1979). It has been proposed that the HxGPRT of T.cruzi and
other trypanosomes is associated with the glycosome as shown by
subcellular fractionation experiments (Gutteridge & Davies,1982). The
enzyme APRT has been detected in the same organisms as HxGPRT
activities by the same authors as given above, and in L.donovani by
Looker _et _al.(1983). In contrast to HxGPRT the enzyme APRT appears to
be a soluble cytoplasmic protein (Hammond & Gutteridge,1984). These
phosphoribosyltransferase enzymes are capable of converting bases to
nucleotides but trypanosomes can also use nucleosides as purine
sources. Therefore, either nucleoside kinases or enzymes capable of
generating free bases from nucleosides must be present. Many animal
cells and bacteria use a nucleoside phosphorylase enzyme to generate
free bases from nucleosides (See Section 1.4.1). Nucleoside
phosphorylase activities have been detected in
L.mexicana amazonensis promastigotes, T.brucei trypomastigotes and
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T.cruzi araastigotes, epiraastigotes and trypomastigotes (Gutteridge &
Davies,1982; Davies _et_ _al_., 1983) all of which contain adenosine and
guanosine phosphorylase activities. These findings are in conflict
with the findings of Ogbunude & Ikediobi(1983); Ogbunude et al.(1985)
and the work in this thesis (Section 3.2.5). Ogbunude &
Ikediobi(1983); and Ogbunude _et al.(1985) were unable to detect any
nucleoside phosphorylase activity in T.brucei or T.vivax but did find
phosphorylase activity in T.congolense. These conflicting results may
be due to differences in the strain of organism investigated. In the
organisms, T.brucei and T.vivax, in which no nucleoside phosphorylase
activity was detected, nucleoside hydrolases (nucleosidases) were
found to be present allowing the production of free base from
nucleoside. Nucleosidases have been detected in other trypanosomes
(Davies _et. al., 1983; Looker _et al., 1983) and purified from
T.gambiense (Schmidt e_t al_., 1975). Nucleosides may also be converted
to nucleotides by the action of nucleoside kinases which have been
detected in a variety of trypanosomes. However there is disagreement
between authors as to whether or not kinase activity is present in
certain species. Adenosine kinase activity has been reported to be
present in extracts of L.donovani (Tuttle & Krenitsky,1980) and
T.cruzi (Gutteridge & Davies,1982). Adenosine, inosine and guanosine
kinases have also been reported to be present in L.m.amazonensis,
T.brucei and all morphological forms of T.cruzi (Davies et al.,1983).
However, adenosine kinase could not be detected in T.brucei by
Ogbunude & Ikediobit 1983), Ogbunude et_ al_. ( 1985) or in this thesis
(Section 3.2.5). Ogbunude et al.(1985) did however detect adenosine
kinase in T.vivax and T.congolense.
The ability of some trypanosomes to grow normally in culture
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when supplied with only one purine base suggests that they are
capable of the interconversion of purines. Aminohydrolases
(deaminases) are responsible for the conversion of the adenine ring
to the hypoxanthine ring. This conversion may take place as a
conversion of adenine to hypoxanthine (adenine deaminase), adenosine
to inosine (adenosine deaminase) or AMP to IMP (AMP deaminase).
Adenine deaminase has been detected in L.donovani, L.mexicana and
T.vivax (Kidder & Nolan,1979). Adenosine deaminase has been shown to
be present in lysates of Leishmania spp. (Looker et al.,1983),
T.cruzi (Gutteridge & Davies,1981) and T.brucei (Davies et al.,1983).
However, the existence of adenosine deaminase in T.brucei has failed
to be confirmed by other workers (Berens et al.., 1981; Ogbunude &
Ikediobi,1983; Ogbunude et al.,1985). The interconversion of purine
nucleotides may be possible via the common intermediate, IMP. The
enzyme AMP deaminase can form IMP from AMP and IMP can be further
converted to GMP by the action of IMP dehydrogenase and GMP
synthetase. This sequence of reactions can be reversed by the
conversion of GMP to IMP by the enzyme GMP reductase, the IMP so
formed can then be converted to AMP by adenylosuccinate synthetase
and adenylosuccinate lyase. The existence of these salvage enzymes in
T.cruzi and C.deani(aposymbiotic) has been shown by their ability to
radiolabel guanine nucleotides when grown in medium containing
labelled adenine and also their ability to label adenine nucleotides
when grown in the presence of labelled guanine or hypoxanthine.
However, C.deani can not incorporate label into adenine nucleotides
when provided with labelled guanine but can label adenine nucleotides
when provided with labelled hypoxanthine which suggests that C.deani
lacks GMP reductase (Ceron et al.,1979). Similar findings have been
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reported for T.gambiense (Fish _et al.,1982a) and L.donovani (Spector
& Jones,1982).
The inability of trypanosomes to synthesise the purine ring
de novo and their reliance on the salvage pathways provides a
potential target for chemotherapeutic treatment of trypanosome
infections with nucleoside analogues which can inhibit enzymes of the
salvage pathways. The effects of some nucleoside analogues such as
allopurinol, tubericidin, coformycin, deoxycoformycin and
dipyridamole have been tested for trypanocidal activity against
T.cruzi (Marr _et al.,1978b), C.fasciculata and L.tropica (Kidder &
Nolan,1979), T.gambiense(Ogbunude & Ikediobi,1982) and T.brucei and
T.congolense (James & Born,1980). Most of the above work was
concerned with the effects of these analogues on the salvage enzymes;
however, their effects on the uptake of nucleosides may also be of
importance as regards their effectiveness as drugs.
The uptake of purines by trypanosomes has not been extensively
studied and in the few cases where investigations have been carried
out little distinction has been made between transport and overall
uptake and metabolism (James & Born,1980). Transport of pyrimidines
has also been investigated by Manjra & Dusanic(1973), who reported
that T.lewisi actively transports pyrimidines. This conclusion is
untenable since these authors made no distinction between uptake and
transport (See Section 1.2). In other trypanosomes uptake of purines
is carrier-mediated although no information is available concerning
whether or not uptake is by facilitated diffusion or by active
transport. That uptake is carrier-mediated has been shown by mutual
inhibition of uptake amongst various purine nucleosides and bases.
The existence of multiple carriers with differing specificities for
-41-
purines has been suggested by Hansen et_ al_. ( 1982) in L.panamensis
which may have three separate purine carriers. Multiple carriers have
also been suggested for purines in T.brucei and T.congolense (James &
Born,1980) and C.fasciculata (Kidder _et al.,1978). Purine transport
in T.vivax has been investigated by Okochi et_ al.(1983); however, the
results presented by these authors must be regarded with some caution
since they report using hypoxanthine and guanine as uptake substrates
at concentrations in excess of 100mM which is not only
unphysiological but almost thirty times more concentrated than a
saturated aqueous solution. Sanchez et _al.(1976) reported uptake of
nucleotides by T.brucei and T.gambiense; however, they did not prove
that the purine nucleotide was taken up intact.
In summary purine nucleosides and bases are taken up by a
carrier - mediated process in those trypanosomes so far studied but no
information is available as to whether or not the carriers are
involved in active transport.
It appears that all trypanosomes are incapable of de novo
synthesis of the purine ring and obtain all their purines preformed
from their hosts. Since the trypanosomes obtain their purines from
their hosts they all appear to be capable of interconversion of
purines although the salvage enzymes used appear to vary from species
to species and perhaps from strain to strain.
1.5 OBJECTIVES OF THE INVESTIGATION.
The two main objectives of this investigation were;
1) to investigate the basic biochemistry of uptake and
metabolism of the enzyme co-factor, vitamin B^, by T.brucei.
2) to investigate the basic biochemistry of the uptake and
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metabolism of purine nucleosides and bases by T.brucei.
Both of the above investigations were carried out with a view to
characterising the transport and metabolising systems in the hope of
detecting differences from the host organisms which may be useful
chemotherapeutic targets. An example of how basic understanding of
transport systems can help in chemotherapy is given by a recent paper
by Ogbunude & Ikediobi(1982) in which they demonstrate the ability of
the mammalian nucleoside transport inhibitor NBTI to protect the host
organism from toxic nucleoside analogues which are lethal to both
host and trypanosomes in the absence of NBTI. The basis for this
chemotherapeutic strategy is that NBTI is a potent inhibitor of the
mammalian nucleoside transport systems but is not an effective
inhibitor of the trypanosomal nucleoside transport systems. This
exemplifies how a knowledge of an organism's basic transport
biochemistry can lead to new strategies for the use of existing
drugs, if not to new drugs.
-A3-
2.MATERIALS AND METHODS
2. MATERIALS AND METHODS.
2.1 STRAIN OF T.BRUCEI STUDIED.
The trypanosome strain used throughout this work was T.brucei
TREU 55 (Trypanosomiasis Research Edinburgh University) which is a
monomorphic population of trypanosomes derived from a pleomorphic
wild population. The original wild type trypanosomes were maintained
by serial passage (an unknown number of times) to produce TREU 1.
This line was subsequently passaged (uncloned) an unknown number of
times in rats to give TREU 55. As stated above TREU 55 is an uncloned
monomorphic strain consisting of long slender bloodstream forms,
which cause a fulminating parasitaemia and death of the host rats
within three days of inoculation with the parasites.
2.2 HOST AND MAINTENANCE.
Male albino wistar rats (350g-750g) were used as host animals
for the T.brucei infection throughout this investigation. Infection
7
was established by intraperitoneal injection of 8 x 10 trypanosomes
in a volume of 0.5 ml phosphate buffered saline pH 8.0. The injection
was prepared by thawing a 0.5 ml stabilate of infected rat blood and
diluting to a final volume of 3 ml with phosphate buffered saline.
This procedure resulted in peak parasitaemia within 72 hours.
2.3 PREPARATION OF STABILATES.
Rats infected as described above were exsanguinated by direct
cardiac puncture under light ether anaesthesia. The blood collected
was immediately diluted with phosphate buffered saline pH 8.0,
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containing 5 IU heparin/ml, to give 4-5 x 10 trypanosomes /ml and
glycerol added to a final concentration of 10% (V/V). The number of
parasites was determined by haemocytometry. The diluted blood was
then dispensed in 0.5ml aliquots into Eppendorf pots and frozen at
-70°C. Stabilates prepared in this fashion remained infective for
over one year but after six months storage a slight decrease in the
yield of trypanosomes obtained was noted. Therefore, fresh stabilates
were prepared as described above every six months to obtain maximum
yields of trypanosomes.
2.4 BUFFER SOLUTIONS.
Phosphate buffered saline (PS buffer) 53mM disodium hydrogen
orthophosphate, 3mM sodium dihydrogen orthophosphate, 45mM sodium
chloride, pH 8.0.
Phosphate saline glucose (PSG buffer) as PS buffer plus 1% (w/v)
glucose, pH 8.0 unless otherwise stated.
Tris saline glucose (TSG buffer) 49.5mM Tris, 42.3mM HC1, 85.5mM
sodium chloride, glucose 1% (w/v), pH 7.4 unless otherwise stated.
Tris choline glucose (TCG buffer) as for TSG but with the 85.5mM
sodium chloride replaced with 85.5mM choline chloride, pH 7.4.
Potassium phosphate buffered glucose (PSGK buffer) 53mM dipotassium
hydrogen orthophosphate, 3mM potassium dihydrogen orthophosphate,
45mM potassium chloride, glucose 1% (w/v), pH 7.4 unless otherwise
stated.
2.5 ISOLATION OF TRYPANOSOMES FROM RAT BLOOD.
Trypanosomes were isolated from infected rat blood by the method
of Lanham(1968) as detailed below. Rats were exsanguinated, 72 hours
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post-infection, by direct cardiac puncture under light ether
anaesthesia and the blood collected into 2ml of PSG containing 5 IU
heparin/ml. After centrifugation of the blood at lOOOxg av. for 10
minutes at 4°C the supernatant plasma fraction was removed and the
white trypanosome layer collected from the top of the erythrocyte
pellet. The trypanosome layer was then resuspended in PSG and the
centrifugation step repeated. The white trypanosome layer was then
collected and suspended in fresh PSG before being applied to the top
of a DEAE 52 cellulose column (bed volume 18-20ml) equilibrated with
PSG. Due to the charge difference between the trypanosomes and the
erythrocytes and platelets at pH 8.0 the latter stick to the column
and allow the trypanosomes to be eluted from the column with PSG. The
trypanosomes eluted from the column were stored as a dilute
suspension in PSG buffer at 0°C and used within thirty minutes. The
above purification method produced, in terms of packed cell volume,
2-3ml of cells per rat. The trypanosome suspension produced by this
method was routinely inspected by phase contrast microscopy and only
cell suspensions with >95% motile cells were used in experiments.
2.6 TRYPANOSOME VIABILITY.
Trypanosome viability was estimated by inspection of cell
motility using phase contrast microscopy, a purely subjective
parameter, and by measurement of their rate of oxygen utilisation
which is more objective. The method used for the measurement of
oxygen uptake is described below.
Trypanosomes (1ml at 1.5mg protein/ml) were added to a
thermostattedchamber with a magnetic stirring bar containing 2ml of
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PSG, pH 7.4 at 37°C. The chamber was sealed and the rate of oxygen
utilisation measured with a Clark oxygen electrode which formed part
of the chamber seal. The oxygen electrode was connected to a slave
recorder calibrated to 100% deflection with air saturated buffer and
calibrated to zero oxygen tension by the addition of sodium
dithionite to the sealed chamber. The above system for measuring
oxygen uptake was used to indicate any deleterious effects of
compounds utilised in experiments on trypanosome transport in
conjunction with inspection by phase contrast microscopy.
2.7 PREPARATION OF TRYPANOSOME LYSATE.
Trypanosomes were lysed by hypotonic shock as follows: the
required number of trypanosomes were pelleted by centrifugation at
1000xg av. for 5 minutes and the cell pellet obtained lysed by the
addition of 5 volumes of double distilled water. This lysate was then
homogenised (five strokes) in a tight fitting Dounce homogeniser and
inspected for whole cells by phase contrast microscopy. Concentrated
buffer was added to this homogenate to give a final concentration of
100mM TrisHCl, 1mM DTT, 1mM benzamidine, 1mM PMSF, pH 7.4. The lysate
was then dialysed against 100 volumes of this buffer (typically 10ml
lysate:1 litre buffer) for 10 hours with one change of dialysis
buffer. The addition of the protease inhibitors PMSF and benzamidine
had no effect on any of the enzyme activities assayed in the lysate.
This was determined by assaying all enzymes in an undialysed lysate
in the presence and absence of the protease inhibitors. Throughout
this thesis trypanosome lysate refers to a cell free homogenate
prepared as described above unless otherwise stated.
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2.7.1 Cell Breakage Methods.
Apart from water lysis three other methods were used to disrupt
the trypanosomes. These were grinding the cells with silicon carbide
(Crystalon: Norton Company. Grit No. 37C 400J, grinding the cells
with glass beads (75-150pm diameter, Sigma Chemical Co.Ltd,) and
sonication for 30 seconds by a Rapidis 150 sonicator (Ultrasonics
Ltd.) in six five second bursts. The three procedures described above
were carried out as follows. The disruption of the cells by grinding
with silicon carbide or glass beads was achieved by grinding a paste
of cells and abrasive in 0.25M sucrose 10mM HEPES, 1mM DTT, 1mM
benzamidine, 1mM PMSF, pH 7.4 in a mortar and pestle at 4°C. Cells
were sonicated as described above after being pelleted by
centrifugation and made into a paste by the addition of a small
volume of 0.25M sucrose 10mM HEPES, 1mM DTT, 1mM benzamidine, 1mM
PMSF, pH 7.4.
2.8 THIN LAYER CHROMATOGRAPHY (TLC).
Thin layer chromatography of purine nucleosides and bases was
carried out on silica coated aluminium TLC plates (Kieselgel 60 ^254'
Merck Co.) impregnated with a fluorescent dye (F^^). Radioactive
samples to be chromatographed were applied to the plates by
calibrated capillaries (Camlab Ltd.) in neutral or slightly acid
solution with 20nmoles of each of the carrier compounds; adenosine,
adenine, inosine, hypoxanthine and xanthine. After air drying the
applied samples and carriers the chromatograms were developed, by
ascending chromatography, in the solvent system of Arch &
Newsholmet1976) which consists of propan-2-ol: ethylacetate: 0.88 NH^
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in the ratio 9:4:3 (v/v/v). Chromatography was carried out in a
sealed tank in a solvent saturated atmosphere. The solvent was
allowed to migrate up the plates to within 1-2cm of the top of the
plates. The plates were then removed, air dried and the resolved
components visualised by their quenching of the plates fluorescence
under UV light. The Rf. values for the compounds listed are given in
the legend to Figure 2.1 which shows a typical chromatogram
photographed in UV light.
2.8.1 TLC of Vitamin B, and Metabolites.
o
Chromatography of Vitamin B. and its metabolites was carried out
b
as described for chromatography of purine nucleosides and bases with
the following exceptions. The solvent system used was
chloroform:methanol in the ratio 75:25 (v/v) (Ahrens & Korytnyk,1970)
and 60nmoles of each of the carriers, pyridoxinetPN), pyridoxal(PA),
pyridoxic acid(PAC), pyridoxamine(PAM), pyridoxal-5-phosphate(PAP)
and pyridoxamine-5-phosphate(PAMP) were chromatographed with
radioactive samples to be analysed. The Rf. values for the compounds









As for TLC of purine nucleosides and bases the resolved compounds
were visualised by quenching of the TLC plates fluorescence under UV
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light.
2.9 HPLC OF PURINE NUCLEOTIDES.
The purine nucleotides AMP, ADP, ATP, IMP, IDP, ITP, GMP and GDP
were separated as described by Marr _et_ al. (1978a) on a silica based
anion exchange column containing 5um spherical silica beads coated
with anion exchange polymer. The "Spherisorb" 5 SAX column (length
25cm internal diameter 4.6mm) was obtained from Anachem Ltd. and used
in conjunction with a guard column packed with the same material
(2.5cm long with internal diameter 4.6mm). The column was connected
to an Altex dual pump HPLC system with a 412 programmable controller.
Column eluent was continuously monitored at 260nm by a Hitachi
variable wave length spectrophotometer equipped with a flow cell
(volume 0.1ml) and 0.5ml fractions collected. Samples for HPLC
analysis were prepared as follows. Cells incubated in radiolabelled
nucleotide precursors were separated from the incubation medium by
silicon sandwich centrifugation (Section 2.11.2) with 40% formic acid
as the lower layer. Samples of the formic acid layer (100/jl) were
removed, carrier nucleotides added (20nmoles of each) and lyophilised
for 36 hours to remove the formic acid. The dried material was then
redissolved in 50^1 0.005M NH^H^PO^ pH 3.5 and passed through a
0.25/im "Millipore" filter before being applied to the column. The
sample (20jal) was applied to the column and eluted with a gradient of
0.005M to 0.505M NH,H„P0, pH 3.5. The formation of the gradient was4 2 4
under the control of the 412 HPLC controller which had been
programmed as follows. The sample was run into the column at a flow
rate of 0.5ml/min for 1 minute at which time a gradient from 0.005M




buffer 30 minutes into the run. At 30.5 minutes into the run the flow
rate was increased to 1ml/min and a second gradient from 0.045M to
0.280M NH^H^PO^ was started, the higher concentration being reached
75 minutes into the run. At this point the gradient was steepened to
give 0.505M NH,H„P0, 85 minutes into the run. After elution at thisA 2 4
concentration for a further 10 minutes, giving a total run time of 95
minutes, the run was terminated and the column re-equilibrated with
the starting buffer. The elution profile obtained with this system
and the gradient used are shown in Figure 2.2. The label incorporated
in each nucleotide was estimated by liquid scintillation counting of
the fractions collected.
2.10 ENZYME ASSAYS
Adenosine hydrolase, APRT and HxF ere assayed by measuring
the production of radiolabelled adenine, AMP and IMP respectively
3 3 3
from [2,8- H] adenosine, [8- H] adenine and [G- H] hypoxanthine,
their respective substrates. The assays were carried out in 10mM
TrisHCl buffer, 1mM DTT at pH 7.4 supplemented with 0.5mM PRPP and
1mM MgCl^ for the assay of APRT and HxPRT. The assay mixes also
contained the labelled substrates at the required concentration
(specific activity lOO^Ci/jumole). The assays were started by addition
of trypanosome lysate and incubated at 22°G for 3 minutes. The assays
were terminated by pipetting samples of the assay mix into glass
tubes heated to 120 C which were maintained at this temperature for a
further 1 minute. Precipitated protein was then removed by
centrifugation and samples of the supernatants mixed with the
2.8. The production of adenine (adenosine hydrolase assay), AMP (APRT
assay) and IMP (HxPRT assay) was estimated by liquid scintillation
counting of the appropriate spots cut from the TLC plates. The
radiolabelled purines used in these assays were obtained from
Amersham International pic.
2.10.1 (X-Glucosidase Assay.
The enzyme o<-glucosidase (EC 3.2.1.20) was assayed by the
fluorimetric method of Steiger et al.(1980). In this assay system the
enzyme catalyses the hydrolysis of the synthetic substrate
A-methylumbelliferyl-oc-D-glucoside (Sigma Chemical Co.Ltd.) causing
the release of 4-methylumbelliferone which is measured
fluorimetrically. The assays were carried out in 0.1M sodium
phosphate buffer (2.5ml) containing 1mM DTT, 0.1% Triton X100,pH 7.A
and 2mM substrate. The incubations were started by the addition of
the enzyme source to the above incubation mix in a thermostated
fluorimeter cell at 35°C. The production of A-methylumbelliferone was
measured in a Perkin Elmer 3000 fluorimeter at an excitation wave-
-length of 366nm and an emission wave —length of 460nm. The
fluorescence was continuously monitored by a chart recorder attached
to the fluorimeter. The amount of 4-methylumbelliferone produced was
estimated from a standard curve.
2.10.2 Na+/K+ Adenosine Triphosphatase Assay.
The activity of ouabain inhibitable Na+/K+ ATPase was determined
by a coupled enzyme assay which measured the production of ADP from
ATP in the presence and absence of ouabain which inhibits the Na+/K+
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ATPase. The use of ouabain allowed discrimination between Na+/K+
ATPase activity and general phosphatase and ATPase activity. The
assay mix contained in a volume of 3ml; 6mM sodium phosphate buffer
pH 7.0, 10mM KC1, 2mM MgCl2> 0.03mM ATP, 0.03mM
phosphoenolpyruvate(PEP), NADH 0.l6mM, lactate dehydrogenase(LDH) (EC
1.1.1.27) 0.2mg (100 units) and pyruvate kinase(PK) (EC 2.7.1.AO)
0.2mg (100 units) either with or without 2mM ouabain. The principle
of the assay is outlined below;(assay temperature 30°C)







The disappearance of NADH was monitored at 3A0nm by a Pye Unicam
SP8000 spectrophotometer linked to a chart recorder.
2.10.3 Adenosine Deaminase Assay.
The activity of adenosine deaminase (EC 3.5.A.A) was estimated
using the spectrophotometric assay described by Agarwal & Parks(1978)
in which the decrease in absorbance at 265nm is measured as adenosine
is converted to inosine by the deaminase. The assays were carried out
in thermostattea 1ml quartz cuvettes containing the protein being
tested for activity, 50mM potassium phosphate buffer pH 7.A
(0.7-0.9ml), 1Opl of adenosine (10mM) to give a final concentration
of 0.1mM in a final volume of 1ml at 30°C. The assays were started by
the addition of adenosine and the change in absorbance recorded on a
chart recorder linked to an SP8000 spectrophotometer.
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2.11 TRYPANOSOMA UPTAKE ASSAYS.
Three methods were evaluated for the estimation of trypanosomal
uptake as detailed in the following sections. The uptake of
radio-labelled substrates by trypanosomes was assayed by incubating
trypanosomes in PSG pH 7.4 with the required concentrations of
labelled substrate, the incubations being terminated by dilution of
the incubation mixture with 10 volumes of ice cold PSG followed by
centrifugation at 3000x£ av. to pellet the cells. The cell pellet was
then resuspended in ice cold PSG and centrifuged a further three
times followed by water lysis of the cells. Protein was then removed
from the lysate by centrifugation after precipitation of the protein
with PCA. This procedure resulted in the production of a supernatant
in which the label taken up was estimated by liquid scintillation
counting.
2.11.1 Rapid Filtration.
The uptake of labelled substrates by trypanosomes was also
assayed by rapid filtration. Cells were removed from the incubating
medium (PSG pH 7.4 and labelled substrate) by rapid filtration
through glass fibre filters (Whatman GF-C). Samples of the incubation
mixture were injected into 4 volumes of ice cold PSG pH 7.4 contained
in the sample well of a "Millipore" filter tower and a vacuum
immediately applied to draw the incubation mix through the filter
which was followed by a further 20ml of PSG. The filters used were
prewashed in high concentrations of the substrate being used for
uptake to minimise background labelling of the filter. Uptake of
label was then estimated by liquid scintillation counting of the
filters after drying for 1 hour at 70°C.
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2.11.2 Silicon Sandwich Centrifugation.
Uptake of labelled substrates by trypanosomes was also
estimated by the silicon sandwich centrifugation technique (Damper &
Patton,1976a & 1976b). In this method the incubation medium
containing the trypanosomes was centrifuged (10,000xg av. for 1.5
minutes) after being layered onto a sandwich consisting of silicon
oil (200jil) and 6M PCA (150jj1). The oil used had a density of 1.04854
3
g/cm which was obtained by mixing the silicon oils MS 550 density
3 3
1.07 g/cm and MS 556 density 0.98 g/cm (BDH Ltd.). The oils were
weighed out on a five place balance in the ratio 3.468:1 (w/w) MS
550:MS 556. One of the drawbacks of this assay method is that some of
the incubation medium is carried through the oil layer on the surface
of the cells. However this can be estimated and corrections made to
the estimated uptake. The carry through was estimated by measuring
14
the amount of an impermeant radiolabel ([carboxy- C] inulin) in the
PCA layer after centrifugation. The average carry—through was found
to be 1.2_+0.2^il/mg trypanosomal protein. It should be noted that
throughout this thesis all results obtained using this method are
shown corrected for carry—through where appropriate. Uptake of
radiolabelled substrate was estimated by liquid scintillation
counting of samples of the PCA layer.
2.12 ESTIMATION OF PROTEIN.
Throughout this work protein was estimated by the dye binding
method of Bradford (1976). The dye reagent used consisted of 0.01%
Serva blue dye (w/v), 4.7% ethanol (w/v) and 8.5% phosphoric acid
(w/v). Samples of protein ( 100pl final volume) were mixed with 3m1 of
the reagent described above and the absorbance at 595nm of the
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resultant solution measured after fifteen minutes. The amount of
protein present was estimated from the absorbance measured using a
standard curve with BSA fraction IV as the standard protein. The
absorbance produced was found to be proportional to the amount of
protein present in the range 1jug to 100jig.
2.13 SDS POLYACRYLAMIDE GEL ELECTROPHORESIS.
The discontinuous SDS PAGE method used was as described by
Laemmli & Favre (1973). The solutions required are listed below.
GEL BUFFER. The composition of the gel buffer was as follows: 1.5M
TrisHCl, 8mM EDTA, 0.4% SDS, pH8.8. The buffer was made up as
follows; 181.5g Trizma base (Sigma Chemical Co. Ltd.), 2.68g Disodium
EDTA (BDH Ltd.) dissolved in distilled water and titrated to pH 8.8
with HC1 (11M) before making the volume up to 1000ml. The SDS (4.0g)
(BDH Ltd. Biochemical grade) was then dissolved in the buffer to
prevent damage to the pH electrode.
ACRYLAMIDE/BIS - ACRYLAMIDE. The acrylamide solution used had the
following composition: 30%(w/v) acrylamide and 0.9% (w/v) methylene
bis-acrylamide. 60g of acrylamide and 1.6g N,N', bis-methylene
acrylamide (BDH Ltd.) were dissolved in 200 ml of water and filtered
through glass wool before storage in the dark at 4°C.
STACKING GEL BUFFER. The stacking gel buffer contained 0.5M Tris HC1,
8mM EDTA, 0.4% SDS, pH 6.8. The buffer was made up as follows: 12.0g
Trizma base. (Sigma Chemical Co. Ltd.), 0.523g disodium EDTA were
dissolved in water and titrated to pH 6.8 with HC1 (11M) before the
-56-
addition of 0.8g SDS and water to a final volume of 200ml.
POLYACRYLAMIDE. The solution of polyacrylamide used consisted of
polyacrylamide 1%, 1mM sodium azide and 1mM sodium fluoride. This
solution was made by adding Polyacrylamide (2g) (Aldrich Chemical
Co.), very slowly with vigorous stirring, to 200ml of the
azide/fluoride solution and filtering through glass wool.
ELECTRODE BUFFER. The electrode buffer contained 0.050M Tris, 0.38AM
glycine, 2mM EDTA, 0.1% SDS which was made up as follows:
30g Tris base(BDH Ltd. general purpose.), 144g glycine (Sigma
Chemical Co. Ltd. ammonia free.), 5g SDS, 3.72g disodium EDTA were
dissolved in 5 1 of double distilled water.
FOUR TIMES CONCENTRATED SAMPLE BUFFER. The sample buffer used was
made up as follows: SDS (8g) was dissolved in 0.5M TrisHCl pH 6.5
(40ml), 0.2M EDTA pH 7.0 (4ml) and glycerol (40ml). This solution
was made up to 100ml with double distilled water to give 0.2M
TrisHCl, 8% SDS, 8mM EDTA, 40% glycerol, pH 6.5.
In all solutions disodium EDTA was used since using the free acid
lowers the pH of the buffers resulting in poor resolution of proteins
on the gel.
All samples were electrophoresed on 8% to 20%(w/v) exponential
gradient gels with a 1cm stacking gel unless otherwise stated. The
gels were prepared by pumping (1.5ml/min) an 8% acrylamide solution
into a 20% acrylamide solution in a mixing chamber held at a constant
volume. The mixed solution was then pumped (1.5ml/min) between two
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chromic acid washed glass plates sealed around three edges with 1.0mm
thick plastic spacers. The plates were 16cm broad and 20cm high with
one plate notched (14cmx1cm) to accommodate the 'comb' mould used to
form sample wells in the stacking gel. The two gel solutions which
were mixed to form the gradient had the following composition. The 8%
gel mix consisted of 5ml of gel buffer, 5.3ml of acrylamid^/
bis-acrylamide, 3.3ml of polyacrylamide, 6.4ml of water, 80^1 of 10%
ammonium persulphate solution and 10pl of TEMED. The 20% gel mix
consisted of 2.5ml gel buffer, 6.6ml of acrylamidqfeis-acrylamide
solution, 1.7ml of polyacrylamide, 60jj1 of 10% ammonium persulphate
solution and 5pl of TEMED. The ammonium persulphate and TEMED
chemically polymerise the gel. The solutions were pumped until the
low percentage gel chamber of the gradient forming apparatus was
empty. The unpolymerised gel was then overlaid with water saturated
butan-2-ol to give a flat surface to the gel. The gel was then left
for 20-30 minutes to polymerise after which time the butanol overlay
was removed and the gel surface washed with water and stacking gel
buffer. The stacking gel (3ml stacking gel buffer, 1.8ml acrylamide/
bis-acrvlamide. 2.6ml polyacrylamide, 5.1ml water, 250^il ammonium
persulphate and 20/il TEMED) was then poured onto the running gel and
the sample 'comb' inserted between the plates before the gel
polymerised. After the gel had polymerised (5 minutes) the 'comb' and
bottom spacer were removed and the plates clipped to an
electrophoresis tank. The top and bottom buffer reservoirs were then
filled with electrophoresis buffer and the protein samples injected
into the sample wells using a Terumo syringe.
Protein samples were prepared for electrophoresis by mixing the
protein, four times concentrated sample buffer and water to give a
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protein solution with a minimum concentration of 1mg/ml and a four
fold dilution of the sample buffer. The samples were prepared with a
protein concentration of Img/ml or greater since "lOOjig to 200/ig of
protein per sample, was required for loading onto the gel and the
maximum sample volume which could be applied to the gel was 120)j1.
The protein concentration of the sample was reduced when dealing with
purified and semipurified proteins, the concentrations quoted being
applicable to whole cell lysates.
After electrophoresis the gels were fixed in a solution of 20%
methanol, 10% acetic acid for 1 hour. The gels were then stained in a
solution of 0.25% Coomassie brilliant blue R-250 in 25% methanol,
10% acetic acid (w/v/v) in water. Gels were destained by soaking in
25% methanol 10% acetic acid. The destaining of the gels was
accelerated by heating in a shaking water bath at 45°C in the
presence of polyurethane packing foam to absorb the dye washed from
the gel.
The molecular weights of proteins were estimated from their
mobilities relative to the marker dye, bromophenol blue, and a set of
standard proteins of known molecular weight. These molecular weight
markers were obtained from Sigma Chemical Co. Ltd. and are listed
below.
The molecular weights of proteins were calculated from a standard























curve. The curve was constructed by plotting log^ of the molecular
weight of the standard proteins listed above against their mobilities
relative to bromophenol blue.
2.14 AUTORADIOGRAPHY AND FLUOROGRAPHY OF RADIOLABELED
PROTEINS ON SDS PAGE GELS.
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Gels of protein mixtures labelled with P or I were fixed,
stained and destained as described above, then soaked in destain
containing 15%(w/v) glycerol for 1 hour in order to prevent cracking
of the gel during drying. Following this the gel was then dried under
vacuum on a Biorad gel drier onto filter paper or acetate sheets. The
dried gels were then placed in light-proof cassettes in contact with
a sheet of X-ray film and exposed at -70°C for a period of time
determined by the amount of radioactivity present in the gel.
3
Gels containing proteins labelled with H were analysed by
fluorography which enables detection of radio—isotopes with low
3
emission energies such as H. The gels were stained and destained as
described above and then soaked in a solution of 1M sodium
salicylate, 15%(w/v) glycerol for 1 hour before drying. The gels were
then exposed to X-ray film as for autoradiography. The distribution
3
of H labelled proteins on gels was also determined by cutting the
gel into 2mm strips and heating the strips in 15%(w/v) H2C>2 at 60°C
for 12 hours to dissolve the gel and release the label for liquid
scintillation counting (Cabantchick & Rothstein,1974). The gel must be
dissolved before counting since the /^-particle emitted by H does not
have enough energy to penetrate the gel and therefore would not be
detected in intact gel slices.
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2.15 SYNTHESIS OF $-32p ATP.
32
The synthesis of P ATP was carried out by the exchange
procedure described by Glynn & Chappellf1964) and England!1979). The
reaction mixture used is listed below.
1M Tris pH 8.0 100jil
0.1M EDTA pH 7.0 5/il
2-mercaptoethanol 0.3}il






The exchange procedure was started by the addition of a mixture of
the enzymes phosphoglycerate kinase (EC 2.7.2.3) and
glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12) as 20yul of a
1:1 activity mixture supplied by The Boehringer Corporation Ltd. The
reaction mixture was left to stand at room temperature for 2 hours.
At the end of this incubation time the reaction mix was diluted with
1ml of water and the incorporation of the labelled phosphate into the
ATP measured. Incorporation was measured by diluting lyul of the
reaction mix to 1ml and counting 5jul by liquid scintillation
counting. The remainder of the diluted reaction mix was then mixed
with 0.3ml of Norit activated charcoal, centrifuged and 5yjl of the
supernatant counted as before. Subtraction of the number of counts in
the charcoal supernatant from the number of counts present before the
addition of the charcoal gives an approximate measure of the
incorporation of label. The incorporation of label was normally >95%.
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The labelled ATP was purified from free labelled phosphate on a
column of 200 mesh Dowex 1x8 ion exchange resin 1.4cm diameter by
0.5cm high. The resin was cycled 3 times with 0.1M NaOH and 0.1M HC1
then washed with 1M HC1 and washed to neutrality with water. The
reaction mix was then applied to the column followed by 2ml of water,
3 x 2m 1 of 0.05M NHZ(C1/0.02M HC1, 2ml of water and finally 0.25M HC1
collecting 0.5ml fractions. The fractions eluted in the final acid
wash were assayed for labelled ATP by the charcoal binding assay. The
fractions containing labelled ATP were then pooled and neutralised
with 2M Tris. The labelled ATP was stored frozen at -20°C until
required.
2.16 IODINATION OF CELL SURFACE PROTEINS WITH 125I IODINE
BY LACTOPEROXIDASE.
Trypanosomes were iodinated by a modification of the method of
Marchalonais(1969) as described by Mancini et al.(1982).
9
Approximately 1x10 trypanosomes were suspended in 200^1 of PSG
buffer pH 7.4 containing 5mM KC1, 1mM MgCl^, 1mCi of carrier free
125
Na I and 50jil of lactoperoxidase (EC 1.11.1.7) (1mg/ml, 2 Units/ml)
on ice. At time zero the iodination was started by the addition of
30^j1 of 0.001% H202 in PSG. An additional 10jj1 of H2<02 was added 1
minute and 2 minutes after the start of the iodination. The reaction
was terminated after three minutes by the addition of 10 volumes of
PSG containing 10yuM KI. The cells were washed by centrifugation and
resuspension in this buffer four times and used immediately in cell
fractionation experiments or frozen until required.
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2.17 MEASUREMENT OF ApH ACROSS THE TRYPANOSOMAL
PLASMA MEMBRANE.
The pH gradient across the trypanosomal plasma membrane was
14
measured by following the distribution of [ C] methylamine across
the plasma membrane in response to the pH on either side. The
principles of this technique are explained below.
In the following equations the subscripts I and 0 refer to
inside and outside the cell respectively. The weak base, methylamine,




In the absence of a pH gradient and at
equilibrium the total concentration of methylamine inside and out
side the cell will be equal.
[ch3nh3pi
_ [ch3nh3+]0
[ch3nh2]: [h'pj [ch3nh2j0 [hpq
Taking logs of the above equation gives
log [CH3NH3+]i - log [CH^H^ + pH-j.
= log [CH3NH3+]q - log [CH3NH2]q + pHQ
At equilibrium irrespective of the presence of a pH gradient across
the plasma membrane the concentrations of the uncharged forms of
methylamine must be equal. Therefore the equation simplifies to;
log [CH3NH3+]i + pH: = log [CH3NH3+]0 + pHQ
PHI " PH0 = loS tCH3NH3+]o _ log [CH NH +] I
ie.
[CH NH +] - [CH NH?]
A PH= log J
[CH3NH3+]i- [CH2NH2JJ
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Given that the pKa of methylamine is 10.6 it can be seen in the above equat
the term CH3NH2 out is negligable at the pH used.
The final equation above is some-what misleading in that
experimentally the total amount of methylamine inside and outside the
cell is measured. However the above equation does show that any
differences in internal and external concentrations of methylamine
will be due to differences in pH across the plasma membrane. The
experimental protocol used in measurements of ApH across the plasma
membrane is detailed in Section 3.6.8.
2.18 LIQUID SCINTILLATION COUNTING.
All radioisotopes were quantified by liquid scintillation
counting in commercially supplied scintillant (Scintran cocktail T.
BDH Chemicals Ltd.) in a programmable Packard scintillation counter.
The counter automatically corrected for quenching using a quench
curve held in the counter's memory. Quenching was estimated from data
obtained from an external radium source and standard channel ratios.
2.19 TREATMENT OF KINETIC DATA.
In all cases the kinetic parameters of uptake or of an enzyme
catalysed reaction were estimated from a Hanes plot (S/V against S).
The line was fitted to the data points by an unweighted linear
regression programme run on a Sinclair microcomputer.
The thermodynamic characteristics of transport were estimated
from Arrhenius plots and the line of best fit was determined by
linear regression as before. The thermodynamic parameters AH
(enthalpy change), AG (Gibbs free energy) and AS (entropy change)




-logK = -4H/4.6 x 1/T
eq
AG = -2.303 RT logK
eq
AS = m - AG/T
Where R = gas constant, T = absolute temperature, Ea = activation
energy and = equilibrium constant.
2.20 CHEMICALS.
All enzymes used were supplied by The Boehringer Corporation
Ltd. All radiochemicals were supplied by Amersham International Pic.
All enzyme substrates were supplied by The Sigma Chemical Co. Ltd.
unless otherwise stated. All other chemicals and solvents were of




3.1 PYRIDOXINE UPTAKE AND METABOLISM.
Various methods were tried for estimating the amounts of radio-
labelled substrates taken up by trypanosomes.
These methods were;
(a) Pelleting the cells by centrifugation after dilution of
the incubation medium by ice cold buffer, repeatedly washing with
buffer followed by water lysis of the cells. Protein could then be
removed by precipitation and centrifugation leaving a supernatant
fraction for the analysis of label taken up (Materials & Methods
2.11).
(b)Cells were removed from the incubating medium by rapid
filtration onto glass fibre filters. Uptake of label was then
estimated by liquid scintillation counting of the filters (Materials
& Methods 2.11.1).
(c) Centrifugation of the cells out of the incubation medium
through a silicon oil layer (silicon sandwich) into an appropriate
stopping solution (Materials & Methods 2.11.2).
Method (c), silicon sandwich centrifugation, was the method
finally chosen since method (a) can not easily be used to obtain
short incubation periods unless the incubation medium can be diluted
by a very large excess of buffer. This method also allows metabolism
of material taken up to continue during washing. Even if ice cold
washing buffers are used, some heating during centrifugation is
unavoidable. Method (b), filtration, is suitable for use with short
incubation periods but it allows metabolism to continue on the
filters, metabolites are difficult to extract quantitatively for
further analysis and non-specific binding of labelled substrate to
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Trypanosomas at a protein concentration of 1.90mg/ml were incubated at
a temperature of 22°C (•) or 2°C (x) with (G-3H] pyridoxine (10/iM;
specific activity lOOjiCi/pmole) for tne times indicated at pa 7.4 in
PSG buffer. The inset shows the time course of pyridoxine uptake at a
concentration of 21nM (specific activity 1. 4Ci//imole) at 22°C. Uptake
was estimated by silicon sandwich centrifugation as described in the
text (Section 3.1.1).The results are shown as means and range of two
determinations.
the filters results in unacceptably high background counts.
The silicon sandwich centrifugation assay system allows short
incubation times and metabolism is stopped at the same time as uptake
when the cells hit the stop solution below the oil layer.
Metabolites of the labelled substrate can easily be recovered
from the stop solution for further analysis.
3.1.1 Time course of Pyridoxine uptake.
Pyridoxine uptake was measured as a function of time using
3
[G- H]-Pyridoxine as substrate and silicon sandwich centrifugation as
described in Materials & Methods (2.11.1).
3
Trypanosomes were incubated with [G- H]-pyridoxine as described
in the legend to Figure 3.1. The uptake assay was started by addition
3
of [G- H]-pyridoxine to a suspension of cells. Samples were then
taken and centrifuged on silicon sandwiches at the times shown in
Figure 3.1.
Samples of the lower layer of the silicon sandwiches, in this
case 6M perchloric acid {PCA.), were taken for liquid scintillation
counting. Uptake was then calculated and expressed as pmol pyridoxine
taken up/mg of protein.
Figure 3.1 shows the results obtained for the time course of
pyridoxine uptake. The insert shows the time course of uptake at 22°C
at a more physiological concentration of pyridoxine (21nM). The














Figure 3.2 SORFACB BINDING OF PYBIDOXINE.
Trypanosomes at a protein concentration of 1.90mg/ml were incubated at
22°C with [G-^H] pyridoxine (10pM; specific activity 100jJCi/>amole) for
the times shown above. The uptake assays were terminated by washing
the cells, in either ice cold PSG (•) or ice cold PSG supplemented
with 5mM pyridoxinef»), as described in the text (Section 3.1.2). The
uptake of pyridoxine was estimated by lysing the cell pellets in water
followed by liquid scintillation counting. The figure shows the mean
and range of duplicate determinations.
The above concentrations were calculated from data published by
Lumeng et al.(1980).
Lowering the incubation temperature from 22°C to 2°C reduces the
amount of pyridoxine taken up by the trypanosomes by approximately
50%. This 50% inhibition suggests that the uptake system consists of
a temperature sensitive component such as metabolism and a less
temperature sensitive component such as diffusion through the plasma
membrane. These findings are similar to those reported for the uptake
of pyridoxine by the erythrocyte (Mehansho & Henderson,1980) and by
liver (Mehansho _et al.,1980).
3.1.2 Surface binding of Pyridoxine.
It could be argued that the apparent uptake of pyridoxine at 2
3
C is due to non-specific binding of the [G- H] pyridoxine to the cell
surface. To investigate this possibility trypanosomes were incubated
3
with [G- H] pyridoxine as previously described (Section 3.1.1) but
instead of terminating the uptake assay by silicon sandwich
centrifugation the cells were pelleted by centrifugation and washed 3
times in either PSG or PSG supplemented with 5mM pyridoxine. If the
observed uptake at 2°C was due to surface binding the 5mM pyridoxine
( 500 times greater concentration than substrate pyridoxine) would be
3
expected to compete for binding sites with the [G- H] pyridoxine.
3
This would result in a reduction of the amount of H present in the
cell pellet when compared to the PSG washed cells. The results of
this experiment are shown in Figure 3.2. The results show that
washing the cells in PSG supplemented with 5mM pyridoxine results in
a slight lowering of the amount of label present in the cell pellet.
If the uptake measured at 2°C in the silicon sandwich centrifugation
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Figure 3.3 CONCENTRATION DEPENDENCE OF PYSIDOXINB UPTAKE.
•
Trypanosomes (1.90mg protein/ml) were incubated at 22°C for 1.5
minutes (□) or 30 minutes (o) or at 2°C for 1.5 minutes (•) or 30
minutes (X) over a range of pyridoxine concentrations 5-65nM (specific
activity 1.4Ci/>imole) and 10-60UM (specific activity 100jiCi/^mole).
All incubations were carried out at pH 7.4 in PSG buffer uptake being
estimated as described in the text Section 3.1.1. The results are
3hown as the mean and range of duplicate determinations.
experiment was due to surface binding a 50% reduction in the
estimated uptake of pyridoxine would be expected in the cells washed
in PSG supplemented with the 5mM pyridoxine. The small reduction in
uptake observed varied with time and may be due to the exchange of
3
free intracellular [G- H] pyridoxine with the extracellular
unlabelled pyridoxine in the wash solution. This point will be
considered in full in the discussion.
If entry of pyridoxine into the cell is by diffusion it should
not be saturable, therefore the concentration dependence of uptake
was investigated.
3.1.3 Kinetic parameters of Pyridoxine uptake.
3
Trypanosomes were incubated with [G- H]-pyridoxine at the
concentrations shown in Figure 3.3. Experimental details are given in
the legend to Figure 3.3. The results show that uptake is
non-saturable over the substrate concentration range 5nM-60pM. This
non-saturability of uptake provides further evidence that uptake is
by diffusion. In this experiment lowering the temperature had no
marked effect on the rates of uptake.
The concentration dependence of uptake was measured using 1.5
minute and thirty minute incubation times, both of which gave linear
plots for uptake. The rates of uptake at thirty minutes are much
slower than the uptake rates measured at two minutes as would be
expected from consideration of the time course of uptake (Figure
3.1). The inability to saturate uptake suggests that either
diffusion through the plasma membrane is the rate limiting step for
uptake or that the pyridoxine metabolising enzymes have high Km's for
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concentrations used. These points will be considered in more detail
in the Discussion (Section 4.1).
As mentioned previously uptake of pyridoxine by the erythrocyte
and by the liver is by diffusion followed by metabolic trapping
(Mehansho and Henderson 1980; Mehansho et al_, 1980), so the metabolism
of pyridoxine by whole cells was investigated.
3.1.4 Time Course of Pyridoxine Metabolism in
Whole Cells.
Samples of the PCA layer from a time course of pyridoxine uptake
were analysed for their content of vitamin B, vitamers as described
o
in the legend to Figure 3.4.
The results shown in Figure 3.4 indicate that the pyridoxine
taken up is oxidised to pyridoxal since pyridoxine levels fall as
pyridoxal levels rise. The next stage in metabolism appears to be the
phosphorylation of pyridoxal to pyridoxal phosphate since the levels
of pyridoxal begin to fall as the levels of the phosphorylated forms
of begin to rise. The apparent oxidation of pyridoxine to
pyridoxal is unexpected since in the liver pyridoxal phosphate is
formed from pyridoxine by first converting pyridoxine to pyridoxine
phosphate using the enzyme pyridoxal kinase (ATP:Pyridoxal
5-phosphotransferase EC 2.7.1.35) which can phosphorylate pyridoxine
or pyridoxal equally well. The pyridoxine phosphate is then oxidised
by pyridoxamine phosphate oxidase (Pyridoxamine phosphaterO^
oxidoreductase (deaminating) EC 1.4.3.5) to pyridoxal phosphate. The
pyridoxamine phosphate oxidase has slightly lower affinity for
pyridoxine phosphate than for pyridoxamine phosphate but both
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Figure 3.5 FRHIXB3NE AND PTRIDOXAL PURIFICATION OH AH AMINO-BTHYL
CELLULOSE COLOMH.
The above figure shows the elution profiles of a mixture of authentic
pyridoxine and pyridoxal (•) and [G-^H] pyridoxine and pyridoxal from
a synthesis of [G-^al pyridoxine from [G-3H] pyridoxal (X)- The figure
also shows the pH of the eluting ouffer. The pyridoxine peak is
labeled PN and the pyridoxal peak PA. All other experimental details
are given in the text (Section 3.1.4).
substrates give the same Vmax value. The pyridoxamine phosphate
oxidase has a very low affinity for pyridoxine which makes the direct
oxidation of pyridoxine unlikely in the presence of an active
pyridoxal kinase (Wada & Snell,1961;Mehansho et al., 1980). There is
however another enzyme, found in E.coli, capable of direct oxidation
of pyridoxine to pyridoxal, pyridoxine — A-dehydrogenase
{pyridoxine:NADP oxidoreductase EC 1.1.1.1). This enzyme produces
NADPH^ whereas the pyridoxamine phosphate oxidase produces and
since bloodstream forms of T.brucei have no haem proteins such as
catalase for the removal of peroxides it seems likely that a
dehydrogenase is responsible for the oxidation of pyridoxine to
pyridoxal in the trypanosome.
To investigate the uptake and metabolism of vitamin B, further
o
3 3
[G- H]-pyridoxal was synthesised chemically from [G- H]-pyridoxine as
3
[G- H]-pyridoxal is not commercially available.
3.1.5 Synthesis and Purification of Radiolabelled
Pyridoxal from Radiolabelled Pyridoxine.
The chemical conversion of pyridoxine to pyridoxal was achieved
by the oxidation of pyridoxine by potassium permanganate at 20°C.
(Snell,19AA). The synthesis was first carried out using unlabelled
pyridoxine and a method for purifying pyridoxal from the reaction
mixture was developed, which is detailed below.
The synthesis was carried out as follows;
Pyridoxine ( 100jil; 1.ACi/mmol) at 1mCi/ml was added to 0.2/imoles of
unlabelled pyridoxine in a total volume of 120jj1. Potassium
permanganate (AOjil of a 10mM solution) was then added giving a
potassium permanganate:pyridoxine ratio of 3:2 on a molar basis. This
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Figure 3.6 TIHR COURSE OF PYRIDOXAX. OPTAXR.
Trypanosomas at a protein concentration of 1.90mg/ml were incubated at
a temperature of 22°C {•) or 2°C (x) with [G-^H] pyridoxal (8.7>iM;
specific activity lOOuCi/pmole) for the times indicated at pH 7.4 in
?SG buffer. Uptake was estimated by silicon sandwich centrifugation
and subsequent liquid scintillation counting of the PCA layer. The
results are shown as tne mean and range of duplicate determinations.
mixture was then allowed to stand in the dark for 2 hr. The
precipitate of manganous dioxide which formed during the reaction was
removed by centrifugation.
The purification of the pyridoxal was carried out on an
amino-ethyl cellulose ion exchange column (0.5cm diameter x 10cm
high) equilibrated with 0.05M disodium hydrogen orthophosphate at pH
9.0. The reaction mixture was then applied to the column and eluted
with 8ml of the phosphate buffer followed by 8-10ml 0.1M acetic acid
pH 3.0. Unreacted pyridoxine and pyridoxic acid are eluted from the
column by the phosphate wash and the pyridoxal is eluted by the acid
wash. When the column eluent was monitored at 295nm the elution
profile shown in Figure 3.5 was obtained. The identities of the peaks
were confirmed by TLC as described in Materials & Methods (Section
2.8.1) and by co-elution with authentic samples of pyridoxine and
pyridoxal.
The pyridoxal peak was collected and lyophilised for 36 hours to
remove the acetic acid from the sample. The pyridoxal was then
redissolved and its purity checked by TLC as above. The radiochemical
purity was 95% at a specific activity of 368.3^uCi//imole. The overall
3
yield of the synthesis was 60%. This [G- H]-pyridoxal was used in the
following experiments.
3.1.6 Time course of Pyridoxal uptake.
Pyridoxal uptake was measured as a function of time as described
in the legend to Figure 3.6. The results of this experiment, shown in
Figure 3.6, are very similar to those obtained for the time course of
pyridoxine uptake. The only difference between the time courses of
pyridoxine uptake and pyridoxal uptake is that the amount of
-72-
Figure 3.7 CONCENTRATION DEPENDENCE OF PYRIDOXAL OPTAKB.
[PYRIDOXAU iJH
Trypanosomes (1.90mg protein/ml) were incubatea at 22°C for 1.5
minutes (•) or 30 minutes (□) or 2°C for 1.5 minutes (♦) or 30 minutes
( x ) over a range of pyridoxal concentrations 10-60pH (specific
activity lOOpCi/pmole). All incubations were carried out at pH 7.4 in
PSG buffer uptake being estimated by silicon sandwich centrifugation
as before.(Figure 3.6) The results are shown as the mean and range of
duplicate determinations.
pyridoxal taken up is greater than the amount of pyridoxine taken up
at any given time point.
The uptake of pyridoxal shows the same partial temperature
dependence as pyridoxine uptake in that a drop in incubation
temperature from 22°C to 2°C results in a 50% to 60% reduction in
uptake. These results as outlined in Section 3.1 suggest a two
component uptake system of which one component is temperature
sensitive, (possibly metabolism or binding to intracellular
proteins), and one component which is less temperature sensitive,
possibly diffusion. As was the case with pyridoxine uptake these
results prompted the investigation of the concentration dependence of
uptake.
3.1.7 Kinetic parameters of Pyridoxal uptake.
The concentration dependence of pyridoxal uptake was determined
as for pyridoxine (Section 3.1.2) with similar results, which are
shown in Figure 3.7. Incubations were carried out for 1.5 minutes and
for 30 minutes at both 2°C and 22°C. The results show that uptake is
non-saturable and only partially temperature sensitive as was the
case for pyridoxine uptake. These results suggest that the uptake of
pyridoxal like that of pyridoxine is by simple diffusion.
3.1.8 Time Course of Pyridoxal Metabolism by Whole Cells.
The time course of the metabolism of pyridoxal was investigated
as described in the legend to Figure 3.8. The various metabolites
were analysed by TLC as described in Materials & Methods (Section
2.8.1). The time course of pyridoxine metabolism (Section 3.1.4)
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suggests that pyridoxine is oxidised to pyridoxal which is then
phosphorylated to give pyridoxal phosphate. It would therefore be
logical to assume that pyridoxal taken up would be metabolised to
pyridoxal phosphate by the enzyme pyridoxal kinase. Examination of
Figure 3.8 shows that little label is incorporated into
phosphorylated forms of vitamin B^. This apparent lack of metabolism
of pyridoxal to pyridoxal phosphate prompted a more detailed
examination of the phosphorylated forms of vitamin B, formed from theb
metabolism of pyridoxine. This experiment was carried out by
digesting the metabolites of pyridoxine with alkaline phosphatase
followed by TLC as previously described (Materials & Methods Section
2.8.1). Comparison of the amounts of pyridoxine and pyridoxal present
before and after alkaline phosphatase treatment allows the estimation
of the relative amounts of pyridoxine phosphate and pyridoxal
phosphate formed. The results and experimental details of this
experiment are given in Figure 3.9 and legend respectively. These
results confirm that pyridoxine is metabolised to pyridoxal and then
to pyridoxal phosphate. However, these results also show that
pyridoxine can be converted to pyridoxine phosphate. These results
are still not consistent with the observation that pyridoxal is not
metabolised to pyridoxal phosphate at a significant rate (Figure
3.8). In order to explain this apparent inconsistency the
hypothetical scheme of metabolism shown below has been developed.
PA ^PA a protein bound
PN PN 1 PA 2 PAP
* * *
. 3 PNP A
If in the above hypothetical system steps 1 and 4 are fast and steps
3 and 2 are slow the observed results can be accounted for. If step 4
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pigure 3.9 PERCENTAGE INCREASE IN PYRIDOXINS AND PYRIDOXAL AFTER















The perchloric acid (PCA) layer from incubations identical to those
descriDed in the legend to Figure 3.4 were neutralised with KOH and
the potassium perchlorate removed by centrifugation. The supernatants
were lyophilised and redissolved in 0.1M sodium bicarbonate buffer pH
10 containing 2mM magnesium chloride. Alkaline phosphatase was then
added to a final concentration of 3mg/ml. This mixture was then
incubated for twenty minutes at 30°C. The digestion was terminated
with PCA followed by neutralisation and clarification oy
centrifugation. The resultant supernatant was analysed by TLC and
liquid scintillation counting as described in Materials and Methods
Section 2.3.1. The results are shown as the mean and range of
duplicate experiments.
is very much faster than step 3 the apparent conversion of pyridoxine
to pyridoxal phosphate shown in Figures 3.4 & 3.9 can be explained in
terms of the rapid step 1 and the slower step 3 competing for the
pyridoxine taken up and if step 4 is rapid then initially little
pyridoxine phosphate would be detectable as it would be rapidly
converted to pyridoxal phosphate. Pyridoxine phosphate levels would
begin to increase as the system comes to a steady state or some feed
back inhibition slows step 4.
3.1.9 Thermodynamic Characteristics of Pyridoxine
and Pyridoxal Uptake.
The uptake of pyridoxine and pyridoxal are not as temperature
dependent as would be expected if uptake was by facilitated diffusion
(Kaback,1968;Stein,1967). The temperature sensitive component of
uptake described (Section 3.3.1) is probably due to the temperature
sensitivity of metabolism. The uptakes of both pyridoxine and
pyridoxal have been shown to be non-saturable which is further
evidence against uptake being mediated by facilitated diffusion. A
further indication of whether a facilitated diffusion step involving
a carrier is involved in the translocation of substrate across the
plasma membrane can be obtained by estimation of the activation
energy (Ea) of uptake. A high Ea would indicate the formation of a
transition complex between the substrate and a carrier protein in the
membrane as is the case for adenosine uptake (Section 3.2.3) and
other uptake systems (Dixon & Webb,1964;Goldman et al.,1968). A low
Ea on the other hand indicates that there is no energetic binding
step required for translocation across the membrane.
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Trypanosomas (l.lOmg protein /ml) were incubated with either pyridoxal
lpM (specific activity 200pCi/>imole) (■) of pyridoxine 3>iM (specific
activity 200>iCi/pmole) (•) in PSG buffer at pH 7.4. Incubations were
carried out over a tenperature range of 0°C to 32°C for 2 minutes.
Optake was estimated by the silicon sandwich centrifugation technique.
The results are plotted as In rate of uptake (dpra/min/mg) against the
reciprocal of the absolute temperature of the incubation. The points
shown are the means and range of triplicate determinations.
3.10 ARRHENItJS PLOTS OF PYRIDOXINS AND PYRIDOXAL OPTAKB.
uptake. The experimental details are given in the legend to Figure
3.10. The information obtained from the Arrhenius plots allows the
calculation of the activation energy (Ea), the enthalpy change (AH),
the entropy change (AS) and the Gibbs free energy change of the
system (AG) for uptake as described in Materials & Methods (Section
2.19). The values calculated for these thermodynamic parameters are
shown below;
PYRIDOXINE UPTAKE PYRIDOXAL UPTAKE
Ea 9.9 kJ/mol 5.A kJ/mol
AH 7.5 kJ/mol 2.9 kJ/mol
AS 128.7 J/mol/K 30.2 J/mol/K
AG -31.1 kJ/mol -6.2 kJ/mol
These values for Ea are 70% to 80% lower than those reported for
uptake systems involving a membrane transport step.(Section 3.2.3;
Damper & Patton,1976b; Goldman _et al.,1968). In fact these activation
energies are much lower than the activation energy of diffusion in
free solution for a molecule the size of pyridoxine or pyridoxal. The
reasons for this and consideration of AS, AH, and AG will be left
until the Discussion (Section 4.1).
3.1.10 Summary of Pyridoxine and Pyridoxal uptake
and metabolism.
Pyridoxine and pyridoxal uptake processes have been shown to be
non-saturable over a wide range of substrate concentrations.(Sections
3.1.2 & 3.1.6). Uptakes of pyridoxine and pyridoxal are only
partially temperature sensitive and both have a very low Ea for
uptake.(Section 3.1.8) These results are qualitatively similar to
those reported by Mehansho & Henderson (1980) for the uptake of
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pyridoxal and pyridoxine by diffusion in the rat erythrocyte.The
metabolism of pyridoxine and pyridoxal will be considered in full in
the Discussion (Section 4.1)
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3.2 ADENOSINE UPTAKE AND METABOLISM.
Since the bloodstream forms of Trypanosoma brucei are incapable
of the de novo synthesis of the purine ring they must obtain all
their purines preformed from the host. Any differences found between
host uptake and metabolism of purines and the trypanosomal system
would provide potential targets for chemotherapy of trypanosome
infections.
Purine nucleosides and bases are present at low concentrations
in mammalian plasma, for example;
Rat plasma Concentrations (pM). Source.
Hypoxanthine 0.7-1.0 Simmonds & Harkness(1981)
Adenosine 1.0-1.5 Von Borstel et al.(1982)
Human plasma Concentrations (jjM) . Source.
Hypoxanthine 0.5-2.8 Taylor et al.(1980a)
Inosine 0.2-1.5 Taylor et al.(1980a)
Adenine 0.1-1.A De Verdier et al.(1977)
Adenosine 0.5-0.9 Maurizio et al.(1982)
Since the concentrations of purines are so low in the plasma it would
be reasonable to assume that the trypanosome has some form of uptake
system for purines. The erythrocyte like the trypanosome can not
synthesise the purine ring de novo but has a high affinity uptake
system for nucleosides.(Oliver & Paterson,1971; Cass & Paterson, 1973;
Cabantchik & Ginsburg,1977; Jarvis & Young,1980). The erythrocyte is
a nondividing cell and so has no purine requirement for DNA synthesis
or RNA synthesis since the mature erythrocyte has lost the ability to
synthesise protein. However the trypanosomes are reproducing in the
host's bloodstream and therefore must have a high purine requirement
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Figure 3.11 TTXK CnCRSE OF ADENOSINE UPTAKE.
Time min
Trypanosomes O.llmg protein/nil were incubated in PSG Duffer pH 7.4,
22°C with IfiM (2,3—J adenosine (specific activity SOpCi/jimole).
Uptake was assayed by liquid scintillation counting of samples of the
PCA layer of silicon sandwiches (500pl of incubation) centrifuged at
the times shown. The results are plotted as the mean and range of
triplicate incubations.
for synthesis of nucleic acids. The fact that T.brucei and
T.gambiense are capable of taking up purines at physiological
concentrations has been shown by James & Born(1980). These authors
showed that the trypanosomes had a saturable uptake system for purine
nucleosides and bases but did not report on the kinetics of uptake or
on the metabolism of purines after uptake.
When assaying uptake James & Born(1980) used centrifugation and
repeated resuspension to remove extracellular label before estimating
the uptake of labelled purine. As stated previously (section 3.1)
there are drawbacks to this experimental approach which are avoided
by the silicon sandwich technique. Also a complete analysis of the
mechanism(s) by which purines are made available as nucleotides for
the parasite, must include investigation of the kinetic and metabolic
aspects of the problem. The following sections present the results of
such an investigation.
3.2.1 Time course of Adenosine uptake.
Adenosine uptake was measured as a function of time by the
silicon sandwich centrifugation technique, described in Materials and
3
Methods (Section 2.11.2), using [2,8- H] adenosine as substrate.
Trypanosomes were incubated with the labelled adenosine as described
in the legend to Figure 3.11.
The uptake assay was started by the addition, with thorough
mixing, of labelled adenosine to 5ml of a cell suspension to give a
final concentration of IjjM adenosine. Samples were then taken and
centrifuged on silicon sandwiches at the times shown in Figure 3.11.
Adenosine uptake was estimated by liquid scintillation counting of
samples of the PCA layer from the silicon sandwiches. The results of
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these experiments are shown in Figure 3.11.
Figure 3.11 shows that the long term 45 seconds to 5 minutes and
short term 10 to 30 second time course of adenosine uptake. The long
time course shows that uptake is initially very rapid but appears to
cease after 2-3 minutes. The short time course shows that uptake is
linear for the first thirty seconds. These results do not agree with
the results obtained by James & Born (1980) who found that uptake,
although slowing down after an initial burst over 2-3 minutes,
continued for up to 30 minutes. The differences in these results and
results obtained for the uptake of other purines, determined in later
experiments (Sections 3.2 to 3.3.5), cannot be wholly explained by
differences in experimental methods but may be due to differences in
the strain of trypanosome used. One major difference is that James &
Born (1980) used a cloned strain whereas TREU.55 used here is
monomorphic but uncloned. It may be that James & Born (1980) were
studying a particular variant of the normal transport system. For
these reasons any further comparisons between work presented here and
that of James & Born (1980) will be considered in the discussion.
When the time course experiment was repeated at a temperature of
0°C the uptake of adenosine was reduced to barely detectable levels.
This temperature dependence suggests the existence of a transport
system for adenosine at the level of the plasma membrane.
The apparent halt in uptake which occurs after three minutes
(Figure 3.11) could be due to utilisation of all the substrate
present in the incubation medium. This is not the case since at four
minutes uptake is 0.6nmol/mg protein and the protein concentration in
the incubation is 0.31mg/ml, therefore the total uptake in a 1ml
incubation will be 0.31x0.6=0.186nmol. The substrate concentration
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released in PSG *Ar
0-5 5-8 £ 10 5 0 £12
1 2-7 ± 0-5 2-7 £0-5
2 2-3 + 0-2 2-5 £0-5
4 4.-3 £0-5 3-0 £ 0-3
Trypanosomas were suspended in PSG pH 7.4 to a concentration of
0.127mg protein/ml (total volume 3ml). [2,8—^H] Adenosine
(SOQMC/jJmol) was then added to a final concentration of and the
mixture incucatea at 22°C for 5 minutes. The trypanosomes were then
centrifuged (8,000xg av) at 0°C and resuspended in P9G at 0°C four
times. After the final wash step the cells were resuspended in either
PSG or PSG supplemented with 2QpM unlabelled adenosine at 22°C. After
resuspension samples of cells were taken and added to liquid
scintillation fluid for estimation of total uptake. Further sanples
were taken at the times shown in the table aoove ana the cells
removed by centrifugation. The lacel in the resultant supernatants
was estimated by liquid scintillation counting. The results shown in
the table are the means and population deviations of five
experiments.
was 1jiM, therefore a 1ml incubation will contain 1nmol of substrate.
It is therefore obvious that lack of substrate is not the reason for
the slowing of uptake since only 18.6% of the available substrate has
been taken up.
It could be argued that at 2-3 minutes the system comes to a
steady state where labelled substrate is leaving the cell as quickly
as it is entering. Considering the results presented in Section 3.2.A
this is unlikely since the levels of adenosine in the cell fall to
barely detectable levels in five minutes. However this hypothesis can
3
be tested experimentally by loading the cells with [2,8- H] adenosine,
washing the cells free of extracellular adenosine at 0°C,
resuspending the cells in warm buffer with and without unlabelled
3
adenosine and measuring any efflux of H. This experiment was
performed as described in the legend to Table 3.1. The results
3
presented in Table 3.1 show that very little of the H taken up is
released on resuspension of the cells in PSG or PSG supplemented with
adenosine.
The fact that addition of unlabelled adenosine does not result
in an increase in label released from the cells suggests that there
3
is very little non-specific surface binding of the H-adenosine since
it would be released by competitive binding of the unlabelled
adenosine. The small amount of label which is released may arise from
cell death due to the repeated centrifugation involved in this
experiment or the non-pelleting of a few cells.
3.2.2 Kinetic Parameters of Adenosine Uptake.
In order to determine the kinetic parameters of adenosine
uptake trypanosomes were incubated with increasing concentrations of
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Figure 3.12a conchjtraticn dependqce of ADecsiNB optake-
[Adenosine]
The rate of [2,8—3a] adenosine uptake over the concentration range 0.2
to 4fJM (constant specific activity 50pCi/>imole) was measured Dy the
silicon sandwich centrifugation technique as described in the legend
to Figure 3.11. All incubations were carried out at 22°C in PSG buffer
at pH 7.4 for 15 seconds. The results are shown as mean and range of
duplicate incubations. (Trypanosomes 0.13mg/ml incubation volume 1ml)
Figure 3.12b hanes plot of the data presented in figure 3.12a.
labelled adenosine as described in the legend to Figure 3. 12a. The
incubation period chosen for this experiment was 15 seconds which
examination of the results of the time course experiment (Figure
3.11) shows that uptake is linear at this time point.
It should be noted that the kinetic parameters of the uptake system
as a whole were measured and not just transport across the plasma
membrane unless the transport step is rate limiting for uptake. In
view of the above consideration the kinetic parameters obtained in
this experiment can only be applied to uptake and not transport
alone.
Figure 3.12a shows that the uptake of adenosine is saturable and
Figure 3.12b is a Hanes plot of the uptake data presented in Figure
3.12a. From the Hanes plot the Km and Vmax can be calculated as 0.5|iM
and 0.50 nmol/min/mg protein respectively.
The low Km of 0.5jiM is probably consistent with estimates of
plasma adenosine concentration of about 1.0juM (Section 3.2). This
value for plasma adenosine concentration is higher than has been
quoted in the past, (<0.1}iM Dobson et_ al. , 1971 & Miyazaki
et_ al., 1974). The reasons for this discrepancy in estimations of
plasma adenosine concentrations are detailed in the Discussion
(Section 4.2).
It is unlikely that adenosine is entering the trypanosome by
simple diffusion across the plasma membrane since uptake is saturable
and highly temperature dependent. If the adenosine is entering the
cell by facilitated diffusion this might be indicated by a high
activation energy (Ea) for uptake.
A high Ea would indicate the binding of adenosine to a carrier at the
level of the plasma membrane, the activation energy being a measure
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Figure 3.13 ARRHENIUS PLOT OF ADENOSINB UPTAKE.
3 3-1 3-2 33 3<> 36 36 37
VTxICr^'K
Trypanosomes (O.Sng protein/ml) were incubated in PSG buffer at pH 7.4
with labelled adenosine lyM (specific activity 50pCi/>imole).
Incubations (30 seconds) were carried out at 0°C/ 22°C and 36°C in
triplicate. The results are plotted (mean and range) as In rate of
adenosine uptake against the reciprocal of the absolute temperature of
the incubation medium.
of the energy required to form the transition complex.
3.2.3 Thermodynamic Characteristics of Adenosine Uptake.
Uptake of adenosine was assayed at various temperatures as
described in the legend to Figure 3.13, which shows the results
expressed as In of the rate of adenosine uptake against the
reciprocal of the absolute temperature. From this Arrhenius plot the
following thermodynamic parameters can be calculated as described in





In using the Arrhenius equation the transport step across the
plasma membrane is being considered as a chemical reaction. The
reaction could be considered to be adenosine taken from outside the
cell (reactant) to adenosine inside the cell (product).(Stein,1976).
The Ea calculated indicates that some form of transport across
the membrane, other than simple diffusion, is taking place. The high
value of Ea calculated above can be compared with the low value
obtained for the uptake of pyridoxine and pyridoxal (Section 3.1.8)
which are taken up by simple diffusion.
The possible significance of AH,AS and AG will be considered in
the discussion.
3.2.4 Metabolism of Adenosine by Whole Cells.
The uptake of adenosine may be dependent on its subsequent
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Figure3.14METABOLISMOF[2,8-3ii)ADENOSINEBYHII LEC L S.
membrane to drive facilitated diffusion. This possibility was
3
investigated by determining the metabolic fate of [2,8- H] adenosine
taken up and determination of the intracellular concentration of
adenosine. The intracellular concentration will be dealt with in a
later section (3.6) when considering the mechanism of adenosine
uptake in more detail.
The experimental conditions for studying the metabolic fate of
adenosine are given in the legend to Figure 3.14. Figure 3.14 shows
3
the variation in distribution of [2,8- H] adenosine in various
nucleotide, nucleoside and base pools as a percentage of the total
label taken up.
This experiment shows that when adenosine is taken up it is very
quickly metabolised to nucleotide. Over 85% of the label taken up at
45 seconds is present as nucleotide. This percentage increases to
over 90% after 20 minutes. The percentage of label present as adenine
falls as nucleotide levels rise, as does the percentage of the label
present as adenosine. However it should be noted that the percentage
of label present as adenosine is always lower than the percentage as
adenine and becomes undetectable before adenine. It should also be
borne in mind that uptake has almost slowed to a stop by 3 minutes
(section 3.2.1), therefore all changes in the distribution of label
after this time are due to metabolism. The possible significance of
the levels of hypoxanthine and inosine will be considered in the
discussion.
Having shown that adenosine taken up is metabolised to
nucleotide the questions asked were, what intermediates are involved,
and what enzymes are responsible for this metabolism ?.
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Table 3.2
METABOLISM OP [2,8-^] ADQCSINE AND [8-^1 ADENINE
BY DIALYSED TRSPANOSCME LYSATB
% OF TOTAL COUNTS
SUBSTRATE h ATP ATP(R) PRPP % NUCLEOTIDE % ADENOSINE % ADENINE
ADENOSINE + — — 5 4 90
ADENOSINE - — + 87 7 4
ADENOSINE - + - 3 5 91
ADENOSINE - — - 0.4 0.4 99
ADENINE + - - 1 0.8 98
ADENINE — — + 97 1 1.2
ADENINE - + - 1 2 95
ADENINE — • — 2.1 4 94
A fresh dialysed trypanosome lysate (Q.lmg protein/ml) was incubated
with labelled substrates at concentrations of lOpM (specific
activity 50yCi/pmol) in PSG buffer pH 7.4, 30°C for 3 minutes. As
shown in the table the incubations contained either ATP (ImM), PRPP
(0.5mM) or ATP(R) which was ATP plus an ATP regenerating system. The
incubations containing the ATP regenerating system contained lOmM SCI,
2mM MgClj, lmM ATP, ImM PEP, NADH 0.16mM, pyruvate kinase 100 units
and lactate dehydrogenase 100 units. All other incubations 'were
suplemented with 2mM Mgcl^. All concentrations given above were the
final concentrations in the incubation. The incubations were
terminated by the addition of PCA (1M final concentration) followed by
neutralisation and TLC of lOyl sanples as aescribed in Materials S
Methods (Section 2.8). Radioactivity in the separated components was
estimated by liquid scintillation counting.
3.2.5 Metabolism of Adenosine by Dialysed Cell Lysate.
In intact mammalian brain tissue exogenous adenosine is taken up
and metabolised to nucleotide by adenosine kinase
(ATP:adenosine 5-phosphotransferase, EC 2.7.1.20 (Shimizu
et al.,1972). In mouse leukaemia cells adenosine kinase is also
responsible for phosphorylation of adenosine taken up with excess
adenosine being deaminated to inosine by adenosine deaminase
(Adenosine aminohydrolase?EC 3.5.A.A) (Lum at al.,1979). In the human
erythrocyte phosphorylation by adenosine kinase appears to be the
main route adenosine takes to nucleotide. Erythrocytes also contain
the enzymes adenosine phosphorylase (Adenosine orthophosphate
ribosyltransferase, EC 2.A.2.1) and adenine phosphoribosyltransferase
(AMP: pyrophosphate phosphoribosyltransferase,, EC 2.A.2.7) (APRT).
However the levels of PRPP in fresh erythrocytes is very low which
would limit the cell's ability to form AMP from adenine, produced by
the phosphorylase, using the phosphoribosyltransferase.(Grimes,1980).
A recent publication by Davies _et_ al. ( 1983) gives a list of
purine metabolising enzymes found in T.cruzi, T.brucei and L.mexicana
with their relative specific activities. The results presented in
this thesis are in broad agreement with those of Davies et al.(1983)
with three exceptions which will be considered below.
With the above background in mind a dialysed trypanosome lysate
was incubated with the substrates as listed in Table 3.2. The
experimental conditions are given in detail in the legend to Table
3.2.
3
When the dialysed lysate was incubated with [2,8- H] adenosine,
ATP and magnesium, 90% of the label was metabolised to adenine with
virtually no nucleotide formed. The same result was obtained in the
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presence of an ATP regenerating system. This result indicates that
there is little or no adenosine kinase activity present in the
lysate. When the experiment is repeated and ATP replaced by PRPP, 87%
of the label is metabolised to nucleotide which demonstrates the
presence of a phosphoribosyltransferase in the lysate. Adenosine
alone added to the lysate results in the conversion of the adenosine
to adenine. These results show that adenosine is first deribosylated
to adenine and then phosphorylated by a phosphoribosyltransferase.
These enzymes and their properties will be considered in section 3.4.
The metabolic steps outlined above are consistent with the
results obtained for the metabolism of adenosine by whole cells
(section 3.2.4). Adenine levels are higher than adenosine levels both
of which fall as nucleotide is formed with adenosine levels falling
to zero before adenine levels.
The absence of adenosine kinase activity is in disagreement with
the results for T.brucei published by Davies et al.(1983) who found
the specific activity of adenosine kinase to be 22% of the specific
activity of APRT. These same authors also detected adenosine
deaminase activity which was not detected (in this work) in the
dialysed lysate since no labelled inosine was detected when adenosine
alone was used as substrate. Adenosine deaminase could not be
detected in trypanosome lysate by the spectrophotometric method
described in Materials and Methods (Section 2.10.3). The lysate also
3
failed to produce any hypoxanthine from added [8- H] adenine
indicating the absence of adenine deaminase (Adenine aminohydrolase
EC 3.5.4.2). Adenine deaminase could not be detected by the
spectrophotometric method used as described in Materials and Methods
(Section 2.10.3). Again the lack of these enzymes is in disagreement
-86-
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Trypanosomas (Lmg protein/ml) were incubated in PSG buffer pfi 7.4,
22°C with 0.5fiM labelled adenosine (lmci/pmole) for 45 seconds to 10
minutes. Samples of the incubation medium (5G0pl) were taken anc
centrifuged on silicon sandwiches with 40% formic acid as the lower
layer. Samples of the formic acid layer (lOOjil) taken and prepared for
analysis by HPLC as described in Materials S Methods (Section
2.9).Radioactivity in the resolved components was estimated by liquid
scintillation counting. The results shown are the mean and range of
duplicate experiments.
with the results of Davies et al.(1983).
The nucleotide produced so rapidly by whole cells may be
metabolised into diverse forms. Therefore the nucleotide content of
3
cells metabolising [2,8- H] adenosine was analysed to determine the
diversity of nucleotides formed.
3.2.6 Diversity of Labelled Nucleotide in Whole Cells.
The experimental details for the analysis of labelled
3
nucleotides, produced by the metabolism of [2,8- H] adenosine, in
whole cells is given in the legend to Figure 3.15 and in Materials
and Methods (Section 2.9).
3
Figure 3.15 shows that the [2,8- H] adenosine taken up is
rapidly metabolised to ATP. Initially AMP is the least significant
adenine nucleotide followed by ADP then ATP. ATP levels are already
at a maximum after 45 seconds of the incubation, ADP levels reach a
maximum after 2 minutes and AMP levels continue to rise for the
duration of the experiment (10 minutes); as the AMP and ADP levels
rise ATP levels fall.
Bearing in mind that after 3 minutes uptake of adenosine has
almost ceased the result could reflect a deficiency of adenine
nucleotide in the cell which is made up after 3 minutes with a rapid
flux of label through the synthetic pathway to ATP followed by a
distribution of the label throughout the adenine nucleotide pool as
general metabolism involving ATP consumption proceeds. The possible
significance of the other nucleotides labelled will be considered in
the discussion.
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Figure 3.16 TIMS COURSE OF HYPOXANTHINE UPTAKE.
Time min.
Trypanosomas 0.61m; protein/ml were incubated in PSG buffer pH 7.4,
22°C with IfiM tG-^H] hypoxanthine ( 5tyil;0.lmM,specificactivity
50pCi/>imole). Uptake was assayed by liquid scintillation counting of
sarrples of the PCA layer of silicon sandwiches (50Cjj1 of incubation)
centrifuged at the times shown. Tne results are given as the mean and
range of triplicate determinations.
3.3 HYPOXANTHINE AND ADENINE UPTAKE AND METABOLISM.
The results of the previous sections have shown that adenosine
is taken up and metabolised by T.brucei, but adenosine is not the
only source of purine found in the plasma. Hypoxanthine and adenine
are present in the plasma at almost the same concentration as
adenosine (Section 3.2). Since hypoxanthine and adenine are present
in the plasma it is possible that the trypanosomes could make use of
these compounds as a source of preformed purine ring.
The ability of T.brucei to take up hypoxanthine and adenine was
investigated using the same methods as were used in the investigation
of adenosine uptake. Before any detailed investigations of
hypoxanthine uptake were considered the time course of hypoxanthine
uptake was determined.
3.3.1 Time Course of Hypoxanthine Uptake.
Hypoxanthine uptake was measured as a function of time by the
silicon sandwich centrifugation technique, described in Materials and
3
Methods (Section 2.11.2), using H-hypoxanthine as substrate.
The uptake assay was started by the addition, with thorough
3
mixing, of [G- H] hypoxanthine to 5ml of a cell suspension to give a
final concentration of I^jM hypoxanthine. Hypoxanthine uptake was
estimated by liquid scintillation counting of samples of the PCA
layer from the silicon sandwiches. The results of these experiments
and the experimental details are given in Figure 3.16 and legend
respectively.
Figure 3.16 shows the long- and short-term time courses for
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released in PSG +Hx
0-5 40 ±1-0 4-3 ±1-1
1 3-4 H-2 4-0 * 1-2
2 3-6 ±0-5 4-0 * 0-4
4 3-1 *0-2 4-2 i 0-5
Trypanosomas were suspenaea in ?SG pH 7.4 to a concentration of
0.127mxg protein/ml (total volume 3ml). [G-^H] Hypuxanthme
(500pC/jx>ol) was then added to a final concentration of 2pM and the
mixture incubated at 22°C for 5 minutes. The trypanosoroes were then
centrifugeo (8,000xg av) at 0°C and resuspended in PSG at 0°C four
times. After the final wash step the cells were resuspended in either
PSG or PSG supplemented with 20prt unlaoelled hypoxanthine at 22°C.
After resuspension samples of cells were taken and added to liquid
scintillation fluia for estimation of total uptake. Further samples
were taken at the times snown in the table above and the cells
removed Dy centrifugation. The laoel in the resultant supernatants
was estimated oy liquid scintillation counting. The results shown in
the table are the means and population deviations of five
experiments.
hypoxanthine uptake. The overall pattern of uptake is similar to that
obtained in the investigation of adenosine uptake, the only
difference being, the amount of hypoxanthine taken up is 30% less
than the amount of adenosine taken up at the same time point. The
uptake of hypoxanthine is initially very rapid but appears to cease
after 2 minutes as was the case for adenosine uptake.
When the time course experiment was repeated at a temperature of
0°C the uptake of hypoxanthine was reduced to barely detectable
levels. This temperature dependence suggests that hypoxanthine uptake
is not by simple diffusion but is a carrier mediated process.
The halt in hypoxanthine uptake is similar to that observed
during the time course of adenosine uptake (Figure 3.11) in that it
is not due to the cells using up all the available substrate.
Calculation, as for adenosine uptake, of the amount of hypoxanthine
taken up at four minutes shows that only 27% of the added
hypoxanthine has been used.
The argument that the system comes to a steady state of influx
and efflux was tested in the same manner as for adenosine uptake
(Section 3.2.1). The results of this experiment and the experimental
details are given in Table 3.3 and legend respectively. As was the
case for adenosine uptake, addition of unlabelled hypoxanthine to
3
cells pre-loaded with [G- H] hypoxanthine does not cause an efflux of
3
H from the cells. This indicates that the apparent halt in the
uptake of hypoxanthine is not due to the system coming to a steady
state. The results also indicate that there is little or no
non-specific surface binding of hypoxanthine to the cell surface as
was the case for adenosine (Section 3.2.1).
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Figure 3.17a OONCanSAnCH D£Pi2®£NCE OF HYPCKANTHINE UPTAKE.
[Hypoxanfhine] /jM
The rate of hyuoxanthine uptake was assayed over the concentration
range 0.2 to 4pM (constant specific activity 50pCi/,uiiole). Incubations
contained trypanosomes at a density of 0.60mg protein/ml in PSG Duffer
pH 7.4, 22°C. All incubations were for 15 seconds uptake oeing
measured by the silicon sandwich centrifugation technique as described
in the legend to Figure 3.11. The results are shown as the mean and
range of duplicate experiments.
Figure 3.17b BANES Pt£JT OP THE DATA PRESENTED IN FIGURE 3.16a.
3.3.2 Kinetic Parameters of Hypoxanthine Uptake.
The kinetic parameters of hypoxanthine uptake were determined by
3
incubating trypanosomes with increasing concentrations of [G- H]
hypoxanthine. Full experimental details are given in the legend to
Figure 3.17a. As shown for adenosine uptake (Section 3.2.1)
hypoxanthine uptake is linear over the first 10 to 30 seconds as
shown by Figure 3.16, therefore initial rates of uptake were measured
with 15 second incubations in this experiment. It should also be
borne in mind that the kinetic parameters measured are those for
uptake and not for transport alone unless transport is rate limiting
for uptake.
Figure 3.17a shows that the uptake of hypoxanthine is saturable
and Figure 3.17b is a Hanes plot of uptake data presented in Figure
3.17a. From the Hanes plot the Km and Vmax can be calculated as 0.3joM
and 0.27 nmol/min/mg protein respectively. The low Km of 0.3pM is
consistent with estimates of plasma hypoxanthine concentration of
0.7-1.0jiM (Section 3.2).
3.3.3 Time Course of Adenine Uptake.
The uptake of adenine was measured as a function of time by the
silicon sandwich centrifugation technique, as described in Materials
3
& Methods (Section 2.11.2), using [8- H] adenine as substrate. The
experimental details are given in the legend to Figure 3.18.
The time course of adenine uptake (shown in Figure 3.18) was
found to be similar to tht obtained for adenosine and hypoxanthine
uptake with uptake being linear for the first 30 seconds.
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figure 3.18 HUB CDCJRSH OP ADENINE OPTARE.
Trypanosomes O.Smg protein/ml were incubated in ?SG buffer pH 7.4,
22°C with luM C8-3H] adenine (50)jl;0.1mM, specif icactivity
50>iCi/jimole). Uptake was assayed oy liqua scintillation counting of
samples of the PCA layer of silicon sandwiches ( 500jj1 of incubation)
centrifuged at the tiroes shown. The results are given as the mean and
range of triplicate determinations.





the concentration dependence cf adenine uptake was determined as
described for hypoxanthine in the legend to Figure 3.17a with labelled
adenine being sucstituted for hypoxanthine.
Figure 3.19b HANES PIOT OF THE DATA PRESENTEE IN FIGURE 3.19a.
3.3.A Kinetic Parameters of Adenine Uptake.
The kinetic parameters of adenine uptake were determined as
described for hypoxanthine uptake in Section 3.3.2 with experimental
details given in the legend to Figure 3.19a. The kinetic parameters
measured only apply to uptake and not to transport alone for the
reasons detailed in the previous sections.
Figure 3.19a shows that uptake of adenine is a saturable process
and Figure 3.19b is a Hanes plot of the data in Figure 3.19a. From
the Hanes plot the Km and Vmax for uptake can be calculated to be
0.35^iM and 0.21nmol/min/mg protein respectively. Again the estimated
Km for uptake is within the normal range of plasma adenine
concentrations.
3.3.5 Metabolism of Hypoxanthine by Whole Cells.
As for the uptake of adenosine the uptake of hypoxanthine may be
dependent on its subsequent metabolism to maintain a hypoxanthine
gradient across the plasma membrane to drive facilitated diffusion.
3
Therefore the metabolism of [G- H] hypoxanthine by whole cells was
investigated and the intracellular concentration of hypoxanthine
estimated.The intracellular concentration of hypoxanthine will be
dealt with in a later Section (3.6) when considering the transport
mechanisms in more detail.
The experimental conditions for studying the metabolic fate of
hypoxanthine are given in the legend to Figure 3.20. Figure 3.20
3
shows the variation in distribution of [G- H] hypoxanthine in various



















The results of these experiments (Figure 3.20) show that when
hypoxanthine is taken up it is very quickly metabolised to
nucleotide. The results also show that as the percentage of label
present as hypoxanthine falls the percentage of label present as
nucleotide rises. The only other compound labelled was inosine (Ir)
which is labelled to a limited extent and is probably produced by the
dephosphorylation of IMP formed from the hypoxanthine. It should be
noted that uptake has almost ceased after 2 minutes (Section 3.3.1),
therefore all changes in the distribution of label after this time
are due to metabolism only.
The direct formation of nucleotide from hypoxanthine can only
take place via the enzyme hypoxanthine phosphoribosyltransferase
(IMP: pyrophosphate phosphoribosyltransferase , EC 2.4.2.8) (HxPRT).
The assay and kinetic parameters of this enzyme are described in
Section 3.4.
The nucleotide produced by whole cells from hypoxanthine may be
metabolised into diverse forms. Therefore the nucleotide content of
3
cells metabolising [G- H] hypoxanthine was analysed to determine the
diversity of nucleotide formed.
3.3.6 Diversity of Labelled Nucleotide in Whole Cells.
The experimental details for the analysis of labelled
3
nucleotides produced by the metabolism of [G- H] hypoxanthine by
whole cells is given in the legend to Figure 3.21 and in Materials
and Methods (Section 2.9).
3
Figure 3.21 shows that the [G- H] hypoxanthine taken up is first
metabolised to IMP. As time passes the IMP is metabolised to IDP and
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22°C with 0.5yM [G-^a] hypoxanthine (Irci/pmole) for 45 seconds to 10
minutes. Sanples of the incuoation medium (SOOjJl) were taken and
centrifuged on silicon sandwiches with 40* formic acid as the lower
layer. Sanples of the formic acid layer (lOOpl) taken and prepared for
analysis by HPLC as described in Materials & Methods (section
2.9).Radioactivity in the resolved components was estimated by liquid
scintillation counting. The results are the mean and range of duplicate
experiments.
eventually to ITP. The formation of ITP from hypoxanthine is much
slower than the formation of ATP from adenosine (Section 3.2.6) which
may reflect a difference in the trypanosome's requirements for these
two nucleotide's precursors. A full comparison between the metabolism
of hypoxanthine and adenosine will be made in the Discussion (Section
4.2.4).
3.4 ENZYMES OF PURINE NUCLEOSIDE AND BASE METABOLISM.
In Sections 3.2 and 3.3 the kinetic parameters of the adenosine,
adenine and hypoxanthine uptake systems were defined. The metabolic
fates of these compounds were also determined (Sections 3.2.4 &
3.3.5) and indications as to the enzymes involved in this metabolism
were obtained (Sections 3.2.5 & 3.3.5). The enzymes involved in
metabolism of purine nucleosides and bases were studied in more
detail with a view to determining their kinetic parameters.
3.4.1 Summary of Adenosine Metabolism and Phosphate
Dependence of Adenosine Hydrolase.
3
The metabolic fate of [2,8- H] adenosine in whole cells was
shown to be rapid conversion to ATP (Sections 3.2.4 & 3.2.6). A time
3
course of this metabolism and the metabolism of [2,8- H] adenosine by
a dialysed cell lysate (Sections 3.2.4 & 3.2.5) showed that adenosine
is first deribosylated to adenine, then the adenine converted to
nucleotide by APRT. No evidence of an adenosine kinase could be
found. Figure 3.22 shows diagrammaticaly the possible routes by which
adenosine could be metabolised. Step 3 of Figure 3.22, representing
phosphorylation of adenosine by adenosine kinase, as stated
previously does not take place (Section 3.2.5). The initial
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RIBOSE-1-PHOSPHATE
Figure 3.22 POSSIBLE ROUTES OF ADENOSINE METABOLISM.
(1) ADENOSINE PHOSPHORYLASE (EC 2.4.2.1)
(2) ADENOSINE HYDROLASE (EC 3.2.2.1)
(3) ADENOSINE KINASE (EC 2.7.1.20)
(4) ADENINE PHOSPHORIBOSYLTRANSFERASE (EC 2.4.2.7)
Table 3.4 PHOSPHATE DEPENDENCE OF ADENOSINE DERIBOSYLASE ACTIVITY.





















[2,8—^H] adenosine (40fiM;speci£ic activity 50fiCi/un»le) was incubated
with dialysed trypanosome lysate (0.02ng pcotein/ml) in lOmM TrisHCl,
lmH DTT buffer pH 7.4 at 2S°C for 2 minutes. The assay was terminated
by heating sanples of the incubation to 120°C a3 aescribed in the text
(Section 3.4.2). Sanples of the incubation media were then analysed
for their content of labelled adenine by TLC and liquid scintillation
counting as described in Materials & Methods (Section2.3). The results
are the mean ana range of duplicate incubations.
deribosylation of adenosine to adenine could take place by either
route 1 or route 2 as shown in Figure 3.22. The first route via
adenosine phosphorylase (Section 3.2.5) is known to take place in the
mammalian erythrocyte, (Tsuboi & Hudson,1957; Huennekens et al.,1956;
Grimes 1980) brain (Huennekens et al.,1956) and liver (Korn &
Buchanan, 1955). The hydrolytic pathway, route 2, is known to operate
in some bacteria (Rabinowitz & Barker,1965) and in bakers yeast
(Heppel & Hilmoe,1952). The hydrolytic pathway has also been shown to
exist in T.gambiense bloodstream forms (Schmidt et_ al., 1975). Davies
et £1.(1983) detected the presence of adenosine phosphorylase in
T.cruzi, T.brucei and L.mexicana; these same three organisms were
also found to be capable of phosphorolysis of guanosine but not
inosine. However all three of the above organisms showed inosine
hydrolase activity. In view of this diversity of distribution of
nucleoside hydrolase and phosphorylase activities the phosphate
dependence of the metabolism of adenosine to adenine was
investigated.
The phosphate dependence of the metabolism of adenosine to
adenine was investigated by incubation of [2,8-^H] adenosine with
exhaustively dialysed trypanosome lysate with increasing
concentrations of inorganic phosphate added. The results of these
experiments and experimental details are given in Table 3.4 and the
legend to Table 3.4. The results show that the metabolism of
adenosine to adenine by the trypanosome lysate is phosphate
independent. This indicates that in the whole cell adenosine is
metabolised to adenine and ribose, via route 2 (Figure 3.22), by
adenosine hydrolase (Kalckar, 1947; Schmidt _et al. 1975). Having
determined the type of enzyme involved in adenosine hydrolysis its
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Figure 3.23 TIME CDCRSE OF ADQCSINE HYDROLASE ACTIVTTY.
The above figure shows the amount of adenine produced by adenosine
hydrolase with time. A trypanoscme lysate (0.2mg protein/ml) was
incubated with [2,8-3H] adenosine at a concentration of 50pM (specific
activity lOOpCi/jmiol) for the times shown at 22°Q. The reaction was
terminated and the amount of adenine formed estimated as described in
the text (Section 3.4.2). The results are given as the mean and range
of duplicate experiments.
kinetic parameters were determined.
3.A.2 Kinetic Parameters of Adenosine Hydrolase.
Preliminary experiments were conducted to determine the optimum
protein concentration and incubation duration for measuring initial
rates of adenosine hydrolase activity. The results of these
experiments are shown in Figures 3.23 (time course) and Figure 3.24
(protein dependence). The experimental details are given in the
figure legends. For estimates of Km and Vmax the following
experimental protocol was followed:
3
Increasing concentrations of [2,8- H] adenosine at a constant
specific activity of 100jjCi/^imol. were incubated with trypanosome
lysate. The lysate was added to the assay mix to a final
concentration of 0.2mg protein /ml in TrisHCl buffer 10mM, DTT ImM at
pH 7.4. The assays were started by addition of trypanosome lysate and
incubated at 22°C for 3 minutes. The assays were terminated by
pipetting samples (200pl) of the assay mix into glass tubes heated to
120°C which were maintained at this temperature for a further 1
minute. Precipitated protein was then removed by centrifugation and
10pil samples of the supernatants with unlabelled adenosine and
adenine carrier added were chromatographed by TLC as described in
Materials and Methods (Section 2.8). The production of adenine was
estimated by cutting the resolved adenine spots from the TLC plate
and estimating their content of radioactive adenine by liquid
scintillation counting. No metabolism of the adenosine to any other
nucleoside or base was detected since all added label was recovered
as adenine or adenosine, no significant radioactivity being detected
on any other sections of the TLC plate. The initial rate of adenine
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figure 3.24 PROTEIN DEPENDENCE OP ADENOSINE HYDROLASE ACTIVITY.
The above figure shows the dependence of adenine production on
increasing protein concentration. All experimental conditions were as
describes in the legend to Figure 3.23 with the exception of protein
concentration. The results are given as the mean and range of
duplicate experiments.
Figure 3.25 CONCENTRATION DEPENDENCE OF ADENOSINE HYDROLASE ACTIVITY.
[Adenosine] jjM
The figure shows a Hanes plot of the initial rates of formation of
adenine from adenosine over an adenosine concentration range 9.6pM to
150pM. The experimental protocol used is described in the text
(section 3.4.2). The results show the mean and range of duplicate
incubations.
Figure 3.26 FfCTEIN DEPBBHJCE OF ADENINE
EBCSPBCBTBOSYT.TRANSFERASE ACTIVITY.
[Protein] mg/ml
The above figure shows the dependence of the amount of nucleotide
produced by adenine pnosphoribosyltransferase on protein
concentration. A trypanosome lysate at the protein concentrations
shown was incubated with [8-^H] adenine at a concentration of 2pH
(specific activity lOQpCi/fimol) for 2.5 minutes at 22°C. The reaction
was terminated and the amount of adenine formed estimated as described
in the text (Section 3.4.3). The results are given as the mean ana
range of duplicate experiments.
production was estimated in duplicate for each adenosine
concentration used in the range 9.6jjM to 24CtyoM.
The results of these experiments are shown as a Hanes plot in
Figure 3.25. From this plot the kinetic parameters of the adenosine
hydrolase were calculated to be : Km 150pM and Vmax 7.69nmol/min/mg
protein. The significance of these results will be considered in
Section 3.4.7.
3.4.3 Kinetic Parameters of Adenine Phosphoribosyltransferase.
After hydrolysis of adenosine to adenine and ribose the next
step in the metabolism of the purine ring is conversion to nucleotide
by APRT using PRPP. The kinetic parameters of this enzyme were
estimated as detailed below.
As for the estimation of the kinetic parameters of adenosine
hydrolase preliminary experiments were conducted to determine optimal
magnesium concentrations and a non-rate limiting concentration of
PRPP for the estimation of initial rates of reaction. The optim um
time and protein concentration for estimation of initial rates of
reaction were also determined as shown in Figures 3.26 and 3.27.
Experimental details are given in the figure legends.
3
The assay mixture contained [8- H] adenine, at a constant
specific activity of 100pCi//amol., over a concentration range of
0.2joM to 4pM. The enzyme source was a fresh trypanosome lysate, added
to the assay mix to give a final protein concentration of 0.024mg/ml.
The assay mix consisted of TrisHCl buffer 10mM, DTT 1mM, MgCl^ImM,
PRPP 0.5mM at pH 7.4. The assays were started by the addition of
lysate and incubated at 22°C for 2.5 minutes. The assays were
terminated by rapid heating to 120°C of 200^il samples as described in
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Figure 3.27 TIME COURSE OF ADENINE
WE3H KTHTSYT.TRANSFERASE ACTIVITY.
The above figure shows the dependence of the amount of nucleotide
produced by adenine phosphoribosyltransferase on time. A trypanosome
lysate at a protein concentration of O.lmg/ml was incubated with
[a-^i adenine at a concentration of 2)iM (specific activity
10tyiCi/>anol) for the times shown at 22°C. The reaction was terminated
and the amount of nucleotide formed estimated as described in the text
(Section 3.4.3). The results are given as the mean and range of
duplicate experiments.
Figure 3.28 aoncansation dependence of adenine
ebospboribosyliransferase activity.
[Adenine]
The figure shows a Hanes plot of the initial rates of formation of
nucleotide from adenine and PRPP over an adenine concentration range
0.2 to tyiM. The experimental protocol used is described in the text
(section 3.4.3). The results are given as the mean and range of
duplicate experiments.
Figure 3.29 PROTEIN DEPENDENCE OP HYPOXANTHINE
PSOSPBORIBOSXLISANSFERASE ACTIVITY.
[Protein] mg/ml
The above figure shows the dependence of the amount of nucleotice
produced by hypoxanthine phosphorioosyltransferase on protein
concentration. A trypanosome lysate at the protein concentrations
shown was incubated with [G-^Hj nypoxanthine at a concentration of 5jiM
(specific activity lOOpCi/pnol) for 3 minutes at 22°C. The reaction
was terminated ana the amount of nucleotide formed estimated as
described in the text (Section 3.4.3). The results are given as the
mean and range of duplicate experiments.
Section 3.4.2. The production of nucleotide was assayed by TLC and
liquid scintillation counting as described in Section 3.4.3. The rate
of reaction was determined in duplicate for each adenine
concentration used.
The results of these experiments are shown as a Hanes plot in
Figure 3.28. The kinetic parameters of the APRT were calculated from
this plot to be: Km 0.84pM and Vmax 4.20nmol/min/mg protein. The
significance of these kinetic parameters along with those of uptake
and other enzymes involved in purine nucleoside and base metabolism
will be considered in Section 3.4.7.
3.4.4 Kinetic Parameters of Hypoxanthine Phosphoribosyltransferase.
3
When [G- H] hypoxanthine is taken up by the trypanosomes the
label appears in the nucleotide pool and no other intermediate. As
described in Section 3.3.4 this conversion to nucleotide can only be
achieved via HxPRT.
The kinetic parameters of HxPRT were estimated in a similar
fashion to the estimation of Km and Vmax for APRT. Preliminary
experiments were carried out to determine optimal assay conditions
with regards to incubation duration, protein and magnesium
concentration for the measurement of initial rates of reaction. The
results of the protein dependence and time course experiments are
shown in Figures 3.29 and 3.30 respectively. The full experimental
details are given in the figure legends.
The assay mix contained TrisHCl buffer 10mM, DTT 1mM, MgCl2 1mM
3
and PRPP 0.5mM. The concentration of [G- H] hypoxanthine, specific
activity 100jiCi/^imol., was varied between 0.76jiM and 17.7}iM. The
assays were started by addition of trypanosome lysate to a final
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figure 3.30 TIME OOURSE Of HYPOXANTHINE
The above figure shows the dependence of the amount of nucleotide
produced by hypoxanthine phosphoribosyltransferase on time. A
trypanosome lysate at a protein concentration of 0.lmg/ml was
incuoated with [G-^a] hypoxanthine at a concentration of 5pM (specific
activity 100pCi/)jmol) for the times shown at 22°C. The reaction was
terminated and the amount of nucleotide formed estimated as descrioed
in the text (Section 3.4.3). The results are given as the mean ana
range of duplicate experiments.
Figure 3.31 OCNCTNTRATTCN DEPEJTOENCE OF HYPOXANIHINE
The figure shows a Hanes plot of the initial rates of formation of
nucleotide from hypoxanthine and FRPP over a hypoxanthine
concentration range 0.76 to 17.7jjM. The experimental protocol used is
described in the text (section 3.4.4). The results are shown as the
mean and range of duplicate experiments.
concentration of 0.13mg protein /ml.
The incubation was carried out at 22°C for 3 minutes, the assay
being terminated by rapid heating to 120°C for 1 minute as described
in Section 3.4.2. Nucleotide formed was estimated by separation of
3
labelled nucleotide from [G- H] hypoxanthine by TLC as described in
Materials & Methods (Section 2.8). The rate of nucleotide formation
was determined in duplicate for each concentration of hypoxanthine
used.
The results obtained from these experiments are shown as a Hanes
plot in Figure 3.31. From this plot the following values for Km and
Vmax were calculated; Km 5.0uM and Vmax 13.05nmol/min/mg protein.
These results will be considered in more detail in Section 3.4.7.
It was thought possible that both the adenine and HxPRT
activities measured could be due to the presence of only one enzyme
with a broad substrate specificity. Therefore the magnesium
dependence and inhibition by other purines of the
phosphoribosyltransferase activity were investigated to detect any
differences which would indicate the presence of two enzymes.
3.4.5 Magnesium Dependence of Adenine and Hypoxanthine
Phosphoribosyltransferase Activity.
The magnesium dependence of adenine and hypoxanthine
phosphoribosyltransferase activities was investigated by assay of the
respective phosphoribosyltransferase activities in a dialysed
trypanosome lysate in the presence of increasing concentrations of
magnesium.
The assays were carried out as described in Sections 3.4.3 &
3.4.4, with the following changes; the final protein concentration in
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Figure 3.32 mGNESIDM DEPENDENCE OF ES0SP9CRIB0SYL3BANSFH?ASE
activity.
The figure shows the dependence of the rate of PRPP depencent
phosphorylation of adenine and hypoxantnine on «g^+ concentration
(Note log scale). The experimental details are given in the text
(Section 3.4.5). The results are given as the mean and range of
duplicate experiments. (• * HxFRT and x * APRT)
o
the assays was 0.12mg/ml, incubation time was 2 minutes at 22 C. The
substrates, adenine and hypoxanthine, were both used at a
concentration of 5jjM (100^iCi/pmol.). The assays were terminated as
described previously (Sections 3.4.3 & 3.4.4). Magnesium, added as
MgCI^, was varied from 0.02mM to 2.0mM. Control incubations were also
carried out to which no magnesium was added.
The results obtained are shown in Figure 3.32 plotted as nmol
nucleotide produced/min/mg protein against log^Q of the magnesium
concentration. The results show that the two enzymic activities have
different magnesium requirements, the magnesium concentration for
half maximal APRT activity is 0.1mM and half maximal HxPRT activity
is obtained with 0.25mM magnesium. In order to obtain more evidence
for the existence of two separate enzymes the effects of inhibitors
on the phosphoribosyltransferase activities were investigated.
3.4.6 Cross Inhibition of Adenine and Hypoxanthine
Phosphoribosyltransferase activities.
The effects of adenine, guanine and hypoxanthine on the
phosphoribosyltransferase activities were determined by assaying the
adenine and hypoxanthine phosphoribosyltransferase activities in the
presence of 20jiM adenine, guanine or hypoxanthine. The assay system
used was as described in Sections 3.4.3 & 3.4.4, except that adenine
and hypoxanthine substrates were present at a concentration of 10jjM
( 100jiCi/)imol.) and MgCl^ ImM. The final protein concentration in the
assay was O.lmg protein /ml.
The various combinations of purine bases used in these
experiments and the results, expressed as percentage inhibition of
control activities, are shown in Table 3.5. These results confirm the
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ADENINE - - - 0.266 0
•
+ - - 0.170 24
0
- + - 0.154 31
HYPOXANTHINE - - - 0.242 0
•
+ _ _ 0.111 54
0
— — + 0-234 3
The table shows the results
phosphoribosyltranst'erase activities
substrates and potential substrates
details are given in the text (Section
of cross inhibition of
in a trypanosome lysate by
of the enzymes. Experimental
3.4.6)
presence of two distinct enzymes. A two-fold excess of hypoxanthine
or guanine over the adenine substrate inhibits APRT activity by 20%
to 30% where as the same concentration of guanine inhibits HxPRT
activity by 54%. Adenine has very little (3%) inhibitory activity
towards HxPRT which suggests that adenine is not a substrate for this
enzyme. The marked inhibition of HxPRT activity by guanine suggests
that guanine may also be a substrate for this enzyme as reported by
Walter & Konigk(1974) and Krenitsky et al.(1969). These differences
in the enzyme activities are evidence that the two
phosphoribosyltransferase activities are associated with different
enzymes.
The kinetic parameters of the uptake and metabolism of
adenosine, adenine and hypoxanthine so far considered individually
can now be considered as a whole.
3.4.7 Summary of Metabolism and Kinetic Parameters of the
Purine Nucleoside and Base Uptake Systems.
Figure 3.33 shows diagrammatically the proposed scheme for uptake
and metabolism of adenosine, adenine and hypoxanthine by
T.brucei(TREU 55) long slender bloodstream forms. The kinetic
parameters of the uptake systems are consistent with the kinetic
parameters estimated for metabolism of nucleosides and bases in that
rates of uptake of purines appear to be less than the possible rates
of metabolism. However the kinetic parameters estimated for the
metabolising enzymes were estimated in a cell free system which may
not be a true representation of the in vivo situation. The cell free
system probably did not contain any potentially regulatory substances
normally found in the cell or if they were present they would be
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diluted out in the preparation of the lysate. These points will be
developed further in the Discussion (Section 4.2.4)
Figure 3.33 shows three separate points of entry into the cell
for adenosine, adenine and hypoxanthine. The next question asked was
are there one or more carriers in the plasma membrane?. In order to
answer this question the specificities of uptake of the three
compounds listed were determined by cross inhibition of uptake and by
the effects of nucleoside analogues on uptake.
3.5 INHIBITORS OF NUCLEOSIDE AND BASE UPTAKE.
The effects of nucleosides, bases and analogues of nucleosides
on the uptakes of adenosine, adenine and hypoxanthine were
investigated. Uptake in the presence or absence of inhibitor was
measured by the silicon sandwich centrifugation technique. The
effects of the nucleosides adenosine, guanosine and inosine, the
bases adenine, guanine and hypoxanthine and the nucleoside analogues
5'-iodo-5'-deoxyadenosine (IDA) and p-nitrobenzylthioinosine (NBTI)
on the uptakes of adenosine, adenine and hypoxanthine were
determined.
3.5.1 Inhibitors of Adenosine Uptake.
The effects of nucleosides, bases and nucleoside analogues on
adenosine uptake were measured as a percentage inhibition of
adenosine uptake determined in the absence of inhibitors. The uptake
3
assay consisted of trypanosomes suspended in PSG at pH 7.4, [2,8- H]
adenosine and the inhibitor being investigated at a range of
concentrations. The uptake assays were started by the addition, with
rapid mixing, of 500jj1 of trypanosome suspension. All other
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Figure 3.34 INHIBITORS OF ADENOSINE UPTAKE.
Trypanosomas ( 500/il,0.72mg protein/ml in PSG pH 7.4) were incubated in
the presence of labelled adenosine (lOpl,0.ImH,SOjiCi/jjmole) at a final
concentration of lpM with Inosine(o), Hypoxanthine(X), Guanine(i),
Guanosine(M), Adenine(O), NBTI (♦) and IDA(e) in PSG pH 7.4 to give a
final volume of 1ml. The uptake assays were started by addition of the
trypanosomes. Incubations were carried out at 22°C;duplicate samples
(400^1) were taken after mixing and layered onto silicon sandwiches
which were centrifuged after 30 seconds. Uptake was estimated by
liquid scintillation counting of the PCA layer.The results are
presented as the mean and range of duplicate experiments.
experimental details are given in the legend to Figure 3.34.
Figure 3.34 shows the effects of the compounds listed in the
Figure legend on the uptake of [2,8-3H] adenosine. The inhibitors can
be classified into two main types on the basis of their maximum
inhibitory activity. Iododeoxy adenosine and adenine are classified
as strong inhibitors whereas hypoxanthine, guanine, inosine and
guanosine are classified as weak inhibitors of adenosine uptake.
Nitrobenzylthioinosine shows an intermediate type of inhibition
towards adenosine uptake which will be considered later. However it
should be noted that NBTI is capable of 100% inhibition of nucleoside
uptake in the erythrocyte at a concentration of 17.5jjM (Pickard &
Paterson,1972). The effect of NBTI shown here demonstrates that there
is a difference between the erythrocyte and the trypanosomal
transporter since at 20jjM NBTI uptake of adenosine by the
trypanosomes is only inhibited by 35%. It should also be noted that
with increasing concentrations of inhibitor the strong inhibitors
never achieve 100% inhibition; rather their inhibitory effects
plateau at 80%-90% inhibition of uptake. The weak inhibitors of
uptake show a similar plateau effect with increasing concentrations
of inhibitor but this time the plateau of inhibition is reached at
20%-40% inhibition of uptake. The reasons for this plateau effect
will be considered in Section 3.5.5.
3.5.2 Inhibitors of Adenine Uptake.
The effects of adenosine, hypoxanthine, inosine, guanine,
guanosine, IDA and NBTI on the uptake of adenine were investigated by
exactly the same method as described in the legend to Figure 3.34.
The incubation conditions were also as described in Figure legend
-102-
Figure 3.35 INHIBITORS OP ADENINE UPTAKE.
Trypanosomes (500^1,0.SOmg protein/ml in PSG pH 7.4) were incubated in
the presence of labelled adenine (lOpl,0.lmM,SOjiCi/pmole) at a final
concentration of 1/iM with Inosine(o), Hypoxanthine(X ), Guanine( 1 ),
Guanosine(O), Adenosines), NBTI(-») and IDA(O) in PSG pH 7.4 to give a
final volume of 1ml. The uptake assays were started by addition of the
trypanosomes. Incubations were carried out at 22° C;duplicate samples
(400^il) were taken after mixing and layered onto silicon sandwiches
which were centrifuged after 30 seconds. Uptake was estimated by
liquid scintillation counting of the PCA layer. The results are
presented as the mean and range of duplicate experiments.
3 33.34 with [8- H] adenine being used as substrate in place of [2,8- H]
adenosine. All additional details are given in the legend to Figure
3.35.
Figure 3.35 shows the effects of the compounds, listed in the
legend to Figure 3.35, on the uptake of adenine. The inhibitors can
again be classified into two main groups of strong and weak
inhibitors. The distribution of inhibitors between these two groups
is different from that obtained for the inhibition of adenosine
uptake. Adenosine is a strong inhibitor of adenine uptake whereas IDA
and NBTI are intermediate in their inhibitory activity with guanine,
guanosine, hypoxanthine and inosine showing weak inhibitory activity.
The inhibitory activities of both the strong and weak inhibitors show
a plateau in activity as described in the previous section.
3.5.3 Inhibitors of Hypoxanthine Uptake.
The effects of adenine, adenosine, guanine, guanosine, inosine,
IDA and NBTI on the uptake of hypoxanthine were investigated. The
experimental methods used were identical to those described in Figure
legends 3.34 & 3.35 except the labelled substrate for uptake was
3
[G- H] hypoxanthine. All other parameters with respect to substrate
concentration, temperature, pH and incubation time are given in the
legend to Figure 3.36
The results of these experiments are shown in Figure 3.36. Again
the inhibitors can be classified as being either strong; (guanosine
and guanine) or weak; (adenosine, adenine, inosine, IDA and NBTI).
This inhibitory pattern is different from those obtained for the
inhibition of adenosine and adenine uptake. Again the plateau in
inhibitory activity with increasing inhibitor concentration is
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[Inhibitor] jjM
Trypanosomes (500jil,0.6mg protein/ml in PSG pH 7.4) were incubated in
the presence of labelled hypoxanthine (10pl,0.1mM,50pCi/jimole) at a
final concentration of lpM with Inosine(X), Guanine(i), Guanosine(n),
Adenine(o), Adenosine(O), NBTK-*) and IDA(e) in PSG pH 7.4 to give a
final volume of 1ml. The uptake assays were started by addition of the
trypanosomes. Incubations were carried out at 22°C;duplicate samples
(400)il) were taken after mixing and layered onto silicon sandwiches
which were centrifuged after 30 seconds. Uptake was estimated by
liquid scintillation counting of the PCA layer. The results are
presented as the mean and range of duplicate experiments.
observed. These results along with the results obtained for the
inhibition of adenosine and adenine uptake are summarised and
considered in more detail in Section 3.5.5.
The data presented so far in this chapter show the results of
investigations into the effects of the purine nucleoside analogues
IDA and NBTI on uptake and the effects of various purine nucleosides
and bases on uptake. However it should be borne in mind that the
uptake may be dependent on metabolism and that the effects observed
could be due to the inhibition of metabolism rather than the
inhibition of transport. Therefore the effects on metabolism of the
compounds found to be inhibitors of uptake were investigated.
3.5.A Effect of uptake inhibitors on Purine Nucleoside
and Base Metabolising Enzymes.
The compounds which inhibited uptake in the previous experiments
(Sections 3.5.1, 3.5.2 and 3.5.3) were tested for inhibitory activity
towards the purine nucleoside and base metabolising enzymes. The
compounds were tested for inhibitory activity towards adenosine
hydrolase, APRT and HxPRT.
The activities of the above enzymes were assayed in the presence
and absence of the putative inhibitors, the inhibitor:substrate ratio
being 50:1 as in the uptake experiments at high inhibitor
concentrations, that is at inhibitor concentrations above those
giving maximal inhibition of uptake.
The assay system for adenosine hydrolase was as described in
3
Sections 3.4.1 & 3.4.2. The [2,8- H] adenosine substrate
( lOOpCi/jamol) was present at a final concentration of 2jiM either
alone or with one of the putative inhibitors at a concentration of
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Table 3.6 EFFECT OF UPTAKE INHIBITORS ON PURINE NUCLEOSIDE AND BASE
METABOLISING ENZYMES.
% PERCENTAGE INHIBITION OF
INHIBITOR ADENOSINE HYDROLASE APRT HxPRT
IODODEOXYADENOSINE 15 18 0
NBTI 23 0 2
ADENOSINE 0 75 0
ADENINE 10 0 3
INOSINE 35 9 15
HYPOXANTHINE 0 31 0
GUANINE 0 24 34
GUANOSINE 31 9 40
The table shows the percentage inhibition of
purine metabolising enzymes by inhibitors of
uptake at an inhibitor:substrate ratio of 50:1 as
used in uptake experiments. Details of the assay
systems used are given in the text (Section 3.5.4)
100jiM. Fresh trypanosome lysate was used as the enzyme source at a
final concentration of 0.02mg protein/ml. All other assay methods and
parameters were as described in Sections 3.4.1 & 3.4.2. Adenine and
hypoxanthine phosphoribosyltransferase were assayed alone or in the
presence of one of the putative inhibitors. The assay system used was
3 3
as follows. [8- H] Adenine or [G- H] hypoxanthine substrate (both
100jjCi/pnol) were present at a concentration of 2pM either alone or
with one of the putative inhibitors at a concentration of 10CtyjM.
Fresh trypanosome lysate was used as the enzyme source at a final
concentration of 0.1mg protein/ml. All other assay parameters and
methods were as described in Sections 3.4.3 & 3.4.4.
The results of the experiments described above are shown in
Table 3.6 as percentage inhibition of enzyme activity. These results
when considered in conjunction with the results of inhibition of
uptake provide good evidence for the presence of a carrier molecule
for nucleosides and bases in the plasma membrane as detailed in the
Discussion (Section 4.2.1). Inspection of the results presented in
Sections 3.5.1 to 3.5.3 and Table 3.6 shows that compounds having a
strong inhibitory effect on uptake are not acting by inhibition of
metabolism of the labelled substrates.
In some cases the weak type of inhibition observed in Sections
3.5.1 to 3.5.3 may be due to inhibition of metabolism of the label
taken up. For example guanine inhibits adenosine uptake to a maximun
of 20%, has no effect on adenosine hydrolase but inhibits APRT by 24%
at the same inhibitorrsubstrate ratio used in the uptake experiments.
On the other hand IDA inhibits hypoxanthine uptake weakly by 35% yet
has no inhibitory effect on HxPRT. Inspection of the results
presented shows many more examples of the above two types, therefore
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the inhibition of uptake observed must take into account any
inhibitory effects on metabolism where appropriate.
The comparisons made between the inhibitory effects of compounds
on uptake and inhibitory effects on metabolism assume that the
compounds acting as inhibitors of uptake enter the cell and
accumulate to the concentrations used in the in vitro assays of
nucleoside and base metabolism. Whether or not the inhibitors of
uptake enter the cell the strong type of inhibition still provides
evidence for the existence of a membrane carrier since in these cases
the inhibitors involved have very little effect on any metabolism
associated with uptake.
The results presented in Table 3.6 show some other interesting
points. Adenosine apparently inhibits APRT by 74% at a 50:1
adenosine:adenine ratio. This can be explained by dilution of the
labelled adenine used as substrate with unlabelled adenine derived
from the adenosine present. The enzyme source used in these
experiments was fresh whole cell lysate which contains a very active
adenosine hydrolase (Section 3.A.2) which would rapidly convert the
adenosine present to adenine and ribose. The fact that this effect
did not occur to the same extent when inosine was tested as an
inhibitor of HxPRT suggests that inosine is not a very good substrate
for adenosine hydrolase. However an alternative explanation may be
that the trypanosomes contain an inosine hydrolase which is less
active than the adenosine hydrolase or no inosine hydrolase at all.
The 40% inhibition of HxPRT obtained with guanosine as inhibitor
is similar to the 34% inhibition by guanine which may indicate the
presence of a guanosine hydrolase or that guanosine is a substrate
for adenosine hydrolase. Guanosine and inosine may be poor substrates
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ADENOSINE 0 25 85
INOSINE 25 35 45
GOANOSINE 30 30 25
IDA 90 25 65
NBTI 70 30 20
ADENINE 92 35 0
GUANINE 20 90 25
HYPOXANTHINE 20 0 30
The table summarises the results presented in Figures 3.34, 3.35 and 3.36.
for the adenosine hydrolase as indicated by their ability to inhibit
adenosine hydrolase by 31% and 35% respectively when present in a
fifty fold excess over the adenosine substrate.
3.5.5 Sunanary of Cross Inhibition of Nucleoside
and Base Uptake Systems.
The results presented in Sections 3.5.1 to 3.5.4 show that when
the concentration of an inhibitor of uptake is increased inhibition
plateaus to a maximium, which can either be high, (in the range
70-90%), or low, (in the range 10-40%). This plateau effect could be
explained by the presence of more than one membrane transporter. An
inhibitor could block one transporter 100% but substrate for that
transporter may use another transporter with different specificities
which is not blocked by the inhibitor used. This explanation of the
plateau effect requires the presence of at least two transport
proteins in the plasma membrane. Evidence for the existence of two or
more transporters is provided by the patterns of uptake inhibition
obtained in Sections 3.5.1 to 3.5.4.
Table 3.7 summarises the results of the effects of inhibitors on
uptake. The results are presented as maximum percentage inhibition,
that is the inhibitors plateau inhibition level described above.The
significance of these results will be considered in detail in the
Discussion (Section 4.2.1).
3.6 MECHANISM OF PURINE NUCLEOSIDE AND BASE TRANSPORT.
So far the results presented here have shown that adenosine,
adenine and hypoxanthine are taken up and metabolised to nucleotide
by T.brucei and that translocation of the nucleosides and bases
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Figure 3.37 INTRACELLULAR CONCENTRATIONS OF ADENOSINE
Time min.
g
Trypanosomes (1.53x10 cells/ml, 0.63mg protein/ml) were incubated
with labelled adenosine or hypoxanthine (both lpM, specific activity
lOOpCi/jimol.) for 1 to 10 minutes in PSG at pH 7.4, 22°C. The
incubations were terminated by silicon sandwich centrifugation with
PCA as the lower layer. Samples of the PCA layer (lOOpl) were
neutralised by potassium hydroxide (50pl), centrifuged to remove
percipitated potassium perchlorate samples of supernatant (lOjil) were
then spotted in triplicate, with carriers, onto silica TLC plates and
chromatographed as described in Materials & Methods*Sect ion 2.3). The
label present in the cell as adenosine or hypoxanthine was estimated
by cutting the appropriate spots from the chromatogram followed by
liquid scintillation counting. In all cases the carry through of
adenosine (Materials & Methods Section 2.11.1) was corrected for as
was quenching of scintillation counting by the TLC plate. The results
are presented as the mean and range of duplicate experiments.
across the plasma membrane involves carrier proteins in the plasma
membrane. The mechanism of this plasma membrane transport has not as
yet been considered in any detail. Calculations made using the
kinetic parameters measured for uptake and metabolism (Section 3.4.7)
show that it is possible for metabolism to maintain a concentration
gradient of substrate across the plasma membrane with transport being
mediated by facilitated diffusion. As stated in Section 3.4.7 the
kinetic parameters for metabolism were estimated in a cell free
system and therefore may not reflect the in vivo situation. The main
alternative to a facilitated diffusion mechanism for transport is
active transport. Active transport would be capable of accumulating
substrate in the cell against a concentration gradient. The ability
of trypanosomes to accumulate adenosine and hypoxanthine against a
concentration gradient was therefore investigated.
3.6.1 Intracellular Concentrations of Adenosine
and Hypoxanthine.
In order to calculate the intracellular concentrations of
adenosine and hypoxanthine the intracellular volume of the cells must
be known. The intracellular volume of the long slender trypanosome
9
has been estimated to be 80pl/10 cells (Damper & Patton, 1976b).
This estimate was made by measuring the dilution of permeant and
impermeant radio-labels on addition of trypanosomes to a mixture of
the two labels. This method requires that very small changes in very
large numbers be measured and is therefore susceptible to large
errors. In view of this the intracellular volume of T. brucei Treu 55
was estimated.
The intracellular water volume of T. brucei was measured by
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incubating cells (1.412x10 cells/ml) with H^O to give a final
isotope concentration of 2000dpm/)il. Duplicate incubations were set
14 3
up in which [carboxy- C] inulin was added in place of H^O. After 15
3
minutes, at which time H20 had distributed to equilibrium, duplicate
0.5ml samples of five separate incubations were centrifuged on
silicon sandwiches. The total cell water was estimated by counting
3
the H found in the PCA layers and subtracting carry through as
14
estimated from the incubations containing [carboxy- C] inulin. The
9
total cell water was calculated to be 32+2.4jul/10 cells expressed as
the mean and population deviation from duplicate determinations of
five experiments. This value for cell water was used in all
subsequent calculations of intracellular concentrations where the
same buffer composition (PSG) was used.
The intracellular concentrations of adenosine and hypoxanthine
were measured as a function of time as detailed in the legend to
Figure 3.37. The intracellular concentrations of adenosine and
hypoxanthine were calculated assuming even distribution throughout
9
total cell water (32^1/10 cells) as determined above. The validity
of this assumption will be considered in the Discussion (Section
4.2.2).
The results shown in Figure 3.37 demonstrate that hypoxanthine
is accumulated against its concentration gradient as is, to a lesser
extent, adenosine. These results show that initially transport is
very rapid with the substrates being accumulated against their
concentration gradients, then metabolism begins to decrease
intracellular concentrations. This reduction in intracellular
concentrations of substrates by metabolism is not surprising since it
has been shown that the uptake of adenosine and hypoxanthine cease
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after two minutes (Sections 3.2.1 & 3.3.1). The concentration of
substrates against their concentration gradients could reflect
intracellular binding without metabolism or true active transport. If
the observed results are due to active transport, transport must be
coupled to an energy source. This energy source could be an ion
gradient established across the plasma membrane by an ion
translocating ATPase such as the Na+/K+ dependent ATPase (EC 3.6.1.3)
or H+translocating ATPase located in the plasma membrane. (For a
comprehensive review of coupled transports in bacteria see
Hamilton,(1975) ). In order to differentiate between intracellular
binding and active transport the effects of various ions and
ionophores on uptake were investigated.
3.6.2 Effect of Gramicidin S and High Potassium Low
Sodium Buffer on Purine Nucleoside and Base Uptake.
Gramicidin S is a cyclic peptide, produced by the bacterium
Bacillus brevis, which is capable of forming dimers in a lipid
bilayer resulting in the transient formation of aqueous channels
across the membrane. Gramicidin shows poor selectivity in relation to
which ions can pass through the channels formed. Such selectivity as
it does show is as follows; H+ > Rb+ > K+ > Na+ > Li+. (Pressman, 1976).
The addition of this ionophore to a cell suspension allows ions to
move down their concentration gradients across the plasma membrane. A
gramicidin S
concentration ofA1jig/ml is sufficient to abolish valinomycin induced
13 T +
uptake of Cs+, which reflects a reduction in membrane potential
from -129mV to -59mV (Midgley,1983). Therefore any reduction in the
uptake of nucleoside or base in the presence of gramicidin would show
that transport was at least partially dependent on a membrane
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Figure3.38EFFECTS0?GRAMI IDINANLOWNa+HIGHKBUFFERN ADENOSINE,NINEDHYPOXANTHI BU T K .
123 [Adenosine]juM
[Adenine]jjM
Uptakesofadenosine,deninedhypoxanthw rassay dv rco centrationra gf0.2/iH 4fiHatspecificact vityolOO Ci/^ moleinlases.The ld n ityu din ubat onswas 0.97mgprotein/ml.Up akefw sme suredbysil cons dwichc ntri ugationnliq i scintillationountingfthePCAlay r,duplicate400/Jlsampl sfe chincub tionb i gssayed. Cellsandsubstrateswerinc atedPSG(ft),SGi hgramici infi lconcentrationl/ig/ml(X)r PSGmadewithpot ssiums ltsthroughoutinplacefso i m(PS K) D)descr bediM terialsi> Methods(S ction2.4).Allincubatio sweretpH7.4,22°Cf r30s conds.Thr sults presentedasthm annra geofduplicateexp riments.23 [Hypoxanthine]/M
potential. The effects of gramicidin S and low Na+ high K+ buffer on
uptake of adenosine, adenine and hypoxanthine were assessed as
described in the legend to Figure 3.38. Trypanosomes to be used in
uptake experiments in PSGK were isolated in this buffer at pH 8.0 and
resuspended at pH 7.4 in PSGK just before use. The assays were
started by the addition of 500/il of cell suspension to 500pl of
buffer containing labelled substrate and the appropriate buffer with
gramicidin at 1jjg/ml when required. Duplicate samples of 400^1 from
each incubation were layered onto silicon sandwiches and centrifuged
after 30 seconds.
The results of these experiments are shown in Figure 3.38. The
results show that the uptake of adenosine, adenine and hypoxanthine
are inhibited by gramicidin. Adenosine uptake is inhibited at all
concentrations of adenosine by 42% _+ 4%, hypoxanthine uptake is
inhibited by 43% _+ 5% and adenine uptake is inhibited by 48% +_ 8%.
This suggests that uptake of all three substrates is at least partly
dependent on a membrane potential. The effects of low Na+/high K+
buffer are also shown in Figure 3.38. The concentratiom of Na+ in the
PSGK buffer was calculated to be 1.7mM from the analyses given by the
manufacturers of the 'Analar' reagents used in making this buffer.
Figure 3.38 shows that the uptake systems for adenosine, adenine and
hypoxanthine are inhibited by the PSGK buffer system possibly
reflecting the dependence of uptake on a membrane potential since
elevation of extracellular concentrations of K+ to near intracellular
concentrations of K+ will abolish the K+ gradient across the plasma
membrane responsible for the maintainance of the membrane potential.
The effect of gramicidin could be due to cell death caused by
disruption of the plasma membrane by the gramicidin and a loss of
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Figure 3.39 EFFECT OF GRAMICIDIN ON OXYGEN OPTAKB.
The figure shows the precentage inhibition in the rate of oxygen
uptake in the presence of increasing gramicidin concentrations.
Trypanosomes (lml,1.50mg protein/ml) were added to a thermostated
chamber (37°C) containing 2ml of PSG pH 7.4. The chamber was sealed
with a Clarke oxygen electrode and the rate of oxygen uptake measured
as described in Materials & Methods (section 2.6). Gramicidin was then
added to give final concentrations im the range l-20;ig/ml.
metal ion co-factors into the incubation medium. This possibility was
investigated by observing the effects of gramicidin on cell motility
by phase contrast microscopy and effects on rate of oxygen uptake as
measured by a Clark oxygen electrode.
3.6.3 Effect of Gramicidin S on Oxygen Uptake and Cell Motility.
Trypanosomes were added to a thermostatted chamber with a
magnetic stirring bar, containing PSG, pH 7.A at 37°C. The chamber was
sealed and the rate of oxygen utilisation measured with a Clark
oxygen electrode the calibration and use of which is described in
Materials & Methods (Section 2.6). All other experimental details are
given in the legend to Figure 3.39.
The results obtained are shown in Figure 3.39 as percentage
inhibition of oxygen uptake as a function of gramicidin
concentration. At each gramicidin concentration used the decrease in
rate of oxygen uptake was paralleled by a decrease in cell motility
as observed by phase contrast microscopy. However in the previous
experiment (Section 3.6.2) gramicidin was used at a concentration of
1jig/ml which as is shown by Figure 3.39 has no effect on the rate of
oxygen uptake by the trypanosomes. Therefore the inhibitory effects
of gramicidin on uptake (Figure 3.38) are not due to inhibition of
general cell metabolism but more probably reflect the effect of the
ionophore on the membrane potential.
3.6.A Effect of Valinomycin and Valinomycin with
Potassium on the Uptake of Purine Nucleosides
and Bases.
Gramicidin S is a general ionophore allowing protons as well as
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figure3.40BPPECTOPVALINONYCINDVALINOM IK+ADB OSINB, ADENINENDHYPOXANTHINBUPT KE.
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monovalent cations through membranes. The observed effects of
gramicidin on purine nucleoside and base uptake (Section 3.6.3) could
therefore be due in part to the collapse of a proton gradient. A high
extracellular concentration of K+ inhibited uptake of purine
nucleosides and bases (Section 3.6.3), possibly by reducing the
membrane potential, but was not as 'effective as gramicidin. The
extracellular K+ concentration of 103 mM in PSGK buffer should have
reduced the membrane potential to the Nernst potential
(Hoffman,1982), as would the addition of gramicidin to a cell
suspension. This suggests that uptake of purine nucleosides and bases
is dependent on more than just the membrane potential. The
contribution of the membrane potential to the uptake of adenosine,
adenine and hypoxanthine was investigated further using the
ionophore valinomycin.
Valinomycin is a cyclic dodecapeptide isolated from Streptomyces
spp. (Brockmann & Schmidt,1955). This ionophore is specific for K+
ions and has a 17,000 fold greater affinity for K+ than
Na+(Pressman,1976). The addition of valinomycin to a suspension of
trypanosomes would, by increasing the membrane's permeability to K+,
clamp the membrane potential or slightly hyper-polarise the cell
(Bashford et_ al.,1985). Preliminary experiments with valinomycin
showed that it had no effect on the uptake of any of the substrates
tested unless the cells were incubated with valinomycin for 10
minutes before rates of purine nucleoside and base uptake were
measured. The reasons for a preincubation being required before
valinomycin has any effect will be dealt with in the Discussion
(Section 4.2.2). The experimental protocol followed in these
experiments is detailed in the legend to Figure 3.40. The effects of
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valinomycin and valinomycin with K+ at a concentration of 103mM were
determined on the uptakes of adenosine, adenine and hypoxanthine. The
incubations were started by the addition of 500pl of cell suspension,
preincubated for 10 minutes in the appropriate buffer, to 50Ctyjl of
buffer containing the labelled substrate. After the addition of the
cells with rapid mixing duplicate samples of the incubation mix were
layered on to silicon sandwiches and centrifuged after 30 seconds to
terminate the uptake assay.
Valinomycin caused a reduction in the uptake of the labelled
nucleoside and bases as shown in Figure 3.AO. Valinomycin caused a
reduction in the uptake of adenosine at all adenosine concentrations
of 56% +_ 6%. The uptakes of adenine and hypoxanthine were reduced by
33% +_ 7% and 46% +_ 4% respectively. This observed reduction in uptake
may be due to the effect of valinomycin on intracellular membranes or
a detergent effect on the plasma membrane. Figure 3.40 shows that
high concentrations of K in the incubation medium in the presence of
valinomycin is even better at inhibiting uptake of the labelled
substrates than valinomycin alone or K+ alone (Section 3.6.3).
Adenosine uptake is inhibited by 68% +■ 4%, adenine uptake is
inhibited by 52% _+ 9% and hypoxanthine uptake is inhibited by 55% +_
5%. These results provide further evidence for uptake of adenosine,
adenine and hypoxanthine being dependent on a membrane potential. The
observed effects of valinomycin on uptake are not due to any adverse
effects on cellular metabolism as determined by observations of cell
motility and measurements of rates of oxygen uptake after incubation
of the cells with valinomycin. These results are discussed in detail
in the Discussion (Section 4.2.2).
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3.6.5 Sodium Dependence of Nucleoside and Base Uptake.
The previous experiments (Sections 3.6.2 & 3.6.3) provide some
evidence that a membrane potential is required for maximal rates of
nucleoside and base uptake. However in many other transport systems
an ion gradient is often involved as well as a membrane potential,
overall transport being driven by an electrochemical gradient
composed of the ions' chemical gradient and the membrane potential.
Therefore the dependence of uptake of adenosine, adenine and
hypoxanthine on the extracellular concentration of Na+ was
investigated. As stated previously (Section 3.6.2) increasing the
extracellular concentration of K+ results in a decrease in membrane
potential therefore any K+ dependence of uptake would be masked by
this effect. K+ dependence of uptake was therefore not investigated
further. However possible methods for investigation of K+ dependence
of uptake will be considered in the Discussion (Section A.2.2). The
sodium dependence of the uptake of adenosine and hypoxanthine was
investigated by incubating cells with labelled substrates in the
presence of increasing concentrations of NaCl as described in the
legend to Figure 3.41. The NaCl concentrations in the incubations
were varied between 0 and 210mM. Figure 3.41 shows the results of
these experiments. The results indicate that adenosine uptake is not
dependent on Na+ but hypoxanthine uptake^while not dependent on the
presence of Na* is stimulated by high concentrations of Na+. These
results will be considered in more detail in Section 3.6.8.
3.6.6 Effect of FCCP and pH on the Uptake of Purine
Nucleosides and Bases.
The uptake of hypoxanthine shows some slight stimulation by Na+
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Figure 3.41 SODIUM DEPENDENCE OP ADENOSINE, ADENINE AND
HYPOXANTHINE UPTAKE.
IN/] mM
Trypanosomas (1.20mg protein/ml) were incubated with adenosine( • ),
adenine(D) and hypoxanthine (♦) {lpM final concentration,specif ic
activity lOOpCi/pmole) in TrisHCl choline chloride glucose buffer
(Materials & Methods,Section 2.4) pH 7.4 with increasing
concentrations of Nad (0-210mM). The concentration of choline cloride
was reduced as the concentration of NaCl was increased so maintaining
a constant osmolality. Uptake was assayed by silicon sandwich
centrifugation of duplicate 400yal samples of each incubation. The
results presented are the mean and population deviation of duplicate
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at high concentrations but adenosine uptake appears to be slightly
inhibited by high Na+ concentrations. Since uptake dependence on K+
was not investigated the only other cation in the incubating media
which could be involved in uptake is the proton. The uptake of
nutrients such as amino acids by certain species of bacteria has been
shown to be coupled to a proton gradient (MacDonald & Lanyi, 1975).
The possibility that the uptake of adenosine and hypoxanthine could
be coupled to an electrochemical proton gradient was investigated by
measuring the uptake of labelled adenosine and hypoxanthine in the
presence of protonophore (FCCP) and at various proton concentrations.
Uptake assays were carried out as described in the legends to
figures 3.42 and 3.43. The protonophore FCCP was used at a
concentration of 2pM which was shown to have no effect on cell
motility or rates of oxygen uptake at this concentration. Increasing
the pH of the incubation medium had the effect of markedly increasing
the rate of oxygen consumption by the cells and their motility. The
rates of oxygen uptake were measured with a Clark oxygen electrode
and cell motility was observed by phase contrast microscopy as
described in Materials & Methods (Section 2.6). All other assay
methods and parameters were as described in Section 3.6.2.
The effects of FCCP on the uptake of labelled adenosine and
hypoxanthine are shown in Figure 3.42. The uptake of adenosine is
inhibited by 30% hk4% and the uptake of hypoxanthine is inhibited by
25% _+ 5% by FCCP. This suggests that the uptake of adenosine and
hypoxanthine may be associated with the movement of protons across
the plasma membrane. The effects of increasing pH (decreasing proton
concentration) on the uptake of adenosine, adenine and hypoxanthine
are shown in Figure 3.43. As the pH of the incubation medium is
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Figure 3.43 EFFECT OF pH ON THE OPTAKB OF ADENOSINE,
PH
Trypanosomas {lmg protein/ml) were incubated with adenosine( • ),
adenine*X ) or hypoxanthine( ■ ) (final concentration ljiM,specific
activity 100>iCi//imole) in PSG buffer over a pH range of 6.5 to 10.0.
All incubations were carried out at 22°C for 30 seconds uptake being
measured by silicon sandwich centrifugation. The results are presented
as the mean and range of duplicate experiments.
Table 3.1 effect or ionopborbs and ion gradients














adenosine |56+6* j42+4% j20+6% Jhigb pH Jao+7% no effect
hypoxanthine |46+4% |43+5% |31 + 6% no effect J25+4I stimulates
adenine 13317* J 48 +8% |24 + 3% no effect n.d. no effect
I- INHIBITION N.D.» NOT DETERNINED
The table suanarises the effects of valinoavcin, graaicidin. TCCP, pB
variation between pa 7 and pa S.5, Ha* and e* on the uptake of purine
nucleosides and bases bases on the results presented in Sections 3.6.1 to
3.6.6.
rigure 3.44 SOHE POSSIBLE MODELS rOR ACTIVE TRANSPORT OF PURINE NUCLEOSIDES
AND BASES BY T.brucei.
increased the rates of uptake of the labelled substrates decreases.
However in the pH range 7 to 8.5 there is no effect on the uptake of
adenine or hypoxanthine although adenosine uptake may be slightly
inhibited by increasing pH over this range.
3.6.7 Summary of Ion, Ionophore and pH Effects on Purine
Nucleoside and Base Uptake and a Possible Model
for the Transport Mechanism.
Table 3.8 summarises the results obtained from the experiments
described in Sections 3.6.2 to 3.6.6. The uptake of adenosine appears
to be dependent on an electrochemical gradient as shown by the
effects of the high extracellular K+ and the ionophores valinomycin
and gramicidin on uptake. A proton requirement for adenosine uptake
is also indicated by the effects of increasing the extracellular pH.
The uptake of adenine appears to have the same sensitivities as
adenosine with respect to K+ and the ionophores valinomycin and
gramicidin. The uptake of hypoxanthine shows the same sensitivities
as adenosine and adenine with respect to K+ and the ionophores but is
also slightly stimulated by high concentrations of extracellular
sodium ion. This suggests that the uptake mechanism for hypoxanthine
is different to the uptake mechanisms for adenosine and hypoxanthine.
Figure 3.44 shows diagramatically some possible models of the
uptake mechanisms for adenosine, and hypoxanthine which are
consistent with the results shown in Table 3.8. Since adenosine
uptake shows some sensitivity to pH the existance of a pH gradient
across the plasma membrane was investigated.
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Figure 3.45 DISTRIBUTION OF HETHLAMINE ACROSS THE TRYPANOSOMA!,
PLASMA MEMBRANE.
Q
Trypanosomes were suspended at a cell density of 3.613 x 10 cells/ml
1 4
in PSG at either pH 7.4 or pH 8.0. The ( C] methylamine (10pl at
0.1pCi//il) was added to suspensions of cells (5ml) at pH 7.4 and at
pH 8.0. The equilibration of the label across the cell membrane was
followed by taking samples of the incubations at the times shown and
centrifuging on silicon sandwiches. After centrifugation the
concentrations of label inside and outside the cells was estimated by
counting samples of the top layer of the silicon sandwiches and the
PCA layer. (•) Methylamine pH 7.4, (♦) Methylamine pH 8.0. The results
are presented as the mean and range of duplicate experiments.
3.6.8 Measurement of ApH Across the Trypanosomal Plasma Membrane.
The detection and measurement of a pH gradient across the
trypanosomal plasma menbrane was carried out by measuring the
14
distribution across the plasma membrane of the C labelled weak base
methylamine at pH 7.4 and pH 8.0.
The weak base distributes across a membrane in a manner dependent on
the pH on each side of the membrane. Calculation of the
concentrations of the label on each side of the membrane allows
calculation of the magnitude of any pH gradient present using the
following equation.
„ M ^3^3 ■'oUTApH=log
[CH3NH3 ]IN
The derivation of the above equation is given in Materials and
Methods (Section 2.17).
The estimation of ApH was carried out as detailed in the legend
to Figure 3.45. Distribution of the label in the cell was assumed to
be even throughout the total cell water. The volume used for total
g
cell water was 32jjl/10 cells as determined in Section 3.6.1. The
results of these experiments are shown in Figure 3.45 expressed as
the ratio of the concentration of the label extracellularly to the
concentration of label intracellularly as a function of time. The
results show that the label has not reached true equilibrium by
twenty minutes. However the calculation of ApH requires the
distribution of the label to be measured at equilibrium (Materials &
Methods Section 2.17). The plots shown in Figure 3.45 were therefore
linearised in the same manner as for a Hanes plot by plotting time
divided by the ratio of label concentration inside the cell to the
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Figure 3.46 LINEARISED PLOT OF THE DATA PRESENTED IN PIGORE 3.45









concentration of label outside the cell as a function of time as
shown in Figure 3.46. The intercept of these plots with the y-axis is
the x-axis intercept divided by the concentration ratios of label
insiderlabel outside at equilibrium (cf. Km/Vmax). The ApH calculated
from the equilibrium distributions of the two labels at pH 7.4 and pH
8.0 are shown in Table 3.9. These results show that at an
extracellular pH of 8.0 the ApH is 0.6 acid inside. At an
extracellular pH of 7.4 the proton gradient is larger with a 4pH of
0.8 acid inside.The significance of these results will be considered
further in the Discussion (Section 4.2.2).
3.7 CELL FRACTIONATION.
In order to characterise the uptake system for adenosine in more
detail experiments were carried out to identify the molecules in the
plasma membrane responsible for transport. The adenosine transport
system was chosen for further study since labelled adenosine can be
readily converted to an affinity label (Section 3.8), for use in
identifying the adenosine transporter. To aid in the identification
of the adenosine transporter a plasma membrane fraction was isolated
from the trypanosomes to enable detection of proteins which may be
present as a very low percentage of total cell protein.
Several methods have been published for the isolation of a
plasma membrane enriched fraction from trypanosomes (Rovis &
Baekkeskov,1980; Steiger et al.,1980; Mancini et al.,1982; Voorheis
et al.,1979), which differ in the methods used for the initial
disruption of the cells , the markers used to identify the plasma
membrane fraction and the centrifugation techniques used to purify
the plasma membrane. The main problem in purifying trypanosomal
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plasma membranes is the lack of an unequivocable marker enzyme for
the membrane. However Steiger et al. (1980) showed that the enzyme
^glucosidase (EC 3.2.1.20) was virtualy non-latent in whole cells
suggesting its presence on the outer surface of the trypanosomal
plasma membrane. Radioiodination of plasma membrane polypeptides,
125
using the enzyme lactoperoxidase (EC 1.11.1.8) and I, was used to
mark plasma membranes prior to fractionation by Mancini _et al.
(1982). This author also used Na+/K+ ATPase (EC 3.6.1.3) as a
membrane marker as did Voorheis _et_ al. (1979). Using ouabain
inhibitable Na /K+ ATPase activity as a plasma membrane marker
suffers from the drawback that in the initial stages of the cell
fractionation it can not be easily detected against the general
background of phosphatase activity and the activities of other
ATPases. The problem of suitable enzyme markers for the trypanosomal
plasma membrane will be considered in more detail in the discussion.
The plasma membrane markers chosen for use in this work were
125 ■+■ ■+■
c*cglucosidase and cell surface proteins labelled with I. Na /K
ATPase was also used as a plasma membrane marker after the cell
membranes had been partially purified.
3.7.1 Cell Breakage Techniques.
The authors listed in the previous section all used different
techniques for the initial disruption of the trypanosomes. Voorheis
et al. (1979) used a combination of osmotic swelling of the cells and
a very tight fitting homogeniser (10-20pn clearance) to disrupt the
cells whereas Mancini et al_. (1982) used sonication to disrupt the
cells. Nitrogen cavitation was the method used by Rovis & Baekkeskov
(1980), while Steiger et al. (1980) ground the cells with silicon
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% TOTAL PROTEIN % TOTAL oA-GLUCASE.
HSS HSP HSS HSP
SONICATION 59% 30% 48% 5%
WATER LYSIS 70% 37% 56% 36%
CARBIDE GRINDING 40% 25% 43% 24%
GLASS BEAD GRINDING 58% 27% 46% 54%
The table shows the distribution of oi-glucosidase activity and
protein between a high speed supernatant and pellet obtained form a
cell lysate produced as shown. All experimental details are given
in the text (Section 3.7.1) and Materials and Methods (Section
2.7).
carbide.
Attempts to disrupt the trypanosomes by the method of Voorheis
et_ _al. (1979) failed due to the lack of a homogeniser with a small
enough clearance, therefore this approach to cellular disruption was
abandoned. The equipment required for carrying out cellular
disruption by nitrogen cavitation was not available therefore this
method was not attempted. Grinding the trypanosomes with silicon
carbide caused complete disruption of the cells but recovery of
material from the silicon carbide/cell paste formed during grinding
was poor. However when 75jim glass beads were used for grinding in
place of the silicon carbide the recovery of material from the
grinding paste was much improved. The recovery of material from the
grinding paste could be further improved by prewashing the glass
beads in a 1mg/ml BSA solution. Sonication as used by Rovis and
Baekkeskov (1980) was also successful in disrupting the trypanosomes
but had some disadvantages as described below.
Four methods of cell disruption were compared; sonication, water
lysis, grinding with silicon carbide and grinding with glass beads.
The grinding material was removed by centrifugation at 100xg for five minutes.
Table 3.10 shows the distribution of protein and the marker enzyme
crt-glucosidase between a high speed supernatant fraction (HSS) and a
high speed pellet fraction (HSP) containing all cell membranes. The
two fractions HSS and HSP were produced by centrifugation ( 150,000xg
av. for 1 hr) of the homogenates produced by the methods listed in
Table 3.10. The experimental details of the disruption methods listed
in Table 3.10 are given in Materials & Methods. The results of the
distribution of ol-glucosidase and protein are expressed as
percentages of the protein or p<-glucosidase activity found in the
starting cell suspension. Protein was estimated by the method of
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Bradford (1976) and ^-glucosidase activity was assayed by the
fluorimetric method described by Steiger _et al. (1980) using
A-methyl-umbelliferyl-oC-D-glucoside as substrate.Full details are
given in Materials & Methods (Sections 2.12 & 2.10.1 respectively).
The results presented in Table 3.10 show that sonication results
in an apparent loss (47%) of cxt-glucosidase activity, the reasons for
this loss of activity are unknown. The loss of activity observed can
not be accounted for by vesicularisation of the plasma membrane
depriving the enzyme of access to the substrate since the
p(rglucosidase assay buffer contained detergent (Triton X-100 at a
concentration of 1%(w/v)) to make permeable any vesicles formed. This
loss of marker enzyme activity made sonication an unsuitable method
for the disruption of trypanosomes.
Water lysis of the trypanosomes results in better recovery of
the marker enzyme activity but caused destruction of the subcellular
organelles of the trypanosomes, such as glycosomes and lysosomes,
which is indicated by the high percentage of the cellular protein
recovered in the high speed supernatant fraction (HSS). Destruction
of the lysosomes in particular is undesirable since this will cause
the release of many proteolytic enzymes into the homogenate. Water
lysis was therefore discounted as a method of cellular disruption.
Grinding the trypanosomes with silicon carbide as stated above
results in poor recovery of protein and ^glucosidase activity from
the cell grinding paste. Therefore grinding with silicon carbide was
not used as a technique for cellular disruption.
Grinding the trypanosomes with 75pm diameter glass beads
resulted in reasonable recovery of protein and 100% recovery of
c^-glucosidase activity from the grinding paste. This method of cell
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breakage also proved to be least harsh as indicated by 50% of the
otglucosidase remaining associated with the cell membranes. It will
be shown later that oC-glucosidase is only loosely associated with
the plasma membrane and easily removed as was observed by Steiger
et_ al_. (1980). In view of the above results grinding with glass beads
was the cell breakage method chosen for use in all subsequent
fractionation experiments.
3.7.2 Preliminary Cell Fractionation Experiments and Estimation of
Plasma Membrane Density.
Before designing a purification scheme for the routine isolation
of a plasma membrane fraction the densities of the plasma membrane
fragments produced by grinding the trypanosomes with glass beads was
determined.
Voorheis et. al. ( 1979) estimated the plasma membrane density to
3
be 1.24g/cm , agreeing with Steiger et_ al_. (1980) who estimated the
3
density to be 1.22g/cm . Mancini e_t a^. (1982) estimate the plasma
3 3
membrane density to be between 1.12g/cm and 1.14g/cm which is in
close agreement with Rovis & Baekkeskov (1980) who estimate the
3
density to be 1.1Ag/cm . The differences between these values for the
plasma membrane densities could be due to the presence or absence of
the subpellicular microtubules associated with the intact plasma
membrane. (Anderson & Ellis, 1965; Angelopoulos, 1970). This point will
be considered again in the discussion.
The density of the plasma membrane fragments, produced by
grinding the trypanosomes with glass beads, was estimated by
centrifugation of a crude membrane preparation on a continuous
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3 3
sucrose density gradient from 1.018g/cm to 1.270g/cm . All densities
were estimated from the refractive index of the gradient fractions.
The trypanosomes (approximately Ami packed cell volume (PCV)) were
suspended to a total of volume of 6ml in 10mM HEPES, 0.25M sucrose,
1mM EDTA, 1mM PMSF, 1mM benzamidine, at pH 7.A. Glass beads (BSA
washed) were added to the cell suspension until a stiff paste of
cells and beads was formed. This paste was then ground in a chilled
mortar and pestle until no whole cells could be observed by phase
contrast microscopy, typically after 1-2 minutes grinding. The broken
cell and glass bead paste was then treated as shown in Figure 3.A7.
Samples of all fractions were taken for estimation of protein content
and oA-glucosidase activity. The distributions of protein and
o^-glucosidase activity in the fractions obtained from this experiment
(Figure 3.A7) are given in Table 3.11. The sucrose interface material
3
(SI) which collected on the 2.08M (1.26g/cm ) sucrose cushion was
resuspended in 10mM HEPES, 0.25M sucrose, 1mM EDTA, pH 7.A and
pelleted at 100,000xg av. for 30 minutes. The pellet was resuspended
in the same buffer and layered onto continuous sucrose gradients,
3
density 1.018-1.270g/cm . The gradients were centrifuged at 150,000xg
av. for 15 hours in a Beckman SWA1 swinging bucket rotor. The sucrose
gradients (1Aml) were fractionated into 1ml fractions by upward
displacement of the gradient by 2.5M sucrose being pumped into the
centrifuge tube through a hole in the bottom of the tube. The
refractive index of each fraction was measured to estimate the
fraction's density. The membrane material in each of the fractions
was collected by dilution of the fractions in 10mM Hepes, 1mM EDTA,
pH 7.A and centrifuging at 100,000xg av. for 30 minutes. The membrane
pellets obtained were resuspended in the same buffer by gentle
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Figure 3.47 CELL FRACTIONATION SCHEME FOR THE ESTIMATION OF
PLASIA MEMBRANE DENSITY.
Grind Cells with Glass Beads.
Wash x3
100X£ av. 5min.
[H] Supernatants-» ! ^Discard pellets
!
;
! 500x£ avt- 20 min.
!
!
Discard-*- !- •Supernatant CH *]
!
[S] Supernatant.
100,000x£ av, 45 min.
*»Pellet [P]
2.08M Sucrose Step
100,000x£ av. 1.5 hr.
[SI] Interface material-o. ! *»Pellet [SP]
!
!
! Continuous Sucrose Gradient




centrifuged 100,000x£ av 1 hr.
resuspend pellets in 10mM HEPES pH 7.4
Table 3.11 DISTRIBUTION OFo<-GLOCOSIDASE ACTIVITY AND PROTEIN IN
THE FRACTIONS LISTED IN FIGURE 3.47.
oA-GLUCOSIDASE







Protein estimations and o<-gluco3ldase assays were carried out
described in Materials 4 Methods (Section 2.12 4 2.10
espectively). sC-glucosidase activity is given as pmol/min.
Figure3.l»8DSltSITT,P*OTKINCONTEMT,Ai u«MDCK-0L0008IDA8I
Theassay■u dforproteinnenxymeactivitiessh wItfigurrsd t ll dMa rial^ke ho s(Se ti n 2.10.1,2.10.2A. ).Theexperim ntald tailsasr gardthmateri luongrad entth rgiv Intheext(S ction3.7.2).D nsityt»)Pro iX ,CXrglucosldaseaMa*/k*ATPase(■
homogenisation for the determination of c<-glucosidase activity,
ouabain inhibitable Na+/K+ ATPase activity and protein content. The
assays used are described in detail in Materials and Methods
(Sections 2.10.1, 2.10.2 & 2.12 respectively).
Figure 3.48 shows the distribution of protein, ob-glucosidase
activity and ouabain inhibitable Na+/K+ ATPase in the various
fractions from the continuous sucrose density gradient. The results
presented in Figure 3.48 show that ©<-glucosidase and ouabain
inhibitable Na+/K+ ATPase band at the same densities. These two
3
plasma membrane markers band at a density of 1.13-1.16g/cm with a
3
peak of activity at a density of 1.14g/cm which is in close agreement
with Rovis & Baekkeskov (1980) and Mancini et al.(1982).
Rovis & Baekkeskov (1980) purified trypanosomal plasma membranes
from endoplasmic reticulum and golgi membranes by dialysis of a
crude microsomal membrane faction against 1mM HEPES,1mM MgCl„ and
protease inhibitors at pH 8.2 for 2 hours followed by centrifugation
onto a plaque of 26%(w/v) dextran in the same buffer. The plasma
membranes were found to form a band on top of the dextran plaque
while the golgi, endoplasmic reticulum and other membranes pelleted
at the bottom of the tube. This dextran centrifugation method has
also been used to produce plasma membranes from adipocytes (Steck &
Wallach,1970) and from Ehrlich ascites carcinoma cells (Wallach &
Kamat,1964). These authors showed that the pH and magnesium ion
concentration used in the dialysis step can make a marked difference
in the distribution of the plasma membrane on the dextran plaque.
Both of the above authors were in agreement that a high pH was
required for optimum yields of plasma membrane. The optimum magnesium
ion concentration used in this dextran centrifugation method appears
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Figure 3.49 PHOTOGRAPH OF A DEXTRAN PLAQUE AFTER CENTRIFUGATION OF
MICROSOMES IN 0.5mM MgSO^.
The fractions arrowed are I interface material, D dextran plaque and
P pelleted material. All other details are given in the text (Section
3.7.3)
to vary depending on the cell type being fractionated. Therefore the
optimum concentration of magnesium ion for the production of plasma
membranes from T.brucei TREU 55 was determined. The physical basis of
this technique will be considered in the discussion.
3.7.3 Optimisation of Magnesium Ion Concentration for
Dextran Centrifugation.
The optimum concentration of magnesium ion to be used in
preparing plasma membranes by centrifugation onto a dextran plaque
was determined as follows. A crude total cell membrane fraction was
prepared by grinding the trypanosomes with glass beads as described
previously (Section 3.7.1)and centrifuging the homogenate at
150,000xg av. for 1 hour, the pellet from this centrifugation was
resuspended in 1mM HEPES,1mM PMSF, 1mM benzamidine at pH 8.6
containing magnesium sulphate at a concentration of 0.5mM, 1.0mM or
2.0mM and dialysed against 10 volumes of the same buffer for 1 hour.
The dialysed material was then layered onto 26%(w/v) dextran plaques
containing the appropriate concentration of magnesium sulphate and
centrifuged in a swinging bucket rotor at 150,000xg av. for 1.5
hours. At the end of this centrifugation 3 fractions were collected.
The sample/dextran interface material(I), the dextran plaque(D) and
the material pelleted at the bottom of the tube. These fractions were
resuspended and washed by resuspension and centrifugation (200,000xj5
av. for 30 minutes) in 1OmM HEPES, 1mM EDTA at pH 7.4. The three
fractions were then assayed for protein content and <?<-glucosidase
activity as described in Materials & Methods (Sections 2.12 & 2.10.1
respectively) .
Figure 3.49 shows a photograph of the dextran plaque after
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Table 3.12
EFFECT OF Mg2* CONCENTRATION ON THE DISTRIBUTION OF THE MEMBRANE
MARKER oC-GUJCOSIDASE AND PROTEIN ON A 26% DEXTRAN PLAQUE.






I 21% 79.3 • 56%
D 22% 25.3 20%
P 56% 10.2 20%
I.OmM
I 20% 47.2 42%
D 22% 29.1 30%
P 58% 10.1 26%
2.0mM
I 9% 30.6 32%
D 14% 30.8 51%
P 77% 1.7 16%
Experimental details for the above experiments are described in the text
(Section 4.7.4). The enzyme assay used and the method of protein estimation are
described in Materials 4 Methods (Sections 2.12 4 2.10.1). The specific activity
of a<-glucosidase is given as nmol/min/mg protein.
centrifugation containing 0.5mM magnesium sulphate. The three
fractions collected are labelled I, D and P as described above. Table
3.12 shows how the distribution of protein and ek-glucosidase activity
between these three fractions varies with changes in the magnesium
ion concentration. As the magnesium ion concentration increases, the
percentage of total protein in the dextran plaque and pellet
increases and less is left on the sample/dextran interface. The
plasma membrane marker enzyme ck-glucosidase shows this same tendency
with increasing magnesium ion concentrations but the activity
migrates into the dextran rather than pelleting. The optimum
magnesium ion concentration for the purification of the plasma
membrane appears to be 0.5mM as indicated by the highest content and
specific activity of ot-glucosidase in the sample/dextran interface at
this magnesium ion concentration.
3.7.A Purification of Trypanosomal Plasma Membrane.
Having found a suitable method of cell breakage (Section 3.7.1),
determined the density of the plasma membrane fraction by equilibrium
density centrifugation (Section 3.7.2) and optimised the magnesium
ion concentration for use in the dextran centrifugation purification
of plasma membrane, a final purification scheme for the routine
production of a plasma membrane-enriched fraction was developed.
The scheme developed for the purification of trypanosomal plasma
125
membrane is shown in Figure 3.50. In this experiment I surface
labelled cells were added to the bulk of the cells prior to
fractionation to act as a plasma membrane marker as well as
^-glucosidase activity. The radio-iodination of the cells was carried
out as described in Materials & Methods (Section 2.16). The labelled
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Figure 3.50 CELL FRACTIONATION SCHEME FOR THE PRODUCTION
OF PLASMA MEMBRANE ENRICHED FRACTION.
Grind cells with glass beads.
!
!
! Hash x3 100x£ av. 5 min.
Supernatants -! »Discard pellets
!
Discard Pellet*
500x£ av, 20 oin.
» Supernatant [H]
! I00,000x£ av. 45 min.
!
!




100,000x£ av. 45 min. ! supernatants [S]
[P] Pellet*--
!
--> Supernatant > !
! resuspend in ImM HEPES
! 0.5mM Magnesium Sulphate pH 8.6
!
t
! 26% Dextran step
! 150,000x£ av, 1.3 hr.
;
Pellet and !
Suspened material* ! interface material
200,000x£ av 30 min.

























cells were added to unlabelled cells (6ml PCV) which were then ground
with glass beads in homogenisation buffer as described in Section
3.7.2. The broken cell debris was washed from the glass beads by
repeated resuspension in homogenisation buffer and low speed
centrifugation. The homogenate obtained was then centrifuged at 500xg
av. for 20 minutes to remove unbroken cells and nuclei. The
supernatant from this centrifugation was designated the start
homogenate (H Figure 3.50). The membrane material present in this
homogenate was pelleted by centrifugation at 100,000xg av. for 45
minutes and the pellet obtained washed once in homogenisation buffer
by gentle homogenisation before repelleting the membranes. The first
supernatant and the supernatant from the washing step were pooled (S
Figure 3.50). The pellet (P Figure 3.50) was resuspended in 1mM
HEPES, 0.5mM Mg S0^ at pH 8.6 and dialysed against 10 volumes of this
buffer for 1 hour. The dialysed material (4ml) was then layered on to
dextran plaques (8ml) and centrifuged at 150,000xg av. for 1.3 hours
in a SW 41 swinging bucket rotor. Two fractions were collected from
the dextran centrifugation step, the sample/dextran interface
material and the material suspended in the dextran along with the
pelleted material. Both of these fractions were resuspended in
homogenisation buffer and pelleted by centrifugation at 200,000xg av.
for 30 minutes. The interface material (IF Figure 3.50), the dextran
suspended material and pellet fraction (DP Figure 3.50) were further
analysed by centrifugation on a sucrose discontinuous step gradient.
The two fractions IF and DP were resuspended by gentle homogenisation
in homogenisation buffer and layered onto the sucrose step gradients.
The gradient steps were designed to collect the maximum yield of
plasma membrane rather than low yield high purity. The density of the
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Table 3.13 DISTRIBUTION OF MEMBRANE MARKERS IN SUBCELLULAR FRACTIONS

















H 117 31.0 96 — _
s«— 99.5 2X1 69 0.7 0.7
r—p «j 32 7X3 21X7 X4 2.2
—♦IF —* 3.5 137.5 326.7 4.4 X4
L=»DP 13.4 54.8 115.1 1.7 1.2
-»DP1 0.003 N.D. 725 — 7.5
—»DP2 0.31 24.7 350 0.8 X6
—»0P3 0.54 10 127.7 0.3 1.3
L.DP4 X5 25.7 107.1 X8 1.1
DI1 «■ 0.12 69.6 511.5 X2 X3
012 «- 1.41 97.1 649.9 X1 6.7
013 «- 0.011 N.O. 397.3 - 4.1
014 J N.O. N.O. N.O. - -
N.D. » NOT DETECTED
The fractions listed in the table were produced as described in
Figure 3.50 and text (Section 3.7.4). oO-Cluccsidase activity was
measured as described in Materials 4 Methods (Section 2.10.1). The
125
I content of the fractions was estimated by liquid scintillation
counting.
first step was 1.080g/cm which would allow through all the plasma
membrane and denser material. The second step was composed of sucrose
3
at a density of 1.176g/cm which would stop all the plasma membrane
material as indicated by the distribution of o<-glucosidase activity
on a continuous sucrose gradient (Figure 3.39). The third step had a
3 3
density of 1.197g/cm followed by a cushion of density 1.286g/cm .
After centrifugation of the gradients at 150,000xg av. for 3 hours,
material from the sucrose step interfaces was collected and washed by
resuspension and centrifugation before finally being resuspended in
125
10mM HEPES, 1mM EDTA, pH 7.A for estimation of protein, I and
^glucosidase activity. The fractions from the sucrose step gradients
were named as fellows; fractionated dextran interface material (IF
3 3
Figure 3.50), DI1 density < 1.080g/cm , DI2 density < 1.176g/cm , DI3
3 3
density < 1.197g/cm and DI4 density < 1.286g/cm (Figure 3.50). The
dextran suspended and pelleted material (DP Figure 3.50) separated on
the sucrose step gradient was collected in identical density
fractions DP1 to DPA.
125
Table 3.13 shows the distribution of I, c<-glucosidase and
protein between the fractions listed in Figure 3.50. The results show
that the dextran interface material (IF) contains plasma membrane
material since sucrose step gradient analysis of this fraction shows
only low density material is present with the highest specific
125
activity of ©<-glucosidase and I in fraction DI2 as would be
3
expected from plasma membrane with a density of 1.14g/cm . Analysis
of the dextran suspended material and pellet on the sucrose step
gradient shows more material present at higher densities with low
125
specific activities of <?<.-glucosidase and I-labelled proteins. The
purification of the plasma membranes as indicated by increasing
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Figure 3.51 SDS PAGE GEL OF THE SUBCELLULAR FRACTIONS PRODUCED BY THE
FRACTIONATION SCHEME GIVEN IN FIGURE 3.50.
DI3 PI 2 011 IF DP4 DP3 DP2 DP
All lanes of the gel were loaded with 200^jg of protein with the
exceptions of lanes DI1 and DI3 which were loaded with 3^jg and 11/Jg
respectively being the entire protein content of these fractions. The
gel electrophoresis system used is described in Materials & Methods
(Section 2.13)
specific activity of p<-glucosidase parallels the increasing specific
125
activity shown by I-labelled proteins until the sucrose step
gradient analysis. The drop in specific activity shown by
^glucosidase is probably due to the loss of «<-glucosidase activity,
either by becoming detached from the membrane or inactivation by some
125
other means. The fraction DP1 shows a high specific activity of I
which is probably due to free iodine at the top of the gradient with
very little protein (0.003mg). It is likely that the specific
125
activity of I in fraction DI1 is an overestimate for the same
reasons. The fractions IF, DI1, DI2, DI3, P, DP1, DP2, DP3 and DP4
were analysed by SDS polyacrylamide gel electrophoresis (SDS PAGE) to
compare the distribution of proteins between fractions. Figure 3.51
shows a photograph of the Coomassie stained gel. The gel shows that
the protein composition of the various fractions is markedly
different. There are a great many differences between the protein
compositions of the dextran interface material, IF, and the dextran
suspended and pelleted materialjP. However there appears to be little
difference between the dextran interface material,IF, and the plasma
membrane fraction,DI2,from the sucrose step gradient. Another point
to notice is that fractions DI2 and IF have a very high lipid
content, as would be expected of a plasma membrane fraction,
indicated by the irregular banding of proteins at the bottom of the
gel. This effect can be eliminated by acetonerethanol extraction of
the membrane fractions before SDS PAGE.
The fraction DI2 was used in all subsequent experiments as the
plasma membrane enriched fraction which shows a 6.7 fold purification
with respect to radioiodinated proteins and a 3 fold purification of
o^-glucosidase although this may be an under-estimate for the reasons
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stated above.
3.7-5 Cellular Distribution of Purine Nucleoside and Base
Metabolising Enzymes.
Before attempting any further characterisation of the adenosine
transport system the cellular distribution of the enzymes involved in
metabolism of nucleosides and bases was investigated. The main reason
for this investigation was to determine whether any of the enzymes
were membrane bound which could indicate an involvement in the uptake
system as in the bacterial and mould phosphotransferase systems for
the uptake of sugars(Oxender,1972; Boos,1974).
The distribution of the enzymes between membranes and cytoplasm
was investigated by making the cells permeable with the detergent
saponin and measuring the leakage of the various enzyme activities
from the cell. Trypanosomes were suspended in Tris saline glucose
buffer (TSG) at pH 7.4, at a protein concentration of 1.5mg/ml,
either with or without 0.1% (w/v) saponin present. The two batches of
cells were then treated in the same way as described below. The cell
suspensions were left on ice for 20 minutes then centrifuged at
10,000xg av. for 5 minutes to pellet the cells. The supernatants
(LSS) and pellets (LSP) were then assayed for the following enzyme
activities; adenosine hydrolase, APRT, HxPRT and the plasma membrane
marker «<-glucosidase as described in Materials & Methods (Sections
2.10 & 2.10.1). The cell pellets were water lysed, homogenised in TSG
buffer, centrifuged at 120,000xg av. for 1 hour and the supernatant
(HSS) and pellet (HSP) assayed for the enzyme activities listed
above. The protein content of all fractions was also determined.
The activities of the above enzymes in each fraction are shown
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WHOLE CELL 100.0 100.0 100.0 100.0 100.0
T LSS 7.2 l.f 0.3 13.1 3.3
R H LSP 35.4 44.0 37.0 64.4 36.0
I C HSS 33.a 23.0 9.2 2.7 3.6
S 1. HSP 36.3 23.0 19.4 37.2 79.3
WHOLE CELL 100.0 100.0 100.0 100.0 100.0
T ♦ LSS 43.2 113.0 96.7 91.0 74.8
R H S LSP 46.7 3.0 6.5 22.0 0.8
I C A HSS 3.0 0.3 2.7 1.1 1.1
S I. P. HSP 31.4 0.3 0.0 22.0 0.0
The methods of producing the fractions LSS (low speed supenatant), LSP
(low speed pellet). HSS (high 3peed supenatant) and HSP (high speed
pellet) are given in the text (Section 3.4.5). The assay methods used
for adenine(APRT), hypoxanthine(HxPRT) phosphoribosyltransferases,
adenosine hydrolasefAr HYDROL) and o4.-glucosidase( ©4.-GLUC.ASE) are
described in Materials & Methods (Sections 2.10 4 2.10.1).
in Table 3.14 expressed as a percentage of the activity in a whole
cell lysate. The low speed supernatant fraction (LSS) should contain
enzymes which leaked from the cells during the 20 minute incubation
on ice. The results show that in the incubation without saponin very
little material has leaked from the cells as shown by the
distribution of enzyme activities between the fractions LSS and LSP,
most of the enzyme activities being recovered in the cell pellet
fraction (LSP). The results obtained for the incubations carried out
in the presence of saponin are markedly different in that half of the
cell protein has been released into the incubation medium (LSS) with
approaching 100% of the enzyme activities measured in whole cell
lysate also appearing in this fraction. The results also show that
the saponin causes release of the plasma membrane marker
oi-glucosidase from the plasma membrane which is in agreement with the
results obtained by Steiger et_ al. (1980) who showed ^-glucosidase to
be loosely attached to the outer surface of the plasma membrane. In
view of this result the fact that the majority of the enzyme
activities measured are released from the cells by saponin may not
indicate that these enzymes are soluble cytoplasmic enzymes since the
detergent may solubilise them if they are not firmly bound to
membranes or are not integral membrane proteins.
When the cell pellets (LSP) from the incubations without saponin
were water lysed and recentrifuged at high speed the results,
expressed as a percentage of the activity found in the cell pellets
(LSP), show that most of the enzyme activities are associated with
the pelleted membrane material (HSP). The majority of the
ofglucosidase activity pellets with the membranes as does the
adenosine hydrolase activity. The distribution of the APRT and HxPRT
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activities are less clear cut in that much of the enzyme activity is
lost during homogenisation of the cell pellet (LSP) and the
distribution of activities between the supernatant fraction HSS and
the pellet fraction HSP are almost equal. The results for the saponin
treated cells show that some of the adenosine hydrolase activity
remains membrane bound even after saponin treatment.
Considered as a whole these results suggest that adenosine
hydrolase and <X.-glucosidase are membrane bound but easily solubilised
by saponin treatment although some adenosine hydrolase activity
appears- to be resistant to solubilisation. The
phosphoribosyltransferase activities may be soluble as indicated by
the almost total release of activity from the cell in the presence of
saponin and by the even distribution of detectable activity between
membrane and soluble fractions in the absence of saponin. Further
investigation into which subcellular fraction the adenosine hydrolase
activity is associated with was not carried out. However this
investigation should be carried out at a later date since as
adenosine hydrolysis is the first step in the metabolism of adenosine
to nucleotide, hydrolysis may be directly involved in the transport
process.
3.7.6 Identification of Polypeptides Associated with the
Outer Surface of the Trypanosomal Plasma Membrane.
The adenosine transport protein must be exposed at the cell
surface to allow the binding of adenosine prior to transport across
the membrane. Therefore as a preliminary to affinity labelling of the
transporter, polypeptides exposed at the cell surface were
identified.
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Figure 3.52 AUTORADIOGRAPH OF 125I LABELLED PROTEINS ON THE GEL
SHOWN IN FIGURE 3.51.











The SDS PAGE gel of the subcellular fractions shown in Figure 3.51 was
prepared for autoradiography and autoradiographed as described in
Materials & Methods (Section 2.14).
Two methods were used to identify proteins exposed at the cell
surface. The first method used was radio iodination of the cell
125surface proteins by the enzyme lactoperoxidase and I as described
in the cell fractionation experiments (Section 3.7.4). Figure 3.52
shows an autoradiograph (Materials & Methods Section 2.14) of the SDS
PAGE gel of subcellular fractions shown in Figure 3.51. This Figure
shows that the fractions indicated as being rich in plasma membrane
on the basis of distribution of ^-glucosidase activity (IF & DI2)
also contain the majority of radiolabeled proteins. The lipid
associated with these two fractions which runs at the bottom of the
gel is also heavily radiolabeled. This is probably due to the
reaction of free iodine, or iodine radicals produced by the
lactoperoxidase, with unsaturated lipids in the plasma membrane.
Figure 3.52 also shows the apparent molecular weights of the
labelled proteins which were estimated from their mobilities on the
gel relative to proteins of known molecular weight.
The second method used to identify cell surface proteins was
labelling with fluorescein isothiocyanate (FITC). To show that only
plasma membrane proteins were being labelled the labelling patterns
obtained in the presence and absence of the plasma membrane barrier
were compared. The fluorescent label FITC was incubated at a final
concentration of 3mM (added as 500^1 of a 30mM solution in 30%
methanol) with 5ml of a whole cell lysate at a protein concentration
of 1.5mg/ml in PSG buffer at pH 7.4. This incubation was repeated
with whole cells in place of the cell lysate. The above mixtures were
incubated on ice for 3 minutes. Samples of the above incubations were
then prepared for SDS PAGE as follows. A sample of the cell lysate
incubation was taken and prepared for electrophoresis without any
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Figure 3.53 SDS PAGE GEL OF FITC LABELED PROTEINS.
3a 2a 1a 1b 2b 3b
a) Coomassie stained gel of (1a) whole cell lysate, (2a) whole cells,
(3a) washed cell lysate.
b) The tracks shown 1b to 3b are identical to tracks 1a to 3a except
labeled with FITC and photographed in UV light. All other experimental
details are given in the text (Section 3.7.6)
further treatmemt, while a second sample was washed five times by
resuspension in PSG buffer and centrifugation at 10,000xg av. for 5
minutes as were the whole cells. After centrifugation samples were
prepared for electrophoresis as described in Materials & Methods
(Section 2.13). The three samples, whole cells, whole cell lysate and
washed cell lysate were loaded on to an 8%-20% exponential
polyacrylamide gradient gel (200pg protein/sample) in duplicate.
After electrophoresis the gel was divided into two portions one of
which was stained for proteins by Coomassie blue dye and the other
was soaked in 50% methanol and photographed under UV. light to
visualise the proteins labelled with FITC.
Figure 3.53 shows a composite photograph of the Coomassie
stained half of the gel (1a to 3a) and the half of the gel
photographed under UV. light (1b to 3b). The lanes shown are 1 cell
lysate, 2 whole cell and 3 washed cell lysate. The labelling patterns
shown indicate that only plasma membrane proteins are being labelled.
The whole cell lysate (1b) shows all the proteins in the cell which
can be labellled by FITC, lane 2b shows which proteins are labelled
in the presence of an intact plasma membrane acting as a barrier to
the FITC. Lane 3b shows the membrane proteins labelled in a cell
lysate once the soluble proteins and microsomal membranes have been
removed by centrifugal washing. The labelling pattern shown in lanes
2b and 3b are identical which indicates that in the whole cell (2b)
FITC does not label microsomal membranes or soluble cytoplasmic
proteins. Figure 3.53 also shows the apparent molecular weights of
the proteins labelled by FITC in whole cells as estimated by their
relative mobilities on the gel compared to proteins of known
molecular weight. The molecular weights of the proteins labelled by
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125FITC and I/lactoperoxidase in whole cells are summarised in Table
3.16.(Opposite page 1 A3)
3.8 AFFINITY LABELLING OF THE ADENOSINE TRANSPORTER.
3
As stated in Section 3.7.1 [2,8- H] adenosine can be readily-
converted to an affinity label (2',3' dialdehyde adenosine) for use
in identification of the plasma membrane transport protein. This
involves oxidation of the ribose moiety of the adenosine by sodium
periodate which splits the carbon bond between carbons 2 and 3 of the
ribose resulting in the formation of two aldehyde groups. It is these
two reactive aldehyde groups which allow the label to form covalent
bonds to proteins which can be stabilised by a reducing agent such as
sodium cyanoborohydride.
3.8.1 Synthesis of [2,8-^H] 2',3' Dialdehyde Adenosine
from Labelled Adenosine.
3
[2,8- H] Dialdehyde adenosine was prepared by essentially the
same method as that described for the synthesis of dialdehyde ATP by
3
Easterbrook-Smith et_ al. (1976) and Kumar et al. (1979) with [2,8- H]
adenosine being used in place of ATP. The synthesis was carried out
using the same ratios of reactants as detailed by the above authors
but at a lower concentration due to the lower solubility of adenosine
compared to ATP. The synthesis was first carried out using unlabelled
adenosine.
An adenosine solution (10ml) containing 0.123 mmoles of
adenosine in water at pH 7.0 was mixed with 0.136 mmoles of freshly
prepared sodium periodate solution (1ml) again at pH 7.0 giving a
periodateradenosine ratio of 1.1:1 on a molar basis. This reaction
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Figure 3.54ABSORBTION SPECTRUM OF ADENOSINE BEFORE AND AFTER





















mixture was stored in the dark at 4°C for 1 hr. The reaction was then
stopped by the addition of 4jjl of ethanediol to react with any
remaining periodate. The reaction mix was then applied to a
'Sephadex' G 10 gel filtration column (2cm diameter,X50cm in length)
and eluted with distilled water. The absorbance of the eluate was
monitored at 259nm and the fractions (1ml) absorbing at this wave
length were pooled. The pooled fractions were then lyophilised and
redissolved in 5m1 of distilled water. This product was then
subjected to further analysis. The melting point of the product was
not determined since it charred at a temperature of 240°C which is in
contrast to the sharp melting point obtained for adenosine at 234°C.
The UV. absorbance spectra of adenosine and the product (Figure 3.54)
both show a maximum at 259nm but at shorter wavelengths (<255nm) the
products spectrum differs from that of authentic adenosine. The
product formed a phenylhydrazone compound when reacted with an excess
of phenylhydrazine at pH 2.0 indicating that the product was indeed
an aldehyde. This was also indicated by a positive reaction with
Tollens reagent (0.1M AgNO^ in ammonium hydroxide solution) which
reacts with aldehydes but not ketones whereas phenylhydrazine reacts
with both aldehydes and ketones. The product was also analysed by
thin layer chromatography on silica gel plates using the solvent
system for nucleosides and bases described in Materials & Methods
(Section 2.8). Figure 3.55 shows a photograph of the thin layer
analysis, the spots being visualised by quenching of the fluorescent
silica, which shows that no adenosine is present in the product. The
thin layer analysis shows that there are two compounds present in the
product; the product which migrates faster than adenine (X Figure
3.55) is a breakdown product from the dialdehyde adenosine produced
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The photograph of the TLC plate was taken under UV light and shows
adenine(A), adenosine(Ar), the major product of periodate oxidation of
adenosine(Y) and an unknown compound(X). TLC was carried out as
described in Materials & Methods (Section 2.8).
by fi-elimination as first described by Khym & Cohn (1961). The major
slow migrating component of the product (Y Figure 3.55) reacts with
phenylhydrazine to give a yellow spot, when the TLC plate is sprayed
with a 10% (w/v) acid phenylhydrazine solution and warmed, indicating
that the compound is an aldehyde. The identity of the product as
2',3' dialdehyde adenosine was confirmed when the Sigma Chemical Co.
introduced periodate oxidised adenosine as a new product which had
the same Rf. value as the major product spot (Y) shown in Figure
3.55.
3
The above synthesis was repeated using [2,8- H] adenosine at a
specific activity of 500jiCi/jumole with the adenosine:periodate ratio
3
1:1.1 as above. The [2,8- H] dialdehyde adenosine eluted from the gel
filtration column was further purified by concentration and TLC
chromatography, the product being eluted from the TLC plate with
3
distilled water. The [2,8- H] dialdehyde adenosine was then stored at
-20°C. It was found that storage in this manner or in solution at A°C
resulted in decomposition of the dialdehyde adenosine to the
contaminant labelled (X) in Figure 3.55.
In view of the instability of the dialdehyde all affinity
labelling experiments were carried out by synthesising the dialdehyde
3
adenosine in situ. Typically 100jjCi of [2,8- H] adenosine
( ICtyjl;21Ci/mmol) was added to lO^moles of sodium periodate ( 10jj1) and
incubated in the dark at 4°C for 1hr. The excess periodate was
removed by the addition of PSG buffer (250-50(3pl), the e^-glucose
reacting with the periodate. The dialdehyde adenosine was then used
as an affinity label. Analysis of the reaction mix by TLC as
described above showed that only 5% of the label present in the
incubation mix remained as adenosine the remainder being present as
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Table 3.15 EFFECT OP DIALDEHYDE ADENOSINE (SYNTHESISED IN SITO AND
PRESYNTHESISED) ON ADENOSINE OPTAXE IN THE PRESENCE AND














The table shows the effects of dialdehyae adenosine synthesised in
situ (ISS) and presynthesised (PS) on adenosine uptake in the presence
and absence of the reducing agent Sodium Cyanoborohydride (Na CNBH^).
All other experimental details are given in the text (Section 3.8.2)
dialdehyde adenosine(80%) and the breakdown product X (Figure 3.55)
( 15%).
3.8.2 Dialdehyde Adenosine as an Affinity Label.
In the previous Section (3.8.1) it was stated that dialdehyde
adenosine synthesised and stored before use spontaneously decomposed
to unidentified compounds. This was shown by TLC as previously
described (Section 3.8.1) and by the following experiment in which
the effect of dialdehyde adenosine, presynthesised and in situ
synthesised, on adenosine uptake was determined. The effect of a
reducing agent on the reaction was also determined since the reducing
agent (sodium cyanoborohydride) reduces any Schiff bases formed
between the dialdehyde adenosine and proteins forming a stable
bond. These experiments were carried out to show that dialdehyde
adenosine is capable of reacting with the adenosine transport
protein, therefore acting as an affinity label.
Dialdehyde adenosine was synthesised and purified as described
above (Section 3.8.1) and used at a final concentration of 20pM in
5ml of trypanosome suspension (1.5mg protein/ml in PSG pH 7.4) either
with or without 1mM NaCNBH^. Dialdehyde adenosine was also
synthesised in situ by mixing O.ljumoles of adenosine with 10pmoles of
sodium periodate in a total volume of 200^1 of phosphate saline
buffer at pH 7.4. This reaction mixture was then stored dark at 4°C
for 1 hour. At the end of this time 500/ul of PSG pH 7.4 was added and
the reaction mix stored at 4°C for a further 20 minutes. Trypanosomes
were then added to this mixture to give a final volume of 5ml (1.5mg
protein/ml) either with or without ImM NaCNBH^. The four reaction
mixtures, 1) presynthesised dialdehyde adenosine, 2) presynthesised
dialdehyde adenosine with NaCNBH^, 3) in situ synthesised dialdehyde
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adenosine and A) in situ synthesised dialdehyde adenosine with
NaCNBH^ were then incubated at 22°C for 5 minutes. The trypanosomes
were then washed three times by centrifugation and resuspension, in
10ml of PSG pH 7.A, and finally resuspended in 5ml pf PSG pH 7.A. The
3
abilities of the four cell suspensions to take up [2,8- H] adenosine
were then determined. Uptake of adenosine was measured by adding
3
900ul of one of the four cell suspensions to 100ul of [2,8- H]
adenosine (0.01mM; 50uCi/umol.) giving a final adenosine
concentration of 1uM. Samples (AOOul) were then taken and layered
onto silicon sandwiches and centrifuged after A5 seconds. Uptake of
3
[2,8- H] adenosine was then estimated by liquid scintillation
counting of the PCA layer.
The results of the above experiments, Table 3.15, show that
presynthesised dialdehyde adenosine blocks less adenosine transport
than the j^n situ synthesised dialdehyde adenosine. This is due to
decomposition of the dialdehyde adenosine on storage as stated
previously. The results also show that including NaCNBH^ in the
incubations enhances the blocking effect of the dialdehyde adenosine
whether presynthesised or synthesised _in situ. The formation of a
stable covalent bond with the transport protein rather than a Schiff
base means that the dialdehyde adenosine can not be removed by
washing the cells, although washing the cells does not appear to have
had too much effect on the binding of the dialdehyde adenosine to the
transporter as indicated by only an 18% difference in inhibition of
adenosine uptake between the cells incubated with and without
NaCNBH^. The results in Table 3.15 also show that the reducing agent
alone had no effect on the uptake of adenosine. Having shown that
dialdehyde adenosine is capable of binding to the adenosine transport
-138-
 
protein identification of the transport protein in whole cells was
3
attempted using H-dialdehyde adenosine as an affinity label.
3.8.3 Labelling of Whole Cells with Dialdehyde Adenosine.
Radiolabelled dialdehyde adenosine was prepared by mixing 100jjCi
3
of [2,8- H] adenosine (10p1; 21Ci/mmol) with 10jimoles of sodium
periodate (10jj1) and storing in the dark at 4°C for 1 hour followed
by the addition of PSG buffer pH 7. A (250^1) and a further incubation
for 20 minutes. The above synthesis was carried out in duplicate.
Trypanosomes (75Op1; 1.5mg protein/ml) either with or without IDA
(20jiM) and in the presence of 1mM NaCNBH^ were then added to the
dialdehyde adenosine mixture and incubated at 22°C for 30 minutes.
The cells were then washed 3 times by centrifugation and resuspension
in PSG pH 7.A. The cells were then prepared for electrophoresis on an
8-20% exponential polyacrylamide gel in the presence of SDS as
described in Materials & Methods (Section 2.13).
After electrophoresis the gel was fixed and stained with
Coomassie blue dye. The protein banding patterns on the gel given by
the cells incubated in the presence or absence of IDA were identical.
The gel was then cut into strips and densitometer traces made of the
banding pattern produced by each sample and standard molecular weight
marker proteins. The gel strips (150mm long) were then sliced into
2mm sections and prepared for liquid scintillation counting by
digestion of the gel in 15% hydrogen peroxide at 60°C for 12
hours (Materials & Methods Section 2.14).
Figure 3.56 shows a typical densitometer trace obtained from the
gel and also the amount of radioactivity in each 2mm gel slice for
the cells incubated in the presence of IDA and those incubated with
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Figure 3.57a REACTION OF DIALDEHYDE ADENOSINE WITH IDA IN THE
PRESENCE OF A REDUCING AGENT.
C25 C20 Cio C'5 T25 T20 T15 T10 T5 TO sidr
Dialdehyde adenosine (1mM) was mixed with IDA (1mM) in PSG pH 7.A
CNBH^ was then added to a final concnetration of ImM. A sample of
the reaction mix was taken immediately on the addition of the CNBH^
and at five minute intervals. The reaction was quenched by adding the
samples taken to 0.1M ethanediol. The samples were then subjected to
analysis by TLC as described in Materials & Methods (Section 2.8)
Figure 3.57a shows a time course of the reaction of IDA and
dialdehyde adenosine (T0-T25). the figure also shows the analysis of
samples of dialdehyde adenosine in solution alone (C5-C25). IDA alone
is shown as a standard (SIDA).
Figure 3.57b REACTION OF DIALDEHYDE ADENOSINE WITH A REDUCING AGENT.
Figure 3.57b shows the reaction of dialdehyde adenosine with
NaCNBH^and the reaction of dialdehyde adenosine and
iododeoxyadenosine in the absence of NaCNBH^. Dialdehyde adenosine
and NaCNBH^ were incubated in PSG pH 7.A at a final concentration of
1mM for 5 minutes then analysed by TLC as described in the legend to
Figure 3.57a. Dialdehyde adenosine and iododeoxyadenosine were
incubated in PSG pH 7.A at a final concentration of 1mM for 5 minutes
then analysed by TLC as described in the legend to Figure 3.57a. The
figure shows IDA as a marker (IDA), dialdehyde adenosine reacted with
NaCNBH^ (DArR), unreacted dialdehyde adenosine (DAr) and IDA with
dialdehyde adenosine (M).
the labelled dialdehyde adenosine alone. The results show that the
presence of IDA in the incubation inhibits labelling of any
trypanosomal proteins. However five proteins are significantly
labelled by the dialdeyde adenosine alone as indicated by arrows and
their apparent molecular weights in Figure 3.56. It could be argued
that the inhibition, by IDA, of labelling with dialdehyde adenosine
is due to IDA reacting with the dialdehyde adenosine. This is not the
case as shown by the results presented in Figures 3.57a and 3.57b.
Dialdehyde adenosine was mixed with IDA in the presence of NaCNBH^ as
described in the legend to Figure 3.57a. The results show that
dialdehyde adenosine breaks down in the presence of NaCNBH^ but does
not react with the IDA as shown by the constant intensity of the IDA
spot during the course of the incubation. Figure 3.57b confirms that
only NaCNBH^ is required to cause the observed shift in position of
the dialdehyde adenosine spot. These results will be considered in
conjunction with other labelling experiments in Section 3.8.5.
3.8.A Labelling of Plasma Membranes by Dialdehyde Adenosine.
3
When whole cells were incubated with [2,8- H] dialdehyde
adenosine five proteins were shown to be strongly labelled after SDS
PAGE (Section 3.8.3). Some of these proteins may be intracellular
enzymes or proteins which have an adenosine binding site but are not
directly involved in transport of adenosine. In order to simplify the
labelling pattern obtained purified plasma membranes were used in
place of whole cells in an affinity labelling experiment.
3 3
[2,8- H] 2',3' dialdehyde adenosine was prepared from [2,8- H]
adenosine as described in the previous Section (3.8.A) with a
specific activity of 21Ci/mmol. A plasma membrane enriched fraction
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Figure 3.58 LABELING OF PLASMA MEMBRANES WITH [2,8-3H] DIALDEHYDE
ADENOSINE.
M 1 2 3 4 Ml 2 3 4
The figure shows an autoradiograph and Coomassie stained gel of plasma
membranes and whole cells labelled with dialdehyde adenosine in the
presence and absence of IDA. 1 ) Whole cells labelled with dialdehyde
adenosine, 2) Whole cells labelled in the presence of IDA. 3) Plasma
membranes labelled with dialdehyde adenosine and A) Plasma membranes
labelled in thepresenceof IDA. The experimental protocol is given in
the text (section 3.8.A).
was prepared as described in Section 3.7.A and resuspended in PSG
buffer pH 7.4 at a protein concentration of 1.5mg/ml. The labelling
reaction was started by the addition of the plasma membranes to the
newly synthesised dialdehyde adenosine. The labelling was carried out
in the presence of ImM NaCNBH^ both with and without 20yM IDA
present. The membranes were incubated at 22°C for 2 hours in the
above reaction mixtures and then washed 3 times by centrifugation and
resuspension in PSG pH 7.4 at 100,000xg av. for 30 minutes. The
membranes were then solubilised in SDS sample buffer for SDS PAGE as
described in Materials & Methods (Section 2.13). The labelled
membranes were then subjected to electrophoresis on 8% to 20%
exponential gradient polyacrylamide gels. Affinity labelled whole
cells from the previous experiment (Section 3.8.4) were also run on
the same gel for comparison. After electrophoresis the gel was
stained, photographed and prepared for fluorography as described in
Materials & Methods (Section3.14) and x-ray film exposed to the
fluorograph for two months.
Figure 3.58 shows a photograph of the Coomassie stained gel and
the autoradiograph. The labelling patterns obtained for the whole
cell and the purified membranes are markedly different in that the
proteins labelled in the plasma membrane fraction do not appear to be
labelled in the whole cell. This is possible if the proteins labelled
in the plasma membrane fraction are only present as a very small
percentage of the total cellular protein which would make their
detection in the whole cell difficult. Figure 3.48 also shows the
apparent molecular weights of the labelled proteins as calculated
from their mobilities on the gel relative to marker proteins of known
molecular weight. These results together with the results of other
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Table 3.16 SUHMARX OF MOLECULAR HEIGHTS OF PROTEINS LABELLED BT
125I, FITC AND [2f8-3H] DIALDEHTDE ADENOSINE IN













169 KD 144 KD
104 KD 91 KD
72 KD 72 KD
63 KD 66 KD 64 KD 69 KD
36 KD 36 KD 37 KD 34 KD
30 KD 32 KD 32 KD 30 KD
43 KD 46 KD 47 KD
43 KD m 46 KD
39 KD 40 KD 38 KD
36 KD 36 KD r 36 KD
_ m 33 KD
29 KD
labelling expeiments will now be considered as a whole.
3.8.5 Summary of Membrane Labelling Experiments.
Table 3.16 summarises the results of all surface labelling and
affinity labelling experiments carried out. This includes labelling
125
of the cell surface with I and FITC (Sections 3.7.A & 3.7.6) also
3
affinity labelling of the adenosine transporter with [2,8- H]
dialdehyde adenosine in whole cells and purified plasma membrane
(Sections 3.8.3 & 3.8.4). It should be borne in mind that the
molecular weights for the labelled proteins quoted in Table 3.16 are
apparent molecular weights since some of these proteins will probably
be glycosylated and will therefore not bind SDS in the normal ratio
of 1.4g/g. This results in a slower migration through the gel which
gives an over estimate of the protein's molecular weight. Estimating
the molecular weights of proteins from their mobilities on a gel
using a standard curve constructed from the molecular weights and
relative mobilities of known proteins involves measurement errors
which result in a cumulative error of _+4% in all molecular weight
estimates. Bearing this in mind the results presented in Table 3.16
show that the adenosine transporter is likely to be a 57 or 52 KDa
polypeptide since proteins of this molecular weight are labelled by
3
[2,8- H] dialdehyde adenosine in whole cells and in purified plasma
membranes. Additional evidence that they are plasma membrane proteins
125
is provided by the fact that they are also labelled by I and FITC
3
in whole cells. The many other bands labelled by [2,8- H] dialdehyde
adenosine in whole cells are probably intracellular proteins although
some are also labelled by the cell surface labels. The fact that they
do not appear to be labelled in the plasma membrane may indicate
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that they are only loosely associated with the plasma membrane and
are lost during the purification of the plasma membranes. If this is
the case it is very unlikely that they are involved in transport
since a transporter would be an integral membrane protein and not
easily removed from the membrane without the use of a detergent. The
proteins of molecular weights quoted as 63, 66, 64 and 69 KDa
labelled by all the labelling methods and in all fractions is
probably the trypanosomes surface glycoprotein coat protein since it
is labelled by the cell surface labels and runs on the SDS gels as a
broad diffuse band, which is a characteristic of glycoproteins.
Having identified the polypeptides most likely to be
constituents of the adenosine transporter further analysis of the
mechanism of action of the transport system could be undertaken by
purifing these proteins and attempting to reconstitute the transport
system in liposomes. This would allow investigation into the
mechanism of energy coupling to active transport without the problems
associated with using metabolic inhibitors on the whole cell system
such as maintaining membrane integrity in metabolically poisoned
cells. However these investigations must be left until some later
date.
3.9 REGULATION OF UPTAKE AND METABOLISM OF PURINE
NUCLEOSIDES AND BASES.
The time courses of the uptake of adenosine and hypoxanthine
presented in Sections 3.2.1 & 3.3.1 show that uptake slows to a stop
after two to three minutes. The results presented in Sections 3.6.1
to 3.6.8 indicate that uptake is probably by active transport and so
should be independent of metabolism of the nucleoside or base taken
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up. This is supported by the observation that metabolism of the
nucleosides and bases taken up continues after the cessation of
uptake.(Sections 3.2.4 & 3.3.4) Consideration of the above results
suggests that the transport system is under some form of control by
the cell.
Regulation of the transport step could be by feed back inhibiton
of uptake by intracellular levels of nucleoside or base but this is
unlikely since the levels of nucleoside and base in the cell continue
to fall after uptake has stopped (Sections 3.2.4 & 3.3.4). The
transporter could be controlled by the levels of intracellular
nucleotide since the nucleosides and bases are metabolised to
nucleotide after they have been transported. As stated above any feed
back effects of nucleotide levels on metabolism of the nucleosides
and bases taken up would be unlikely to affect transport since
transport is an active process independent of further metabolism of
the transported substrate. Another method the trypanosome could use
to control the activity of the transport system is phosphorylation.
Phosphorylation has recently been implicated in the control of
glucose transport in the erythrocyte. Witters et _al. (1985) have
shown that a protein kinase C stimulated by phorbol esters
phosphorylates the glucose transporter both in vivo and in vitro.
This correlates with the observation that phorbol esters stimulate
glucose uptake in the erythrocyte. Therefore it is not unreasonable
to suppose that transport of substrates across the trypanosomal
plasma membrane may be regulated by phosphorylation.
The above possibilities for regulation of purine nucleoside and
base transport were investigated with the exception of the effects of
free intracellular nucleosides and bases on transport since there is
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, 0. 18 3.0 9.3
AMP 0.18 2.9 9.2
IMP 0. 18 3.0 8. 1
ATP 0. 17 3.1 6.9
AMP ♦ ATP 0.17 2.9 7.8
IMP ♦ ATP ro•o 3.1 6. 1
ADENOSINE 0. IS 1.3 8.9
HYPOXANTHINE 0. 12 3.0 9.3
The table shows the effects of various nucleotides, combinations of
nucleotides, hypoxanthine and adenosine on the activities of
adenlne(APRT), hypoxanthine(HxPRT) phosphoribosyltransferases and
adenosine hydrolase(Ar hydrolase). Experimental details are given in
the text (Section 3.9.1).
no way to control the required parameters, such as intracellular
concentrations of nucleoside or base, in the whole cell.
3.9.1 Effect of Nucleotides,Nucleosides and Bases
on Enzymes of Purine Metabolism.
Although it is unlikely that transport of nucleosides and bases
is affected by any regulation of metabolism, for the reasons stated
above,the effects of nucleotides and bases on some of the purine
metabolising enzymes were investigated. The effects of 1mM AMP, IMP,
ATP, adenosine, hypoxanthine, AMP with ATP and IMP with ATP on the
enzymes adenosine hydrolase, APRT and HxPRT were investigated as
detailed below. The enzyme activities were assayed as described in
Materials & Methods (Section 2.10). The labelled substrates were
present at a specific activity of lOCtyuCi/ymol. and the following
concentrations; adenosine 50juM, adenine 2)aM and hypoxanthine 5jiM.
The enzyme source for the assays was fresh dialysed trypanosome
lysate at a final protein concentration of 0.02mg/ml for the
adenosine hydrolase assay and 0.1mg/ml for the adenine and HxPRT
assays. All assays were carried out at a temperature of 22°C in
TrisHCl buffer at pH 7.4. The assays were started by the addition of
the trypanosome lysate and incubated for 3 minutes.
The results of the above experiments are shown in Table 3.17.
Adenosine hydrolase activity does not appear to be affected by any of
the additions of nucleotide but does show some slight inhibition in
the presence of 1mM hypoxanthine. This inhibition has no immediate
significance with respect to regulation of transport. The
combinations of a nucleoside monophosphate with ATP were included in
this experiment to try and detect any nucleotide monophosphate
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effects on the enzyme mediated by a protein kinase.
The activity of APRT appears to be sensitive to product
inhibition by AMP but this observed inhibition could be due to
dilution of the labelled adenine substrate by adenine derived from
the added AMP via phosphatase activity and adenosine hydrolase. The
inhibition of APRT activity by adenosine is almost certainly due to
this effect.
The activity of HxPRT does not appear to be sensitive to product
inhibition at a concentration of 1mM IMP but does appear to be
inhibited by 1mM ATP. The results presented above have little
significance with regards to transport regulation but may be
significant with respect to control of metabolism of purine
nucleosides and bases once taken up and would be worth investigating
in more detail.
3.9.2 Effect of Purine Nucleotides, Nucleosides and Bases
on Phosphorylation of Trypanosomal Proteins in a
Whole Cell Lysate and a Crude Membrane Fraction.
The possible regulation of transport by phosphorylation was
investigated by examining which proteins were phosphorylated in a
whole cell lysate and in a crude membrane fraction, when incubated
32
with P ATP and various purine nucleotides,nucleosides and bases.
32
The j- P ATP used in the following experiments was synthesised
32
from Pi phosphate and unlabelled ATP using an enzymatic exchange
system which is described in detail in Materials & Methods (Section
2.15). The phosphorylation of proteins was carried out by incubating
either whole cell lysate or membranes prepared from a whole cell




.59 EFFECT OF NUCLEOTIDES AND NUCLEOSIDES ON PROTEIN
PHOSPHORYLATION OF CRUDE MEMBRANE PROTEINS.
-i- Vanadate
c amp imp Ar Hx c amp
1 J
26KD
The figure shows the effects of AMP, IMP, adenosine(Ar) and
hypoxan thine (Hx) on phosphorylation of trypanosomal membrane proteins
in the presence and absence of sodium ortho vanadate. Part b) is an
32
auto radiograph of the Coomassie stained gel of P labelled proteins
shown in part a). The full experimental protocol is given in the text
(Section 3.9.2).
reaction mixture contained 0.2mg of the appropriate trypanosome
protein susupension (60jj1) to give a final protein concentration of
1mg/ml. The incubation mixture also contained 5mM (final
concentration) MgCl2 (25/il), TrisHCl buffer pH 7.A to a final
32
concentration of 10mM (20^il), P ATP(specific activity
80mCi/piol.) to a final concentration of 75^iM (Ktyil) and one of AMP,
IMP, adenosine or hypoxanthine at a final concentration of ImM (20jil)
and water to give a final volume of 200^1. All incubations were
repeated with 2mM sodium orthovanadate present to inhibit general
ATPase activity. The reaction mixtures described above were incubated
at 30°C for 10 minutes. The incubations were then terminated by the
addition of 10 volumes of acetonerethanol (1:1) at a temperature of
-18°C. This step precipitated the protein and removed lipid before
preparing the proteins for SDS PAGE as described in Materials &
Methods (Section 2.13). After electrophoresis the gels were stained
for protein and photographed prior to autoradiography by exposure to
x-ray film for 2 days at -70°C.
The results of these experiments are shown in Figures 3.59a,
3.59b and 3.60. Figure 3.59a shows the gel of the crude membrane
preparation stained for protein. The incubation which contained IMP
shows a different banding pattern to the other incubations since the
bands marked with arrows in the control track are absent. The effect
is independent of the presence of sodium orthovanadate in the
incubation and does not correlate with any changes in phosphorylation
pattern as is shown in Figure 3.59b which is an autoradiograph of the
gel shown in Figure 3.59a. The significance of these results is
unknown and requires further investigation. The autoradiograph of the
gel of the phosphorylated crude membranes shows that AMP is a general
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Figure 3.60 EFFECT OF NUCLEOTIDES AND NUCLEOSIDES ON PROTEIN
PHOSPHORYLATION IN A WHOLE CELL LYSATE.
4 Vanadate
32The figure shows an autoradiograph of P labelled proteins in a whole
cell lysate in the presence of AMP, IMP, adenosine(Ar) and
hypoxanthine(Hx) both in the presence and absence of sodium ortho
vanadate. The full experimental protocol is given in the text (Section
3.9.2).
inhibitor of the protein kinase present as is adenosine but the AMP
stimulates phosphorylation of one band at an apparent molecular
weight of 51 KDa. This is close to the molecular weight estimated for
the adenosine transport protein by affinity labelling experiments
(Section 3.8.5). This specific phosphorylation appears to be
inhibited by the presence of sodium orthovanadate in the incubation
which may indicate that the protein kinase involved is inhibited by
vanadate ions. Adenosine appears to be a good inhibitor of all
protein kinase activity which is in disagreement.with the results of
other authors. Full consideration of this result will be given in the
Discussion (Section A.5). Figure 3.60 shows the autoradiograph of
phosphorylated proteins in a whole cell lysate. The results are much
the same as for the crude membrane fraction with the following
exceptions. The sodium orthovanadate has had a more marked effect on
the overall phosphorylation. This probably reflects the presence of
vanadate sensitive ATPases in the lysate which were not associated
with the membranes. The AMP again reduces the amount of
phosphorylation observed but this time the 51 KDa band is
phosphorylated in the other incubations except those containing
vanadate ion and adenosine. This may indicate that the protein kinase
responsible for this phosphorylation is a soluble cytoplasmic protein
which was mostly removed from the crude membrane preparation. The 51
KDa band is also much fainter in the whole cell lysate providing more
evidence that it is membrane associated since semi-purifing the cell
membranes intensifies the band.
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3.9.3 Summary of Regulation of Purine Nucleoside and Base
Transport and Metabolism.
The results presented in the previous two sections provide some
evidence for regulation of adenosine transport by phosphorylation of
the transport protein. This result is by no means conclusive but
further work with a reconstituted transport system and purified
trypanosomal protein kinases could settle the question. The
trypanosomal protein kinases, their purine nucleoside, nucleotide and
base dependencies and subcellular distributions will be considered in
the Discussion (Section 4.5).
Regulation of metabolism of purine nucleosides and bases taken
up has been considered here only briefly in order to determine if
there was any possibility of metabolism having any regulatory effect
on the transport system. The results presented make this possibility
highly unlikely but any further work on the sensitivities of the
metabolising enzymes to regulation should be carried out on purified
enzymes since the effects of adenosine are difficult to determine in




The results which have been presented in this thesis will now
be compared with the results of other authors where available.
The results presented will also be discussed against the background
of the general literature as regards general transport and more
specifically the transport of purines and vitamin B^.
A.1 PYRIDOXINE AND PYRIDOXAL UPTAKE AND METABOLISM.
The results presented in Sections 3.1 to 3.1.10 provide some
evidence that the uptake of pyridoxine and pyridoxal by T.brucei is
mediated by simple diffusion followed by metabolic trapping as
pyridoxine phosphate and pyridoxal phosphate. These conclusions are
supported by the observations that the pyridoxine and pyridoxal
uptake systems are non-saturable at physiological substrate levels
and above, are only partially temperature sensitive and have low
energies of activation.
Calculation of the intracellular concentrations of pyridoxine
and pyridoxal shows that these compounds are not accumulated against
their concentration gradients. This, in conjunction with the
nonsaturability of uptake, suggests that diffusion through the plasma
membrane may be the rate limiting step for the uptake of pyridoxine
and pyridoxal, or that the metabolising enzymes involved in the
conversion of the compounds taken up to pyridoxal phosphate have high
Km's for their substrates. The kinetic parameters of the T.brucei
vitamin metabolising enzymes are unknown but the table below lists
the Km values of pyridoxal kinase with pyridoxal or pyridoxine as
substrate in other organisms.
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ENZYME SOURCE SUBSTRATE Km (mM)
E.coli PA 0.3
E.coli PN 0.008
Rat liver PA 0.015
Rat liver PN 0.025
Beef brain PA 0.050
Beef brain PN 0.020
(Snell,1944)
The maximum concentration of pyridoxine or pyridoxal used in the
uptake assays carried out in this work was 0.06mM. It therfore would
appear that diffusion across the membrane may be the rate limiting
step for uptake since at a concentration of 0.06mM, pyridoxine or
pyridoxal would be beginning to show some signs of saturating the
metabolising enzymes assuming that the trypanosomal enzymes are
similar to those found in other organisms.
The thermodynamic parameters of uptake calculated from Arrhenius
plots of the uptake of pyridoxine and pyridoxal indicate that uptake
is by simple diffusion, by virtue of the low activation energies
calculated for pyridoxal and pyridoxine uptake (Dixon & Webb,1964;
Goldman et al.,1968; Damper & Patton,1976b).
The calculated activation energies for the uptake of pyridoxine and
pyridoxal, 9.9 kJ/mol and 5.4 kj/mol respectively, are much lower
than would be expected for a molecule of the same size in free
solution. However, it should be noted that the Arrhenius plot is a
plot of In rate of uptake against reciprocal temperature and the rate
being measured is not the rate of diffusion in free solution but the
rate of diffusion through the plasma membrane. The rate of diffusion
in free solution can be disregarded if the pore size of the membrane
is close to, or smaller than ( in the case of partition into the
membrane), the size of the diffusing molecule (Bull, 1964; Kedem &
Katchalsky, 1958). Diffusion through a membrane cannot be accurately
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described by Fick's law of diffusion. The diffusion coefficient must
be replaced by a constant which takes into account the interactions
between solute and membrane as well as membrane solvent interactions.
As stated above the interactions of solute and solvent become less
significant as the effective pore size of the membrane decreases
(Kedem & Katchalsky,1958). When these additional factors are taken
into account the diffusion coefficient is replaced by the coefficient
of permeability. If pyridoxine and pyridoxal partition into the
trypanosomal plasma membrane in the process of entering the cell this
will have a marked effect on the permeability coefficient. In most
respects the permeability coefficient behaves in the same way as the
diffusion coefficient in Ficks law in that as temperature increases
the diffusion coefficient increases therefore the permeability
coefficient will increase and hence the rate of diffusion will
increase. As the temperature increases the partition coefficient will
also change affecting the permeability coefficient. This may result
in a reduction of the effect of temperature on the permeability
coefficient and hence reduce the slope of the Arrhenius plot and the
calculated Ea. This hypothesis, although speculative, is supported by
the fact that pyridoxal and pyridoxine both migrate more quickly than
other forms of B, in the chloroform : methanol solvent system
o
described in Materials & Methods (Section 2.8.1). Since this is a
completely organic solvent with no aqueous component both pyridoxine
and pyridoxal must be appreciably lipophilic . The Arrhenius plots
obtained for pyridoxine and pyridoxal uptake were linear and showed
no sharp changes in slope which would have indicated a change in
membrane fluidity affecting uptake (Plagemann & Erbe,1975; Stein &
Rosengurt,1975; Zylka & Plagemann,1975) as has been shown to occur
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for the uptake of pyridoxine and pyridoxal by the erythrocyte
(Mehansho & Henderson,1980). The other parameters calculated from the
Arrhenius plot,AH and AS, are difficult to interpret with regard to
uptake or transport systems. The AH calculated can be regarded as a
measure of the degree of deformation of structure involved in the
uptake process (Cornish-Bowden, 1979), a large AH indicating extensive
deformation of structure in either the substrate, the enzyme or the
carrier protein. The calculated AS can be regarded as a measure of
the probability of the transition state forming. However, the above
only applies to enzyme catalysed reactions or carrier-mediated
transport which is not the case for pyridoxine or pyridoxal. The only
significance which can be attached to the negative AG values obtained
is that the formation of the transition state, if one exists, is
favoured energetically. A comparison of the thermodynamic parameters
obtained for uptake of pyridoxine and pyridoxal by simple diffusion
and the adenosine active transport system is considered in Section
4.2.1. In general the results obtained from the investigations of
pyridoxine and pyridoxal uptake by T.brucei are in agreement with
results obtained in studies of vitamin uptake by other eukaryotic
cells such as rat jejunum cells (Middleton,1977), intestinal mucosa
cells (Mehansho et_ a_l., 1978) and the rat and human erythrocyte
(Mehansho & Henderson,1980). There are two exceptions to this general
statement, the yeast Saccharomyces carlsbergensis takes up pyridoxine
by an active transport mechanism (Shane & Snell,1976) and the choroid
plexus of the rabbit actively transports vitamin B^ (Spector^ 1978a &
1978b). Uptake of pyridoxine and pyridoxal by bacteria appears to be
mediated by facilitated diffusion as shown for Salmonella typhimurium
(Mulligan and Snell } 1976) and Streptococcus faecalis (Mulligan &
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Snell,1977). Active transport of pyridoxal by erythrocytes has been
reported by Yamada & Taugi,(1968 & 1970); however, these authors did
not differentiate between the transported form of pyridoxal and its
metabolites when estimating intracellular concentrations of
pyridoxal.
Investigations into the metabolism of pyridoxine and pyridoxal
by T.brucei (Sections 3.1.A to 3.1.8) show that both pyridoxine and
pyridoxal are converted into phosphorylated compounds within the
cell. The results presented in Section 3.1.A show that pyridoxine is
oxidised to pyridoxal and may be slowly phosphorylated by pyridoxal
kinase to pyridoxal phosphate. This route to pyridoxal phosphate
differs from that of mammalian cells (eg. intestinal mucosal cells,
Mehansho et al., 1979); liver cells (Mehansho et_ al_., 1980)) which use
pyridoxal kinase to phosphorylate pyridoxine to pyridoxine phosphate
and then oxidise pyridoxine phosphate to pyridoxal phosphate using
the enzyme pyridoxine phosphate oxidase. However, the model for
metabolism presented in Section 3.1.8 requires that pyridoxine be
metabolised as in mammalian systems. The oxidation of pyridoxine to
pyridoxal in T.brucei is probably carried out by pyridoxine
dehydrogenase which, as stated in Section 3.1.A, produces NADPH
rather than which is produced by pyridoxine phosphate oxidase.
The use of pyridoxine dehydrogenase would appear to be to the
trypanosome's advantage since the bloodstream forms of the organism
are reported to contain no catalase activity for the removal of H^O^.
In this work no catalase activity could be detected in trypanosome
lysate using an oxygen electrode or a fluorometric assay to detect
the production of oxygen from hydrogen peroxide (results not shown).
The most prevalent usable form of vitamin B, found in the mammalian
o
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bloodstream is pyridoxine. Pyridoxal is also released by the liver
for utilisation by muscle cells since they cannot form pyridoxal from
pyridoxine as they lack the enzyme pyridoxine phosphate oxidase
(Anderson et ail., 1971). This supply of pyridoxine may be the main
source of utilised by the trypanosomes if the proposed model for
metabolism is correct. Pyridoxal released by the liver may also be
utilised to a lesser extent. Pyridoxal phosphate may also be a source
of pyridoxal if it is degraded to pyridoxal by a phosphatase before
being taken up since it is present in the bloodstream in high
concentration for the reasons detailed in Section 1.3.2. The
metabolism of in this organism requires futher investigation in
order to verify or disprove the model presented.
4.2 PURINE NUCLEOSIDE AND BASE TRANSPORT AND METABOLISM.
The study of purine nucleoside and base uptake, transport and
metabolism presented in Sections 3.2 to 3.6 will be considered as
three separate components, overall uptake, mechanism of transport and
metabolism.
4.2.1 Uptake of Adenosine, Adenine and Hypoxanthine.
The uptakes of adenosine, adenine and hypoxanthine are carrier
mediated processes and in the case of adenosine and hypoxanthine some
evidence has been presented which indicates that uptake is mediated
by an active transport process. The evidence for these conclusions is
considered below.
The plasma concentrations of purines in the rat and in the
human, and the values obtained for the kinetic parameters of
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adenosine, adenine and hypoxanthine uptake (Sections 3.2.2, 3.3.2 and
3.3.4 respectively) are shown below.
Rat plasma Concentrations (jjM). Source.
Hypoxanthine 0.7-1.0 Simmonds & Harkness (1981)
Adenosine 1.0-1.5 Von Borstel et al. (1982)
Human plasma Concentrations (jaM). Source.
Hypoxanthine 0.5-2.8 Taylor et al. (1980a)
Inosine 0.2-1.5 Taylor et al. (1980a)
Adenine 0.1-1.4 De Verdier et al. (1977)
Adenosine 0.5-0.9 Maurizio et al. (1982)
SUBSTRATE UPTAKE Km UPTAKE Vmax
Adenosine 0.50/uM 0.50nmol/min/mg protein
Adenine 0.30/jM 0.27nmol/min/mg protein
Hypoxanthine 0.35;uM 0.21nmol/min/mg protein
As stated in the results, the values quoted for the plasma
concentrations of adenosine are higher than those reported by authors
before 1980. This discrepancy is due to the fact that no precautions
were taken, previous to 1980, to prevent the destruction of adenosine
by plasma adenosine deaminase which gave high estimates for plasma
inosine concentrations and low estimates for adenosine
concentrations. The estimates for plasma adenosine levels quoted were
obtained from blood samples taken into anticoagulant with the potent
adenosine deaminase inhibitor 2-deoxycoformycin present (Capogrossi
_et al_., 1982) . It should be noted that the kinetic parameters shown
apply only to overall uptake for the reasons stated in Section 3.2.2.
Comparison of the data presented in the two tables above shows that
the uptake systems for adenosine, adenine and hypoxanthine will be at
least 50% saturated at the mean plasma concentrations of their
substrates. The inability of the bloodstream forms of trypanosomes to
synthesise the purine ring de novo (Marr _et al., 1978a; Gutteridge &
Gaborak,1979; Ceron _et al.,1979; Berens et al.,1981;
Fish et al.,1982a) suggests that they must obtain all of their purine
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from the host bloodstream. The following calculations, based on the
kinetic parameters and plasma purine concentrations listed above,
show that the adenosine transport is capable of meeting the cell's
demand for adenosine. All assumptions made below are biased towards
over estimating the amount of purine required by the cells.
At a plasma adenosine concentration of 1.25pM (mean rat plasma
concentration) the rate of adenosine uptake would be 0.36nmol/min/mg
protein. The DNA and RNA content of T.brucei will be taken to be
881/ig/1010 cells and 6430jig/1010 cells respectively. These values are
based on the values reported by Voorheis (1979) and Rovis &
Baekkeskov (1980) who are in close agreement as regards the amount
of DNA present but differ as to the amount of RNA present by several
orders of magnitude: 11.6/jg/1010 cells (Rovis & Baekkeskov, 1980) and
10
6430^ig/10 cells (Voorheis,1979). The value of Voorheis, 1979 wil be
used in the following calculations. The reason for this vast
discrepancy is probably due to degradation by endogenous nucleases.
The adenosine/adenine requirement of the cells can be calculated as
follows.
Assume DNA is 25% adenine nucleotide and cell numbers double
from 1010 cells to 2x1010 cells in eight hours.
This would require 881/4 = 220pg of adenine nucleotide
= 6.37x10-7 moles of AMP/1010 cells
Assume RNA is 35% adenine nucleotide (including poly A tails of
messenger RNA) doubling from 1010 cells to 2x1010 cells as before
requires 6430/100x35 = 2250}ig of adenine nucleotide
= 3.49x10 ° moles of AMP/1010 cells
10
The adenine nucleotide requirement for 10 cells doubling in eight
hours is therefore 3.83^imoles. This is equivalent to a requirement of
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10
7.9nmoles/min/10 cells. The rate of uptake of adenosine at a
plasma concentration of 1.25/iM is 0.36nmol/min/mg protein which is
g
equivalent to 0.36nmol/min/1.96x10 cells. Therefore, the rate of
uptake for 101(^ cells would be 18nmol/min which is aproximately *the
A
rate required. However, if the total purine content of rat plasma is
estimated using the highest estimates for plasma purine
concentrations, a calculated value of 216nmole is obtained (assuming
a blood volume of 40ml in a 250g rat) which if utilised at a rate of
~7.9nmol/min, as calculated above, will be cleared from the rat's
plasma }~f times in the course of 8 hours. The rat must therefore
release purine into the bloodstream to maintain plasma levels or the
trypanosomes may cause destruction of host cells resulting in the
release of purine into the bloodstream.
The Km and Vmax values quoted above are in disagreement with
those obtained by James & Born,1980, who estimated the Km for
adenosine uptake to be 1.8pM as opposed to 0.5jiM. However, these
authors made no attempt to differentiate between uptake and transport
since they used methods to measure uptake which do not give estimates
of initial rates. The method used to estimate uptake consisted of a 3
minute incubation at 37°C in the presence of labelled substrate
followed by centrifugation for 30 seconds and repeated centrifugation
in cold buffer to remove extracellular label. This procedure would
not result in estimates of initial rates of uptake being measured but
would measure initial rates of reaction of the metabolising enzymes
and accumulation of metabolised label. This view is supported by the
results presented in Section 3.2.4 which show that after 45 seconds
exposure to labelled adenosine, over 85% of the label taken up is
converted to nucleotide. The use of incubation times greater than one
-158-
minute has been shown to result in the misinterpretation of the
results of uptake experiments in several cell types (Wohlhueter
et_al. ,1976 & 1979; Plagemann, 1971b; Lum et_ al., 1979; Marz
et al., 1979; Cybulski,1982). The methodologies applicable to the
study of transport systems are given in detail in the Introduction
(Section 1.2.2)
It should also be noted that James & Born (1980) found that
adenosine uptake continued for up to 20 minutes whereas adenosine and
hypoxanthine uptake ceased after two minutes in the time course
studies carried out in this investigation(Sections 3.2.1 & 3.3.1
respectively). This discrepancy may be due to differences in the
strain of trypanosomes used, or, since James & Born used a cloned
strain of trypanosomes their clone may have been an atypical
representative of the original uncloned population. The observed
cessation in uptake of adenosine and hypoxanthine suggests the
existence of some form of regulation of uptake as will be discussed
later.
Evidence for adenosine, adenine and hypoxanthine uptake being
mediated by a carrier or carriers comes from estimations of the
thermodynamic parameters of adenosine uptake, (in particular the
activation energy Section 3.2.3) and experiments investigating the
effect of nucleoside analogues on uptake. The existence of a carrier,
or carriers, in the plasma membrane is also supported by the
observations that the uptake systems for adenosine, adenine and
hypoxanthine are all saturable and highly temperature dependent.
(Sections 3.2.1 to 3.2.2 and 3.3.1 to 3.3.A respectively.)
The thermodynamic parameters calculated from an Arrhenius plot
of adenosine uptake (Section 3.2.3) are shown below along with the
parameters calculated for pyridoxine and pyridoxal for comparison.
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Parameter Ar Uptake PN Uptake PA Uptake
Ea 3A.2 kJ/mol 9.9 kJ/mol 5.A KJ/mol
AH 31.7 kJ/mol 7.5 kJ/mol 2.9 kJ/mol
AS 1A9.0 J/mol/K 128.0 J/mol/K 30.0 J/mol/K
AG -13.2 kJ/mol -31.1 kJ/mol -6.2 kJ/mol
As stated in the previous Section (A.1) a high activation energy is
associated with a carrier mediated process. The results listed above
show that the activation energy for adenosine uptake is 3 to 6 times
greater than the Ea for pyridoxine or pyridoxal uptake which appears
to be mediated by simple diffusion and not by a carrier. The value of
AH for adenosine uptake is also greater than AH for pyridoxine or
pyridoxal uptake as would be expected if AH is a measure of the
degree of bond stretching involved in a binding process as suggested
by Cornish-Bowden (1979). The binding of the adenosine to the carrier
molecule is likely to involve some deformation of the adenosine, the
transport protein, or both. These steps would not be involved in
simple diffusion where a lower AH would be expected as is in fact the
case.
The results presented in Sections 3.5.1 to 3.5.5 show the
effects of nucleoside analogues and other nucleosides and bases on
the uptake of adenosine (Section 3.5.1), adenine (Section 3.5.2) and
hypoxanthine (Section 3.5.3). The results presented not only prove
that uptake is carrier mediated but also that more than one carrier
is present. The evidence for the existence of a carrier molecule in
the plasma membrane comes from consideration of the results presented
in Tables 3.6 & 3.7. At a 50:1 inhibitor:substrate concentration
ratio IDA inhibits adenosine hydrolase activity by 15%, APRT activity
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by 18% and has no effect on HxPRT activity, whereas at the same
inhibitor:substrate ratio IDA inhibits adenosine uptake by 90%,
adenine uptake by 65% and hypoxanthine uptake by 25%. This suggests
that the IDA is inhi'oitng uptake at some point other than metabolism,
such as a plasma membrane carrier. The same arguments can be applied
to the results obtained for the effects of NBTI since it inhibits
adenosine hydrolase by 23%, has no effect on APRT and inhibits HxPRT
by only 2% while at the same inhibitor:substrate ratio it inhibits
adenosine uptake by 70% and hypoxanthine uptake by 80%, again
suggesting inhibition of some step in uptake before metabolism.
As stated in Section 3.5.1 inhibitors can be classified as
strong (giving 70% to 90% inhibition) or weak (giving 10% to 40%
inhibition). The percentage inhibitions of uptake quoted are the
plateau inhibition values described previously (Section 3.5.1). This
plateau effect may reflect a multiplicity of transport proteins in
that any one inhibitor may block one transporter 100% but not the
others for which the substrate being studied may have a low affinity.
The evidence for more than one transporter in T.brucei is supported
by the markedly different inhibition of adenosine uptake and
hypoxanthine uptake by IDA, adenosine uptake being inhibited by 90%
and hypoxanthine uptake being inhibited by 25% (Table 3.7). This
difference is not due to any differential inhibition of metabolism
since IDA has very little effect on the activity of the purine
metabolising enzymes (Table 3.6). The same arguments can be applied
to the results obtained using NBTI as an uptake inhibitor since NBTI
like IDA has little effect on the activity of the purine metabolising
enzymes. NBTI inhibits the uptake of adenosine by 70% and
hypoxanthine uptake by 80% suggesting that hypoxanthine and adenosine
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may use the same transporter. However, when the inhibitions of uptake
by NBTI and IDA are considered together with the inhibition of
adenine uptake which NBTI inhibits by 20% and IDA inhibits by 65%,
the existence of three separate transport systems is suggested. One
transport system specific for adenosine, one for hypoxanthine and one
for adenine, IDA being a good inhibitor of the adenosine and adenine
carriers and NBTI being a good inhibitor of the adenosine and
hypoxanthine carriers. Table 3.7 summarises the results of the
effects of inhibitors on uptake. The results are presented as maximum
percentage inhibition, that is the inhibitors plateau inhibition
level described above.The results show that there is one transporter
which appears to recognise 6-amino substituted purine nucleosides and
bases such as adenosine, adenine and IDA. This is shown by adenosine
uptake being inhibited by adenine and IDA and adenine uptake being
inhibited by adenosine and IDA, whereas compounds lacking the 6-amino
substitution such as hypoxanthine, guanine and guanosine are not
strong inhibitors of either adenine or adenosine uptake.
There also appears to be a transporter which recognises
6-hydroxy substitutions as in hypoxanthine, guanine and guanosine.
This is shown by inhibition of hypoxanthine uptake by guanosine and
guanine, while adenosine, adenine and IDA have very little effect.
The inhibitory patterns obtained with inosine and NBTI as
inhibitors do not fit the simple specificities described above. This
may be due to one of the transporters having some specificity towards
the ribose moiety of nucleosides or the existence of three
transporters. Further information on the exact number of transport
proteins present or their specificities must await further
investigation with a greater range of structural analogues or
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purification of the proteins themselves.
4.2.2 Mechanism of Purine Nucleoside and Base Transport.
The uptake of adenosine and hypoxanthine by T.brucei appears to
be mediated by active transport since they are accumulated by the
cells against a concentration gradient as free adenosine and
hypoxanthine. This is shown by the results presented in Figure 3.37
(Section 3.6.1). The intracellular concentrations of adenosine and
hypoxanthine shown in Figure 3.37 were calculated assuming
distribution of the label throughout total cell water which is
unlikely considering the presence of intracellular organelles such as
the glycosomes and the kinetoplast. As a result the values given for
the cytosolic concentrations of adenosine and hypoxanthine are likely
to be underestimates. The variation of intracellular concentration
with time (Figure 3.37) shows that metabolism rapidly decreases the
intracellular concentrations of adenosine and hypoxanthine, the
metabolism of adenosine being more rapid than the metabolism of
hypoxanthine. In both cases it should be borne in mind that uptake
stops after 2-3 minutes and at this point the intracellular
concentrations of adenosine and hypoxanthine are still greater than
the external concentration. It should also be noted that the results
presented in Tables 3.1 and 3.3 show that intracellular and
extracellular adenosine and hypoxanthine do not exchange, indicating
a one way transport system. The concentrations of intracellular
adenosine and hypoxanthine quoted above refer only to the
concentrations of labelled substrate; no account is taken of any
endogenous pools of unlabelled purines. However, considering the
efficiency with which the labelled adenosine and hypoxanthine are
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metabolised, it seems unlikely that any significant endogenous pools
of adenosine or hypoxanthine are present within the cell. It could be
argued that the unmetabolised adenosine and hypoxanthine measured are
not free in the cell but bound intracellularly in which case
transport need not be an active process. Further evidence that active
transport of adenosine and hypoxanthine occurs comes from
investigations into the dependence of uptake on a membrane potential
and ion gradients since active transport must be coupled to some
energy source.
The dependence of adenosine and hypoxanthine uptake systems on
a membrane potential was investigated by perturbing the membrane
potential with ionophores and changing the composition of the
incubation media. The ionophore gramicidin S allows all monovalent
cations to pass through a lipid bilayer by forming aqueous pores
through the membrane. This ionophore shows little specificity and
also allows protons to pass through the membrane. The results of
uptake assays conducted in the presence of gramicidin S are shown in
Figure 3.38 as is the effect of high concentrations of K+ in the
incubation medium. Gramicidin S inhibits the uptake of adenosine,
adenine and hypoxanthine as do high concentrations of K+(103mM) in
the incubation medium. The presence of gramicidin S at a
concentration of 1jjg/ml has been shown by Midgley (1983b) to reduce
the membrane potential of T.brucei by 54%, from -129mV to -59mV,
which equals the Nernst potential which would be obtained across a
membrane permeable to ions but not to macromolecules. Similar effects
of gramicidin S on the membrane potential of lymphocytes have been
reported by Rink ert al. (1980). Midgley (1983a), when using
fluorescent probes of membrane potential found that gramicidin S
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caused a depolarisation of the membrane reflected by inhibition of
uptake of the fluorescent probe. In this paper Midgley acknowledges
that gramicidin S may have an effect on any intracellular membrane
potentials. However, Montecucco et al. (1979) showed that in
lymphocytes gramicidin S did not partition into the mitochondrial
membranes in whole cells. Gramicidin S is a potent uncoupler of
mitochondrial oxidative phosphorylation (Montecucco et_ al., 1979) and
would be expected to have the same effect in whole cells if the
ionophore entered the cells intracellular membranes. Montecucco
et al. (1979) showed that there was no significant difference in the
ATP levels of lymphocytes treated with gramicidin S and controls.
These results contrast with the effect of valinomycin on
intracellular membranes. Davis et al. (1985) and Wilson et_ al. (1985)
used valinomycin in combination with variations in extracellular K+
concentrations to estimate the contribution of mitochondria to the
uptake of fluorescent probes of membrane potential. High
extracellular concentrations of K+ depolarise the plasma membrane but
not the mitochondrial membrane. However, in the presence of
valinomycin, which partitions into intracellular membranes, and high
concentrations of K+ the mitochondria are depolarised. Comparison of
the results obtained under these different conditions allows
estimation of the contribution of the mitochondrial membrane
potential to the measured plasma membrane potential using fluorescent
probes.
In the case of T. brucei TREU 55 any contribution to a plasma
membrane potential from the mitochondrion is unlikely to be
significant since in the long slender bloodstream form the
trypanosomal mitochondrion is virtually inactive. The oligomycin
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sensitive ATPase reported to be present in some lines of long slender
bloodstream forms of T. brucei (Opperdoes et al., 1976 & 1977b) which
may be able to generate a mitochondrial membrane potential is not
present in T.brucei TREU 55 (Flynn I.W. personal communication). This
observation is consistent with the fact that TREU 55 is unable to
multiply in culture or generate short stumpy forms which is a
characteristic of trypanosome lines lacking the oligomycin sensitive
ATPase (Opperdoes et al., 1976 & 1977b). In view of the above
information it is unlikely that any of the results obtained with
ionophores in this work are affected by ionophore effects on the
mitochondrion.
The high external K+ medium (Figure 3.38) also reduces the
membrane potential by reducing the K+ gradient across the membrane
which is responsible for the membrane potential. The reduction in
uptake of all three purines by lowering the membrane potential
indicates that transport is at least partially dependent on a
membrane potential or an ion gradient. A high extracellular K+
concentration is less effective in inhibiting uptake than gramicidin
S which will allow the equilibration of protons and Na+ and K+ across
the membrane. This may indicate that uptake is also dependent on an
ion gradient as well as a membrane potential. It should be noted that
all ionophores were tested for trypanocidal activity and were found
to have no effect on cell motility or rates of oxygen uptake at the
concentrations used. This is exemplified by the results of the
investigation into the effects of gramicidin S on oxygen uptake by
the trypanosomes (Section 3.6.3). All the ionophores used were tested
in the same manner.
Valinomycin, a K+ specific ionophore, had no effect on
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adenosine, adenine or hypoxanthine uptake unless the cells were
preincubated with the ionophore before uptake of substrates was
assayed. The observation that valinomycin had no effect on uptake in
the absence of a preincubation period is as would be expected, since
valinomycin, in the absence of extracellular K+, docs not depolarise
plasma membranes and may even cause a slight hyperpolarisation
(Bashford _et_ al_., 1985). The inhibition of uptake of adenosine,
adenine and hypoxanthine by valinomycin after a preincubation period
may be due to non-specific interaction with membrane proteins after
it has partitioned into the plasma membrane. The possibility that the
preincubation is required for the valinomycin to have an effect on
the mitochondrion is unlikely in view of the lack of an oligomycin
sensitive ATPase as discussed above.
Incubating cells in the presence of K+ (103mM) and valinornycin
resulted in even greater inhibition of uptake than that caused by
either K+ or valinomycin alone, indicating that, in the presence of
K+, valinomycin may be causing a depolarisation of the membrane over
and above its effect in the absence of K+.
The Na+ dependence of adenosine and hypoxanthine uptake was
determined as described in Section 3.6.5. It was found that while
neither adenosine uptake nor hypoxanthine uptake was dependent on
Na+, hypoxanthine uptake was stimulated by high concentrations of
Na+. The significance of this result will be considered later. The K+
dependence of uptake was not investigated since changing the
extracellular K+ concentration would affect the membrane potential
which has been shown to have an effect on uptake. Therefore any
direct dependence of uptake on K+ concentrations would be masked by
this effect. Investigations of the K+ dependence of uptake could be
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conducted using phospholipid vesicles into which the transport system
could be incorporated and K+ gradients established across the vesicle
membrane.
The pH dependence of adenosine, adenine and hypoxanthine uptake
was investigated as detailed in Section 3.6.6. The results of this
investigation (Figure 3.43;Section 3.6.6) showed that as the pH of
the incubating medium was increased the rate of uptake of adenosine,
adenine and hypoxanthine decreased. This observed decrease in uptake
is probably due to effects on cell motility and metabolism since the
rate of oxygen uptake and cell motility increased markedly as the pH
of the medium was increased. It should be noted that adenosine,
adenine and hypoxanthine have no pK's in the pH range used in these
experiments. In the pH range 7-8.5 the uptake of adenine and
hypoxanthine appears to be unaffected by changes in pH. The uptake of
adenosine does appear to be slightly inhibited by increasing the pH
from pH 7 to 8.5. It should be noted that in the pH range 7-8.5 no
significant changes in rates of oxygen utilisation or cell motility
were observed. Figure 3.42 (Section 3.6.6) shows the effect of the
protonophore FCCP on the uptake of adenosine and hypoxanthine. Both
adenosine and hypoxanthine uptake are partially inhibited by FCCP.
The addition of FCCP to the cells may be resulting in a slight
increase in the magnitude of a proton gradient across the plasma
membrane in a fashion similar to the hyperpolarisation of a membrane
in the presence of valinomycin. Increasing the membrane permeability
to H+ would allow the protons to distribute across the membrane
according to the membrane potential which in the case of trypanosomes
is negative inside (Midgley, 1983b). Considering the effect of FCCP
on uptake it seemed possible that a proton gradient could be involved
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in the mechanism of purine uptake. The existence of a pH gradient
across the plasma membrane is shown by the results presented in
Figure 3.45, Figure 3.46 and Table 3.9. It was found that a proton
gradient exists with the inside of the cell acid relative to the
outside.
The results of the investigations into the dependence of uptake
on a membrane potential and its dependence on extracellular ions are
summarised in Table 3.8. A speculative model for the uptake
mechanisms of adenosine, and hypoxanthine is shown in Figure
3.44.
The model for adenosine uptake shown in Figure 3.44, although
highly speculative, is consistent with the results presented in
Section 3.6. Adenosine uptake is inhibited by the addition of the
ionophore gramicidin S to the incubation which will reduce any
membrane potential by allowing potassium to leave and sodium to enter
the cells. This suggests that adenosine uptake is dependent on a
membrane potential or iongradient. Further evidence for adenosine
uptake being dependent on a membrane potential is provided by the
observation that high concentrations of extracellular potassium,
which reduce any potassium membrane potential, also inhibit adenosine
uptake. The inhibition of adenosine uptake by valinomycin has been
discussed above. The model for adenosine uptake presented in Figure
3.44 in which the substrate enters the cell in exchange for a
potassium ion and entry of a proton, was first suggested by Riggs
et_al.(1958) and later by Crane (1977). This is consistent with the
results presented in Section 3.6 in that the efflux of potassium
would be- inhibited by increasing the extracellular potassium
concentration or this pathway for potassium efflux may be by-passed
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in the presence of high concentrations of valinomycin. Reduction of
the membrane potential by high extracellular concentrations of
potassium or by gramicidin S would inhibit the influx of protons
since the proton is entering the cell against a proton gradient
(Section 3.6.8). The inhibition of adenosine uptake by FCC? is also
consistent with this model since the addition of FCCP to the cells
makes their membrane more permeable to protons so that the proton
gradient across the membrane may be increased as protons enter the
cell in response to the membrane potential. A similar effect is
observed as regards the membrane potential when valinomycin is added
to cells in the absence of potassium, as discussed above. The slight
inhibition of adenosine uptake caused by increasing the extracellular
pH is also consistent with this model in that reducing the
extracellular proton concentration effectively creates a greater
gradient of protons across the membrane. The potassium lost from the
cell in this model could be reclaimed by the plasma membrane Na+/K+
ATPase.
The model proposed for the uptake of hypoxanthine (Figure 3.44)
shows the entry of hypoxanthine by a sodium symport mechanism with
the sodium being removed from the cell either by the membrane Na+/K+
ATPase or sodium/proton antiport. The observation, that hypoxanthine
uptake is stimulated by high extracellular concentrations of sodium,
is consistent with the proposed model. Inhibition of uptake by
factors reducing membrane potential (discussed above) could be due to
reducing the rate of entry of the protons in the proton/sodium
antiport system in response to the membrane potential. The membrane
potential may also have an effect on the rate of entry of the sodium
ions in the hypoxanthine/sodium symport system. This type of active
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transport has been reviewed by Eddy (1978). In conclusion it should
be borne in mind that the models presented are speculative, but the
sensitivity of uptake of hypoxanthine and adenosine to factors known
to affect membrane potentials and cellular ion gradients suggests
some form of dependence on a membrane potential. The active transport
hypothesis is also supported by the observation that both adenosine
and hypoxanthine are accumulated against their concentration
gradients by the cell.
Having discussed the results obtained from the work carried out,
and some of the conclusions which can be drawn from the data, these
results will now be considered in conjunction with what is known
about purine nucleoside and base transport in other organisms.
A.2.3 Comparison of Transport of Purine Nucleosides
and Bases in T.brucei and other Organisms
The results discussed in the previous section give a strong
indication that the uptake of the purines adenosine, adenine and
hypoxanthine by T.brucei is mediated by an active transport system.
This active transport contrasts with the facilitated diffusion
mechanisms prevalent in other eukaryotic cells. Evidence has also
been presented indicating the presence of more than one transporter
with differing specificities which again appears to differ from other
eukaryotic cells.
The uptake of nucleosides by the mammalian erythrocyte has been
extensively studied and found to be mediated by facilitated diffusion
(Cabantchik & Ginsburg,1977; Cass & Paterson,1972 & 1973) using a
single carrier which shows little specificity towards the base
portion of the nucleoside but is relatively specific for the ribose
moiety (Oliver & Paterson,1971; Cass & Paterson.1973). The uptake of
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bases by the erythrocyte appears to occur via a different carrier
since the uptake of nucleosides is strongly inhibited by NBTI (Jarvis
& Young, 1980) whereas the uptake of bases is not (Paterson &
Oliver, 1971). The uptake of nucleosides by mammalian cells has been
investigated in great detail and recently reviewed by Plagemman &
Wohlhueter (1980) and Young et _al. (1983). The general opinion given
in these reviews is that in animal cells the uptake of nucleosides is
mediated by facilitated diffusion followed by metabolic trapping.
This has been shown to be the case for uptake of nucleosides by
Novikoff rat hepatoma cells (Marz _et _al., 1979), mouse leukemia cells
, canine thymocytes, canine peripheral blood leukocytes (Lum
et_ al.,1979) and brain tissue (Shimizu et al.,1972). Lum et al.
(1979) and Marz et al. (1979) showed that the nucleoside and base
carriers allow equilibration of nucleosides and bases across the
plasma membrane in a few seconds, all further uptake being due to
metabolism of the nucleosides and bases maintaining a concentration
gradient across the membrane. In animal cells other than erythrocytes
several carriers of differing specificites were thought to exist as
indicated by cross inhibition studies of nucleoside and base uptake
in rat hepatoma cells (Plagemann & Erbe,1974) and HeLa cells (Cass &
Paterson,1977). This apparent specificity was later shown to be due
to the specificity of the nucleoside and base metabolising enzymes
and not the membrane carriers. This is caused by the cross inhibition
experiments being conducted with incubation periods greater than 1
minute in which the measured uptake is due to metabolism rather than
the initial rapid transport step (Section 1.2.1; Taube & Berlin,1972;
Mulder & Harrap,1975; Heichal et al.,1979).
The results of cross inhibition studies using various
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nucleosides and bases to inhibit each other's uptake must be
considered with caution since even with incubation periods as short
as 30 seconds a substantial amount of the nucleoside and base taken
up is metabolised to nucleotide and some of the nucleosides and bases
used in the cross inhibition experiments are substrates for the
metabolising enzymes. However, guanine inhibits HxPRT activity by 34%
at a guanine:hypoxanthine concentration ratio of 50:1 but at the same
concentration ratio guanine inhibits hypoxanthine uptake by 90%
indicating that the observed inhibition is not due only to the
inhibition of HxPRT.
It should also be noted that the percentage inhibitions of
uptake quoted are the maximum inhibition levels which could be
obtained as described in Section 3.5.1. The inhibitions of uptake
plateau at certain fixed percentage inhibitions which do not increase
with increasing inhibitor concentration. If uptake was being
inhibited by inhibition of metabolism then inhibition of uptake would
be expected to continue to increase with increasing inhibitor
concentration. The plateau effect is probably a reflection of the
presence of multiple carriers since any given inhibitor may block
completely the substrate's normal carrier, but allow uptake of the
substrate via one of the other carriers for which the substrate may
have a low affinity.
The number of nucleoside and base transporters in rat hepatoma
cells has been investigated using nucleoside analogues in the same
manner as described above (Cohen e_t aJ., 1979). The results of these
investigations suggested the existence of distinct nucleoside and
base transports. The uptake systems of T.brucei appear to be more
complex than those of mammalian cells in that there does not appear
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to be a simple distinction between a nucleoside transporter and a
base transporter, but rather some specificity towards the purine base
moiety as opposed to the presence or absence of ribose (Section
4.2.1).
Purine nucleoside and base uptake by bacteria has also been
extensively studied. Peterson & Koch (1966) and Peterson et al.
(1967) investigated the mutual inhibitory effects of nucleosides and
bases on each other's uptake and concluded that in E.coli there was
more than one transport system distinguishable from metabolism. A
group translocation mechanism for the uptake of purine nucleosides
and bases by E.coli and S.typhimurium has been proposed by Hochstadt
& Stadman (1972) and Rader & Hochstadt (1976). However, by the use of
mutants deficient in nucleoside phosphorylase and phosphoribosyl
transferase enzymes required for the proposed group translocation
system it has been shown in E.coli that uptake is independent of
these enzymes, the mutant bacteria still being capable of
accumulating nucleoside against a concentration gradient (Hoffmeyer &
Neuhard, 1971; Mygind & Munch-Petersen, 1975;Munch-Petersen &
Mygind,1976). Two uptake systems have been identified in E.coli
designated the C and G systems, the C system being specific for
cytosine and the G system being specific for guanosine
(Munch-Petersen e_t al. , 1979). The C system has also been found to
transport adenosine and deoxyadenosine but no other purine
nucleosides whereas the G system will transport all nucleosides,
whether purine or pyrimidine.
As stated in the Introduction (Section 1.4.2) little information
is available on the purine transport systems of trypanosomes. In the
few cases where the uptake of purines by trypanosomes has been
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investigated little effort has been made to distinguish between
transport and overall uptake (James & Born,1980). Uptake of purines
by L.panamensis has been shown to be carrier mediated (Hansen
et al_. ,1982) with three separate carriers involved as determined by
studies of mutual inhibition of uptake amongst purine nucleosides and
bases. Multiple carriers have also been suggested for purines in
T.brucei, T.congolense (James & Born,1980) and C.fasciculata (Kidder
et. el. , 1978). Although the results reported by James & Born (1980)
agree in part with the results presented here, the long incubation
times used by these authors mean that in many cases the reported
inhibitions could be due to inhibition of metabolism and therefore
overall uptake, and not inhibition of transport. Active transport of
pyrimidines by T.lewisi has been reported by Manjra & Dusanic (1973);
however these authors made no distinction between transport and
uptake (Section 1.2) and did not show accumulation of unmetabolised
pyrimidines. As a result, their conclusion that uptake was mediated
by active transport is invalid. Active transport of purine
nucleosides or bases has not been shown to occur in any mammalian
cells studied to date but has been shown to occur in E.coli K12,
E.coli B and S.typhimurium. Active transport was demonstrated by the
ability of mutant cells, lacking purine metabolising enzymes, to
concentrate purine nucleosides and bases several hundred fold.
(Munch-Petersen & Mygind,1976; Munch-Petersen & Pihl,1980). The
active transport process was shown to be dependent on a proton
gradient by its sensitivity to the uncoupler 2,4-dinitrophenol. In
membrane vesicles transport was supported by the addition of electron
donors suggesting that the proton gradient is generated by a
proton-pumping electron transport chain (Munch-Petersen et al.,1979).
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Similar results have been obtained in studies on S.typhimurium (Rader
& Hochstadt,1976) and E.coli B (Roy-Burman et al.,1978).
The results presented in this work are indicative of an active
transport system for the uptake of purine nucleosides and bases by
T.brucei. This is supported by the observations that adenosine and
hypoxanthine are accumulated against their concentration gradients
(Section 3.6.1) and the sensitivity of uptake to reduction of the
cell membrane potential (Sections 3.6.2 & 3.6.4). The sensitivity of
uptake to inhibition by the uncoupler FCCP and, in the case of
adenosine, high external pH (Section 3.6.6) suggests that a movement
of protons is involved in the uptake mechanism. The points above are
discussed in detail in Section 4.2.2.
The existence of active transport systems in trypanosomes is not
unknown, as demonstrated by the examples given below. The transport
of glucose by L.donovani is an active process as indicated by the
organism's ability to accumulate glucose and the partially
metabolisable glucose analogue 2-deoxyglucose against their
concentration gradients (Zilberstein & Dwyer,1984). This active
transport process was also found to be sensitive to inhibition by the
uncoupler 2,4-dinitrophenol suggesting the involvement of a proton
gradient in the transport process. The uptake of threonine by
T.brucei is mediated by active transport (Voorheis, 1971; Fricker
et al_., 1984) but the energy source to which transport is coupled has
not been conclusively identified. The transport is independent of Na+
concentration (Voorheis 1971; Fricker _et_ al., 1984) and independent of
a proton gradient (Voorheis, 1979). Fricker et al. (1984) proposed
that transport is coupled to an exchange of alanine which is produced
from pyruvate by transamination and accumulated to high
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concentrations in the cell (Chappell et al.,1971); however no direct
evidence for this hypothesis is available. Voorheis (1980) provided
some evidence that a glycolytic intermediate from before the aldolase
reaction was required for transport, but this hypothesis does not
appear to have been investigated further. In contrast to the findings
of the above authors, Hansen (1979) found threonine uptake in
T.brucei to be Na+ dependent and inhibitable by ouabain, suggesting
that a Na+/K+ ATPase is responsible for the maintenance of the
required Na+ gradient and the membrane potential. The requirement for
a membrane potential for active transport by C.fasciculata has also
been demonstrated, in that an electrochemical proton gradient was
found to be required for the uptake of If -aminobutyric acid by a
proton symport mechanism (Midgley 1978; Midgley & Stephenson,1980).
The proton gradient across the trypanosomal plasma membrane
(Section 3.6.8) may be generated by a proton pumping ATPase or by an
antiport with another ion such as K+. A K+/H+ antiport working to
expel protons is known to operate in K+ depleted yeast cells (Ryan &
Ryan, 1972). It has also been proposed that the efflux of lactate in
fermentative bacteria can be used to establish a proton gradient
across the cell membrane by a symport mechanism (Konings,1985). The
possibility that the trypanosomal proton gradient may also be
generated by the efflux of the metabolic end product pyruvic acid
should be investigated since the bloodstream forms of the African
trypanosomes produce large amounts of pyruvic acid from glycolysis.
The mechanism of generating the proton gradient would differ from
that found in bacteria since the direction of the gradient would be
reversed. This could be achieved by expelling pyruvate as an anion in
either antiport or symport with a cation.
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4.2.A Metabolism of Purine Nucleosides and Bases
by T.brucei.
The effect of the nucleoside analogues NBTI and IDA on the
purine metabolising enzymes APRT, HxPRT and adenosine hydrolase have
been discussed (Section 4.2.1) in relation to inhibition of uptake as
distinct from metabolism. That these three enzymes are involved in
the initial stages of salvage of purine nucleosides and bases is
shown by the results presented in Sections 3.2.4 & 3.2.5. When
trypanosomes were incubated with radiolabelled adenosine for varying
periods of time it was found that over 85% of the label taken up
after 45 seconds was present in the cell as nucleotide. At later time
points it was noted that the levels of nucleotide slowly increased
while the levels of free adenosine and adenine fell. It was also
noted that the levels of labelled adenosine in the cell fell below
detectable levels more rapidly than adenine. This suggests that
adenosine is deribosylated to adenine before being converted to
nucleotide. Experiments in which a dialysed cell lysate was incubated
with labelled adenosine showed that the lysate contained deribosylase
activity as it rapidly deribosylated adenosine to adenine. This
activity was shown to be adenosine hydrolase as opposed to adenosine
phosphorylase by the enzymes ability to function in phosphate free
media with no loss of activity (Section 3.4.1). The conversion of
adenosine to nucleotide was shown not to occur when a lysate was
2+
supplied with adenosine, ATP and Mg +, but nucleotide was formed when
2 j
the lysate was supplied with adenosine, PRPP and Mg (Section
3.2.5). These results lead to the conclusion that adenosine when
taken up is first hydrolysed to adenine and ribose before being
converted to AMP by APRT.
* or with an ATP regeneration system present.
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A time course of hypoxanthine metabolism (Section 3.3.A) showed
that hypoxanthine entered the cell as hypoxanthine and was
subsequently metabolised to nucleotide but at a much slower rate than
observed for the conversion of adenosine to nucleotide. An
interesting observation from the time courses of adenosine and
hypoxanthine metabolism by whole cells is that metabolism of the
label taken up continues for up to 20 minutes but uptake ceases after
2 minutes as shown by the time courses of adenosine and hypoxanthine
uptake (Sections 3.2.1 & 3.3.1). This observation will be discussed
in detail later. The only known pathways for the conversion of
hypoxanthine to nucleotide are via the enzymes HxPRT or HxGPRT.
The kinetic parameters of these three enzymes, adenosine
hydrolase, APRT and HxPRT were estimated (Sections 3.4.2, 3.4.3 &
3.4.4 respectively) for comparison with the kinetic parameters
estimated for overall uptake of adenosine, adenine and hypoxanthine.
The kinetic parameters of the uptake systems are listed in Section
4.2.1. These data show that in all cases the Km for uptake is lower
than the Km for the enzymes involved in metabolism. Observed
saturability of uptake must therefore be due to saturation of
transport rather than metabolism, since saturation of uptake occurs
at a substrate concentration below that needed to saturate any of the
metabolic steps. Calculation of the rates of uptake at a substrate
concentration of 1pM, when compared to the rates of reaction of the
metabolising enzymes (estimated in cell lysates) at the same
substrate concentration, show that metabolism is capable of much
higher reaction rates than uptake. This calculation assumes that
intracellular and extracellular concentrations are equal which may
not be the case if active transport is occurring. Also this ignores
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the fact that the kinetic parameters calculated for the metabolising
enzymes apply only to a cell free situation. In the cell these
enzymes could be under many forms of regulation which would affect
their kinetic characteristics making any calculations based on the
experimentally obtained kinetic parameters invalid. The simple
calculation carried out deals with only one static time point which
is a poor representation of the in vivo situation where the
intracellular concentration of transported substrate will increase
rapidly consequently increasing the rate of metabolism. Any
meaningful calculations to determine the rate limiting step in uptake
would require the construction of a computer model of the system for
which much more data would be required regarding possible regulation
of transport, metabolism and also the intracellular concentrations of
other substrates such as PRPP.
In other systems, as will be discussed later, the HxPRT may also
utilise guanine as substrate. This is indicated by the results
presented in Section 3.4.6 which show that guanine is a good
inhibitor of HxPRT activity and therefore may be a substrate. The
results presented also show that the APRT and HxPRT activities are
associated with separate enzymes since the two enzyme activities have
different Mg dependence curves (Section 3.4.5) and HxPRT activity
is not inhibited by adenine and inhibited 50% guanine (Section
3.4.6).
Figure 3.33 summarises the uptake and metabolism of adenosine,
adenine and hypoxanthine by T.brucei with the exception of the
interconversion of nucleotides. The data presented in Sections 3.2.6
& 3.3.5 shows the diversity of nucleotides labelled during a 10
minute incubation of whole cells with labelled adenosine and
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hypoxanthine respectively. The results presented in Figure 3.15
(Section 3.2.6) show that adenosine when taken up is rapidly
incorporated into the cell's ATP pool and then distributed through
the ADP and AMP pools as metabolism proceeds. The formation of
labelled GMP and GDP indicates the presence of AMP deaminase, IMP
dehydrogenase and GMP synthetase which would convert AMP to IMP, IMP
to XMP and XMP to GMP respectively. The results of a similar
experiment using labelled hypoxanthine as substrate for the uptake
system are presented in Figure 3.21 (Section 3.3.5). The results show
the incorporation of label into IMP, and as time progresses,
incorporation of label into IDP and ITP. If, as stated above, the
enzymes IMP dehydrogenase and GMP synthetase are present, labelling
of GMP and GDP would be expected. From the data shown it is not
possible to tell if GMP is labelled but very little labelled GDP was
detected. However the formation of GMP by GMP synthetase requires ATP
and if, as suggested by the rapid incorporation of exogenous labelled
adenosine into the cell's ATP pool, the cells are deficient in ATP
this reaction would not occur at a significant rate. The little label
incorporated into ATP after ten minutes incubation may reflect the
presence of adenylosuccinate synthetase and adenylosuccinate lyase
which can convert IMP to AMP. The metabolism of purines in T.brucei
will now be compared with what is known of purine metabolism in other
organisms.
A.2.5 Comparison of Purine Nucleotide,Nucleoside and Base
Metabolism in T.brucei and other Organisms.
The metabolism of purine nucleosides and bases by T.brucei, as
determined in this work, has been discussed in Section 4.2.4 and will
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now be considered in relation to the metabolism of purine nucleosides
and bases in other organisms. The results discussed in Section 4.2.A
indicate that when adenosine is taken up it is deribosylated to
adenine and ribose by hydrolysis as opposed to phosphorolysis. The
apparent inhibition of APRT by adenosine can be explained by dilution
of the labelled adenine used as substrate with unlabelled adenine
derived from the adenosine present due to the action of adenosine
hydrolase (Section 3.5.4). The fact that this effect was not observed
to occur to the same extent when inosine was tested as an inhibitor
of HxPRT suggests that inosine is not a good substrate for adenosine
hydrolase. However the existance of an inosine hydrolase cannot be
ruled out since the inosine hydrolase may be much less active than
adenosine hydrolase.
The inhibition of HxPRT obtained with guanosine as inhibitor is
similar to the inhibition by guanine (Section 3.5.4) which may
indicate the presence of a guanosine hydrolase or that guanosine is a
substrate for adenosine hydrolase. Alternatively guanosine and
inosine may be poor substrates for the adenosine hydrolase as
indicated by their ability to inhibit adenosine hydrolase by 31% and
35% respectively when present in a fifty-fold excess over the
adenosine substrate.
Adenosine phosphorylase (Section 3.2.5) is known to be the
enzyme responsible for deribosylation of adenosine in the mammalian
erythrocyte, (Tsuboi & Hudson,1957; Huennekens _et al_., 1956; Grimes
1980) brain (Huennekens _et_ al_. , 1956) and liver (Korn &
Buchanan,1955). The hydrolytic pathway is known to operate in some
bacteria (Rabinowitz & Barker,1965) and in bakers yeast (Heppel &
Hilmoe,1952). Nucleoside phosphorylase activities have been detected
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in L.mexicana amazonensis promastigotes, T.brucei trypomastigotes and
T.cruzi araastigotes, epimastigotes and trypomastigotes (Gutteridge &
Davies,1982; Davies et al_. ,1983) all of which contain adenosine and
guanosine phosphorylase activities. These findings are in conflict
with the findings of Ogbunude & Ikediobi (1983), Ogbunude et al.
(1985) and this work Section 3.2.5. Ogbunude & Ikediobi (1983) and
Ogbunude et_ al. (1985) did not detect any nucleoside phosphorylase
activity in T.brucei or T.vivax but did find activity in
T.congolense. In the organisms, T.brucei and T.vivax, in which no
nucleoside phosphorylase activity was detected, nucleoside hydrolases
(nucleosidases) were found to be present allowing the production of
free base from nucleoside. Nucleosidases have also been detected in
other trypanosomes (Davies et al.,1983; Looker et a^.,1983) and
purified from T.gambiense (Schmidt et al.,1975).
Nucleosides may also be converted to nucleotides, without
conversion to free bases, by the action of nucleoside kinases which
have been detected in a variety of trypanosomes. Adenosine kinase
activity has been reported to be present in extracts of L.donovani
(Tuttle & Krenitsky, 1980) and T.cruzi (Gutteridge & Davies,1982).
Adenosine, inosine and guanosine kinases have also been reported to
be present in L.m.amazonensis, T.brucei and all morphological forms
of T.cruzi (Davies et al.,1983). However adenosine kinase could not
be detected in T.brucei by Ogbunude & Ikediobi (1983), Ogbunude
et al. (1985) or this work (Section 3.2.5). Ogbunude et al. (1985)
did however detect adenosine kinase in T.vivax and T.congolense.
Nucleoside kinases have also been detected in mammalian systems such
as the erythrocyte (Agarwal & Parks,1978), brain (Shimizu
et al.,1972) , and mouse leukemia cells (Lum et al.,1979).
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Hypoxanthine, guanine and adenine phosphoribosyltransferase
activities have been detected in Crithidia fasciculata (Kidder
et_ al.,1979), L.donovani (Tuttle & Krenitsky,1980), T.cruzi
(Gutteridge & Davies,1981 & 1982) and T.brucei and L.mexicana (Davies
et_ al.,1983). In most cases the hypoxanthine and guanine
phosphoribosyltransferase activities have been found to be associated
with the same enzyme, as occurs in mammalian tissues, which is in
agreement with the results obtained in this investigation. However
these activities have been shown to be associated with separate
enzymes in C.fasciculata (Kidder et al., 1979) .
The presence of adenosine deaminase in trypanosomes is a matter
of debate in that Davies _et al. (1983) reports that adenosine
deaminase is present in T.brucei and T.cruzi but not present in
L.mexicana whereas Ogbunude et al. (1985) found no adenosine
deaminase in T.brucei, T.vivax or T.congolense. Experiments carried
out during this investigation also failed to detect any adenosine
deaminase activity in T.brucei. The lack of adenosine deaminase
precludes the interconversion of adenine and hypoxanthine. Therefore,
any interconversion of bases must take place at the level of the
nucleotides. This must be the case since single purines are capable
of supporting the growth of trypanosomes in culture (Marr
et al. , 1978; Schmidt et al., 1975; Fish et_ al., 1982a & 1982b;
Gutteridge & Gaborak,1979). The formation of labelled GMP and GDP
from labelled adenosine (Section 3.2.6) indicates the presence of AMP
deaminase, IMP dehydrogenase and GMP synthetase which would convert
AMP to IMP, IMP to XMP and XMP to GMP respectively. Using labelled
hypoxanthine as the substrate for uptake, label is incorporated into
IMP and as time progresses IDP and ITP are labelled. If, as stated
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above, the enzymes IMP dehydrogenase and GMP synthetase are present,
GMP and GDP would be expected to be labelled. From the data obtained
it is not possible to tell if GMP is labelled but very little labelled
GDP was detected. The little label incorporated into ATP after ten
minutes incubation may reflect the presence of adenylosuccinate
synthetase and adenylosuccinate lyase which can convert IMP to AMP.
The enzymes adenylosuccinate synthetase and adenylosuccinate lyase
have been shown to be present in T.gambiense and T.rhodesiense along
with IMP dehydrogenase and GMP synthetase (Fish et_ al., 1982b). These
enzymes have also been shown to be present in L.donovani and
L.braziliensis (Marr et al.,1978)
A.3 PREPARATION OF PLASMA MEMBRANE ENRICHED FRACTION.
In order to investigate the adenosine transporter in more detail
a purification scheme for the preparation of a plasma membrane
enriched fraction was developed. It was hoped that this would aid in
the detection of proteins present in the membrane as a low percentage
of the total protein.
As previously stated in Section 3.7 several methods for the
purification of trypanosomal plasma membranes have been published
(Rovis & Baekkeskov,1980; Steiger et_ al., 1980; Mancini et al.,1982;
Voorheis _et_ _al_., 1979) . One of the main differences between the
methods published by these authors was the method of disrupting the
cells before fractionation. The method of osmotic swelling and
homogenisation used by Voorheis e_t al. (1979) required a precision
homogeniser which was not available during this investigation.
Mancini et al. (1982) used sonication to disrupt the cells which in
this investigation was found to destroy marker enzyme activity and so
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was not used. Rovis & Baekkeskov (1980) used nitrogen cavitation to
disrupt the cells; however the equipment required for this technique
was not available during this investigation. Steiger et al_. ( 1980)
ground the cells with silicon carbide to disrupt the plasma
membranes. Where possible these methods plus water lysis were
evaluated for the production of a cell homogenate as described in
Section 3.7.1. The method finally chosen for the disruption of the
cells was a modification of the silicon carbide grinding method of
Steiger et al. (1980) in which 75/jm diameter glass beads were
substituted for the silicon carbide. The use of glass beads was found
to enable greater recovery of material from the grinding paste.
One of the main problems encountered in attempting purification
of the trypanosomal plasma membrane was the lack of suitable plasma
membrane marker enzymes. However Steiger _et_ al. (1980) showed that
the enzyme ^-glucosidase is located on the outer surface of the
plasma membrane of T.brucei and is therefore suitable as a plasma
membrane marker enzyme. The observation that this enzyme is located
on the outer surface of the plasma membrane suggests that it may be
involved in processing the glycosylated residues of the glycoprotein
coat to their mature forms after insertion of the glycoprotein into
the membrane. Ouabain inhibitable Na+/K+ ATPase has been used as a
plasma membrane marker in T.brucei subcellular fractionations
(Voorheis _et_ al_. (1979) but as stated in Section 3.7.1 this marker
was only found to be useful in semi-purified fractions due to the
high levels of non-specific phosphatase activity and the activities
of other ATPases found in the initial homogenate. The presence of
phosphatases makes difficult the use of 5'-nucleotidase activity as a
marker. The enzyme 5'-nucleotidase is one of the most frequently used
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plasma membrane marker enzymes in fractionations of mammalian cells
(Solyom & Tranns,1972). However this enzyme was not detected in
T.brucei by Rovis & Baekkeskov (1980). Plasma membranes have been
artificially marked to aid in the identification and purification of
membrane proteins (Mancini et_ al_., 1982). The cell surface proteins
125
were marked by labelling the cell surface with I and by incubation
3
of the cells with [ H]-mannose which was incorporated into the cell
surface glycoproteins. Purification of the membranes was then
followed by monitoring the purification of the radiolabelled
proteins. The markers used in this investigation were oC-glucosidase,
125 I +
I iodinated surface proteins and ouabain inhibitable Na /K ATPase
in some semi-purified fractions.
The density of the plasma membrane enriched fraction (Section
3
3.7.2) was found to be 1.14g/cm which is in agreement with the
densities estimated by Mancini _et al. ( 1982) and Rovis & Baekkeskov
3
(1980) but is much lighter than 1.22 -1.24g/cm as estimated by
Steiger _et al_. (1980) and Voorheis et al. (1979). This difference
between the densities estimated by these authors could be due to the
presence or absence of microtubules attached to the plasma membrane.
If the tubules remain attached to the membrane during fractionation
they would be expected to markedly increase the apparent density of
the membrane since the subpellicular microtubular array of
trypanosomes is quite extensive (Anderson & Ellis,1965;
Angelopoulous,1970). Whether or not the microtubules remain
associated with the plasma membrane appears to depend on the
homogenisation buffer used in the cell breakage procedure. It has
been found that the equilibrium density of the plasma membrane marker
3 3
cK-glucosidase shifts from 1.22g/cm to 1.17g/cm if the initial
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disruption of the cells is carried out in Tris buffer rather than
imidazole buffer (Walter & Opperdoes,1982). Voorheis et al. (1979)
and Steiger et al. (1980) used TES and imidazole buffers respectively
during homogenisation and, as stated previously, estimated the plasma
3
membrane equilibrium density to be 1.22g/cm whereas the buffers used
by Mancini _et_ al. ( 1982) and Rovis & Baekkeskov were Tris and HEPES*
respectively. These authors estimated the equilibrium density of the
3
plasma membrane to be 1.14g/cm . These comparisons show that detailed
consideration must be given to experimental method when comparing
results obtained by different authors.
The purification scheme finaly adopted for the production of a
plasma membrane enriched fraction is given in Section 3.7.A. The
purification consists of simple differential centrifugation steps and
a sucrose step gradient centrifugation. One step of interest is the
collection of the plasma membranes by centrifugation onto a dextran
plaque in a high pH and low osmotic strength buffer. The physical
basis of this procedure is explained in detail by Wallach & Kamat
(1964) and Avruch & Wallach (1971). The principle of the method is
described briefly below. The fractionation of microsomal and plasma
membrane vesicles occurs due to differential swelling in a
hypo-osmotic medium. Due to the fixed charge on the inner surface of
the membrane vesicles an assymmetric distribution of permeant ions
occurs as determined by the Gibbs-Donnan equilibrium this in turn
causes an osmotic swelling of the vesicles. The osmotic effect of the
assymmetric distribution of ions is insignificant in a medium of high
osmotic activity (eg. sucrose ) or high ionic strength (eg. CsCl).
However this osmotic effect becomes significant in media of low
osmotic activity such as high molecular weight dextran. In this case
* HEPES was used in this work.
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the vesicles will swell until ionic-osmotic equilibrium is reached
which markedly reduces their buoyant density. The magnitude of this
effect can be manipulated by changing the ionic strength of the
medium and titration of the fixed charges on the membrane by changing
the pH of the medium. The separation of the microsomal and plasma
membranes in this investigation was achieved due to the greater
negative charge of the plasma membrane pulling in more ions and
swelling the vesicles to a point where their buoyant density was less
than the dextran and much less than the microsomal vesicles.
The 04-glucosidase activity found in the microsomal fraction after
dextran centrifugation may have been due to fragments of plasma
membrane which did not form vesicles. The effect of changing the
concentration of the permeant ions on the separation of plasma
membranes and microsomal membranes on a dextran plaque is shown in
the Section 3.7.3. The effect of pH and ionic composition on the
relative buoyant densities of endoplasmic reticulum and plasma
membrane is demonstrated in a series of experiments conducted by
Avruch & Wallach (1971) in which the degree of separation of the two
fractions was measured over a broad pH range and at different ionic
strengths giving varying degrees of purification and different yields
of the two fractions.
4.3.1 Cellular Distribution of Purine Nucleoside and Base
Metabolising Enzymes.
While conducting preliminary cell fractionation experiments the
cellular distribution of the purine metabolising enzymes adenosine
hydrolase, APRT and HxPRT was determined. The results presented in
Section 3.7.5 indicate that adenosine hydrolase is probably membrane
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bound and that APRT and HxPRT are soluble cytoplasmic enzymes.
However it has been proposed that the HxPRT of T.cruzi is associated
with the glycosome (Gutteridge & Davies,1982). The enzyme APRT
appears to be a soluble cytoplasmic enzyme in a variety of
trypanosomal species (Hammond & Gutteridge,198A).
The observation that adenosine hydrolase appears to be membrane
bound may be significant in consideration of the mechanism of
adenosine transport since hydrolysis of adenosine to adenine is the
first step in its metabolism to nucleotide. It is possible to
envision a system where adenosine is hydrolysed to adenine and the
adenine transported instead of adenosine, with the ribose being taken
up by another transport system. However this is unlikely since
transport of adenosine can be inhibited by IDA without inhibition of
adenosine hydrolase activity.
A.3.2 Identification of Plasma Membrane Proteins.
As described in Section 3.7.6 cell surface proteins were
labelled with ^ ^1 and FITC and subjected to analysis by SDS PAGE
from which the apparent molecular weights of the labelled proteins
were estimated. The molecular weights of the proteins labelled by
these methods are summarised in Table 3.16 . These results show that
125
many proteins appear to be labelled by both I and FITC. The
reasons for the differences between the labelling patterns obtained
with the two labels is unknown although the differences could be due
to differing availability or accessibility of the required chemical
groups for reaction with the labels, which would be tyrosine residues
125
in the case of the I label and primary amino groups for FITC.
These results will be discussed further in conjunction with the
results of experiments in which the adenosine transport protein was
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affinity labelled.
4.4 AFFINITY LABELLING OF THE ADENOSINE TRANSPORTER.
The adenosine transport protein was covalently labelled with
3
[2,8- H] 2',3'-dialdehydeadenosine in whole cells and in the plasma
membrane enriched fraction as described in Sections 3.8.3 & 3.8.4.
Before attempting to affinity label the transporter with dialdehyde
adenosine it was shown that the dialdehyde adenosine was capable of
irreversible inhibition of adenosine transport (Results Section
3.8.2) .
Table 3.16 summarises the results of all surface labelling and
affinity labelling experiments carried out. This includes labelling
125
of the cell surface with I and FITC (Sections 3.7.4 & 3.7.6); also
affinity labelling of the adenosine transporter with dialdehyde
adenosine in whole cells and purified plasma membrane (Sections 3.8.3
& 3.8.4). It should be borne in mind that the molecular wieghts for
the labelled proteins quoted in Table 3.16 are apparent molecular
weights since some of these proteins will probably be glycosylated
and will therefore not bind SDS in the normal ratio of 1.4g/g. This
results in a slower migration through the gel which gives an over
estimate of the proteins' molecular weight. Estimating the molecular
weights of proteins from their mobilities on a gel using a standard
curve constructed from the molecular weights and relative mobilities
of known proteins involves measurement errors which result in a
cumulative error of +_5% in all molecular weight estimates. Bearing
this in mind the results presented in Table 3.16 show that the
adenosine transporter is likely to be a 57 or 52 KDa polypeptide
since proteins of this molecular weight are labelled by dialdehyde
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adenosine in whole cells and in purified plasma membranes. Additional
evidence that they are plasma membrane proteins is provided by the
125
fact that they are also labelled by I and FITC in whole cells. The
many other bands labelled by dialdehyde adenosine in whole cells are
probably intracellular proteins although some are also labelled by
the cell surface labels. The fact that they do not appear to be
labelled in the plasma membrane may indicate that they are only
loosely associated with the plasma membrane and are lost during the
purification of the plasma membranes. If this is the case it is very
unlikely that they are involved in transport since a transporter
would be an integral membrane protein and not easily removed from the
membrane without the use of a detergent. The proteins of molecular
weights quoted as 63, 66, 64 and 69 KDa labelled by all the labelling
methods and in all fractions is probably the trypanosomes surface
glycoprotein coat protein since it is labelled by the cell surface
labels and runs on the SDS gels as a broad diffuse band, which is a
characteristic of glycoproteins. Alternatively these may be separate
proteins since the glycoprotein coat band on SDS gels masks other
bands beneath.
Having identified the polypeptides most likely to be
constituents of the adenosine transporter further analysis of the
mechanism of action of the transport system could be undertaken by
purifing these proteins and attempting to reconstitute the transport
system in liposomes. This would allow investigation into the
mechanism of energy coupling to active transport without the problems
associated with using metabolic inhibitors on the whole cell system,
such as maintaining membrane integrity in metabolicaly poisoned
cells. However these investigations must be left until some later
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date.
The estimated molecular weights (52 and 57KDa) of the proteins
likely to be the transport proteins compare with estimates of 45-65
KDa for the nucleoside transporter of the erythrocyte estimated by
14
affinity labelling with C-NBTI followed by analysis by SDS PAGE
(Young et al.,1983; Young & Jarvis,1983). Estimates have also been
made of the molecular weight of the erythrocyte nucleoside transport
protein in its native state in the membrane by radiation inactivation
analysis (Jarvis et_ al.,1980) which indicated that the transportermay
exist as a dimer with a molecular weight of 120KDa. No comparable
information is available for the nucleoside transporters of other
cell types.
4.5 REGULATION OF PURINE NUCLEOSIDE AND BASE TRANSPORT.
The time courses of adenosine and hypoxanthine uptake show that
uptake ceases after two minutes. This is not due to metabolism of the
purines being switched off since metabolism of the labelled purines
taken up continues for up to 10 minutes (Results Sections 3.2.4 &
3.3.4). The results presented in Sections 3.6.1 to 3.6.8 indicate
that adenosine and hypoxanthine are probably taken up by an active
transport process which is independent of the metabolism of the
transported substrates. This suggests that regulation of transport
must occur at the level of the transport process itself.
Transport could be regulated by simple feed-back inhibition of
transport when the transported substrates reach a certain
intracellular concentration. This is unlikely since nucleoside and
base concentrations within the cell fall very rapidly after uptake
stops but transport does not restart. An alternative feed-back to the
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transport system could be mediated by the levels of intracellular
nucleotide. The effects of nucleotide concentrations on the
activities of the purine metabolising enzymes should not affect
transport since this is an active process independent of the
metabolism of the transported substrates. Transport may also be
regulated by phosphorylation of the transport protein as has been
shown for glucose transport in the erythrocyte (Witters et al.,1985).
These authors have shown that a protein kinase C stimulated by
phorbol esters phosphorylates the glucose transporter both in vivo
and in vitro. This correlates with the observation that phorbol
esters stimulate glucose uptake in the erythrocyte. It does not seem
unreasonable to assume that in other systems phosphorylation of a
transport protein may be inhibitory.
Where possible these mechanisms of regulation were investigated.
The regulation of transport by high intracellular nucleotide levels
was not investigated since there is no way to control the
intracellular concentrations of nucleotides in a live cell. Although
as stated above it is unlikely that regulation of purine metabolism
would have any effect on transport the effects of nucleosides and
nucleotides on the activities of these enzymes was investigated.
The results of investigations into the regulation of the purine
metabolising enzymes adenosine hydrolase, APRT and HxPRT are shown in
Section 3.9.1. Adenosine hydrolase activity does not appear to be
affected by any of the mononucleotides added or mononucleotides with
ATP added but does show some slight inhibition in the presence of 1mM
hypoxanthine. This inhibition has no immediate significance with
respect to regulation of transport. The incubations in which ATP was
included with the mononucleotide were carried out in case regulation
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of any of the enzymes was mediated by a protein kinase stimulated by
mononucleotide since nucleoside dependent protein kinases have been
reported to be present in T.gambiense (Walter,1976 & 1978)
The APRT activity appears to be sensitive to product inhibition
by AMP but this observed inhibition could be due to dilution of the
labelled adenine substrate by adenine derived from the added AMP via
phosphatase activity and adenosine hydrolase. The inhibition of APRT
activity by adenosine is almost certainly due to this effect.
The activity of HxPRT does not appear to be sensitive to product
inhibition at a concentration of 1mM IMP but does appear to be
inhibited by 1mM ATP. The results presented above have little
significance with regards to transport regulation but may be
significant with respect to control of metabolism of purine
nucleosides and bases.
The possible regulation of transport by phosphorylation of the
transport protein was investigated as detailed in Section 3.9.2.
The results of these experiments are shown in Figures 3.59a, 3.59b
and 3.60. Figure 3.59a shows the gel of the crude membrane
preparation stained for protein. The incubation which contained IMP
shows a different banding pattern to the other incubations since the
bands marked with arrows in the control track are absent. This effect
was found to be independent of the presence of sodium ortho-vanadate
in the incubation and does not correlate with any changes in
phosphorylation. The significance of this result is unknown and
requires further investigation. AMP was found to be a general
inhibitor of the protein kinases present as was adenosine, but the
AMP stimulated phosphorylation of one band at an apparent molecular
weight of 51KDa. This ,considering the errors involved in the
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estimations of molecular weight, is the same molecular weight
estimated for one of the proteins affinity labelled by dialdehyde
adenosine in the plasma membrane enriched fraction at 52KDa. This
specific phosphorylation is inhibited by the presence of sodium
ortho-vanadate in the incubation which may indicate that the protein
kinase involved is inhibited by vanadate ions. Adenosine appears to
be a good inhibitor of all protein kinase activity which is in
disagreement with the results of Walter (1965 & 1978) who found
protein kinases in trypanosomes to be stimulated by nucleosides and
inhibited by nucleotides. Figure 3.60 shows the autoradiograph of
phosphorylated proteins in a whole cell lysate. The results are much
the same as for the crude membrane fraction with the exception that
sodium ortho-vanadate has a more marked effect on the overall
phosphorylation. This probably reflects the presence of vanadate
sensitive ATPases in the lysate which were not associated with the
membranes. The AMP again reduces the amount of phosphorylation
observed but this time the 51 KDa band is phosphorylated in all
incubations except those containing vanadate ion. This may indicate
that the protein kinase responsible for this phosphorylation is a
soluble cytoplasmic protein which was mostly removed from the crude
membrane preparation. The 51 KDa band is also much fainter in the
whole cell lysate providing more evidence that it is membrane
associated since semi-purifyingthe cell membranes intensifies the
band. It is interesting to note that Walter & Opperdoes (1982) have
determined the subcellular distribution of protein kinases in
T.brucei and found a soluble cytoplasmic nucleoside stimulated




In summary the work presented in this thesis will be considered
in three parts, the transport of the compounds studied, their
subsequent metabolism and finally the identification of the transport
system.
The results presented show that T.brucei (TREU 55) is capable of
absorbing vitamin B, from the environment. The results obtained
b
indicate that this process is mediated by simple diffusion followed
by metabolic trapping the details of which are given below. That
vitamin is taken up by simple diffusion is indicated by the
non-saturability of uptake (Sections 3.1.3 & 3.1.7) and the low
activation energy estimated for uptake (Section 3.1.9).
In contrast to this simple mechanism for the uptake of vitamin
Bg the trypanosome has active transport systems for the uptake of
adenosine, adenine and hypoxanthine. The transport of adenosine,
adenine and hypoxanthine were shown to be active processes by the
ability of the trypanosomes to accumulate unmetabolised adenosine and
hypoxanthine against their concentration gradients (Section 3.6.1)
and the sensitivity of uptake to ionophores capable of destroying the
membrane potential (Sections 3.6.2 to 3.6.4). Also evidence was
obtained implicating the movement of protons in the transport process
(Section 3.6.6). The existance of at least two and possibly three
separate transporters is indicated by the sensitivities of the uptake
of adenosine, adenine and hypoxanthine to inhibition by nucleoside
analogues (see Section 3.5.5 for summary) which have no significant
effect on the intracellular metabolism of the purines (Section
3.5.4).
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The metabolism of the transported compounds studied is
summarised below. The metabolism of vitamin by the trypanosomes
results in the production of the enzymic co-factor
pyridoxal-5-phosphate.The trypanosome does not appear to
phosphorylate pyridoxal to pyridoxal phosphate at a significant rate
but rapidly converts pyridoxine to pyridoxal. The production of
pyridoxal phosphate from pyridoxine appears to take place by the same
route as in mammalian systems.
The metabolism of adenosine, adenine and hypoxanthine to
nucleotide by the trypanosomes was found to be carried out by
phosphoribosyltransferases in the case of adenine and hyoxanthine
with adenosine first being hydrolysed to adenine before being
phosphorylated (Sections 3.4.1 & 3.4.7). The distribution of labelled
purines through the nucleotide pool (Sections 3.2.6 & 3.3.5)
indicated that little interconversion of nucleotides takes place but
the incorporation of labelled adenosine into ATP was very rapid as
indicated by the observation that most of the label taken up appeared
as ATP at the earliest time points obtainable by the experimental
technique used. The metabolism of hypoxanthine to ITP was found to be
much slower since most of the label taken up appeared as IMP with
only small amounts of ITP being formed by the end of the experiment.
The identification of the adenosine transport protein was
attempted by affinity labelling with dialdehyde adenosine in whole
cells and semipurified plasma membranes (Sections 3.8.3 & 3.8.4). The
results obtained from these experiments and labelling cell surface
proteins (Sections 3.7.6) allowed the adenosine transport protein to
be tentatively identified as either a 57 or 51 KDa protein or it may
be that both these proteins are part of the transport system (Section
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3.8.5).
The observed control of adenosine uptake by the trypanosomes may
be mediated by phosphorylation of the 51 KDa protein as indicated by
the results presented in Sections 3.9 to 3.9.3.
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